
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Endothelial transdifferentiation of glioma stem cells: a literature review - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A5778AF2305305A5770050027C77.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="actaneurocomm">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372203/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Acta Neuropathologica Communications">
<meta name="citation_title" content="Endothelial transdifferentiation of glioma stem cells: a literature review">
<meta name="citation_author" content="Andrei Buruiana">
<meta name="citation_author_institution" content="Department of Morphological Sciences—Histology, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania">
<meta name="citation_author_institution" content="Department of Medical Oncology, Prof. Dr. I. Chiricuta Oncology Institute, 400015 Cluj-Napoca, Romania">
<meta name="citation_author" content="Stefan Ioan Florian">
<meta name="citation_author_institution" content="Department of Neurosurgery, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania">
<meta name="citation_author_institution" content="Department of Neurosurgery, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania">
<meta name="citation_author" content="Alexandru Ioan Florian">
<meta name="citation_author_institution" content="Department of Neurosurgery, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania">
<meta name="citation_author_institution" content="Department of Neurosurgery, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania">
<meta name="citation_author" content="Olga Soritau">
<meta name="citation_author_institution" content="Research Department, Prof. Dr. I. Chiricuta Oncology Institute, 400015 Cluj-Napoca, Romania">
<meta name="citation_author" content="Sergiu Susman">
<meta name="citation_author_institution" content="Department of Morphological Sciences—Histology, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania">
<meta name="citation_author_institution" content="Department of Pathology, IMOGEN Research Center, Louis Pasteur Street, 400349 Cluj-Napoca, Romania">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="13">
<meta name="citation_firstpage" content="181">
<meta name="citation_doi" content="10.1186/s40478-025-02031-x">
<meta name="citation_pmid" content="40841988">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372203/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372203/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372203/pdf/40478_2025_Article_2031.pdf">
<meta name="description" content="Endothelial transdifferentiation represents a multifaceted process wherein glioma stem cells (GSCs) gradually adopt endothelial characteristics, marked by the expression of endothelial markers (CD31, CD34) and functional traits, while concurrently ...">
<meta name="og:title" content="Endothelial transdifferentiation of glioma stem cells: a literature review">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Endothelial transdifferentiation represents a multifaceted process wherein glioma stem cells (GSCs) gradually adopt endothelial characteristics, marked by the expression of endothelial markers (CD31, CD34) and functional traits, while concurrently ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372203/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372203">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s40478-025-02031-x"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/40478_2025_Article_2031.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372203%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372203/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372203/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372203/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-actaneurocomm.png" alt="Acta Neuropathologica Communications logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Acta Neuropathologica Communications" title="Link to Acta Neuropathologica Communications" shape="default" href="https://actaneurocomms.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Acta Neuropathol Commun</button></div>. 2025 Aug 21;13:181. doi: <a href="https://doi.org/10.1186/s40478-025-02031-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s40478-025-02031-x</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Acta%20Neuropathol%20Commun%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Acta%20Neuropathol%20Commun%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Acta%20Neuropathol%20Commun%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Acta%20Neuropathol%20Commun%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Endothelial transdifferentiation of glioma stem cells: a literature review</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Buruiana%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Andrei Buruiana</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Andrei Buruiana</span></h3>
<div class="p">
<sup>1</sup>Department of Morphological Sciences—Histology, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania </div>
<div class="p">
<sup>2</sup>Department of Medical Oncology, Prof. Dr. I. Chiricuta Oncology Institute, 400015 Cluj-Napoca, Romania </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Buruiana%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andrei Buruiana</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Florian%20SI%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Stefan Ioan Florian</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Stefan Ioan Florian</span></h3>
<div class="p">
<sup>3</sup>Department of Neurosurgery, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania </div>
<div class="p">
<sup>4</sup>Department of Neurosurgery, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Florian%20SI%22%5BAuthor%5D" class="usa-link"><span class="name western">Stefan Ioan Florian</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Florian%20AI%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Alexandru Ioan Florian</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Alexandru Ioan Florian</span></h3>
<div class="p">
<sup>3</sup>Department of Neurosurgery, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania </div>
<div class="p">
<sup>4</sup>Department of Neurosurgery, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Florian%20AI%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexandru Ioan Florian</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soritau%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Olga Soritau</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Olga Soritau</span></h3>
<div class="p">
<sup>5</sup>Research Department, Prof. Dr. I. Chiricuta Oncology Institute, 400015 Cluj-Napoca, Romania </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soritau%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Olga Soritau</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Susman%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Sergiu Susman</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Sergiu Susman</span></h3>
<div class="p">
<sup>1</sup>Department of Morphological Sciences—Histology, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania </div>
<div class="p">
<sup>6</sup>Department of Pathology, IMOGEN Research Center, Louis Pasteur Street, 400349 Cluj-Napoca, Romania </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Susman%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sergiu Susman</span></a>
</div>
</div>
<sup>1,</sup><sup>6,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Morphological Sciences—Histology, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania </div>
<div id="Aff2">
<sup>2</sup>Department of Medical Oncology, Prof. Dr. I. Chiricuta Oncology Institute, 400015 Cluj-Napoca, Romania </div>
<div id="Aff3">
<sup>3</sup>Department of Neurosurgery, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania </div>
<div id="Aff4">
<sup>4</sup>Department of Neurosurgery, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania </div>
<div id="Aff5">
<sup>5</sup>Research Department, Prof. Dr. I. Chiricuta Oncology Institute, 400015 Cluj-Napoca, Romania </div>
<div id="Aff6">
<sup>6</sup>Department of Pathology, IMOGEN Research Center, Louis Pasteur Street, 400349 Cluj-Napoca, Romania </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Aug 12; Accepted 2025 May 5; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372203  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841988/" class="usa-link">40841988</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Endothelial transdifferentiation represents a multifaceted process wherein glioma stem cells (GSCs) gradually adopt endothelial characteristics, marked by the expression of endothelial markers (CD31, CD34) and functional traits, while concurrently relinquishing their stem-like properties. This phenomenon is heterogenous in glioblastoma (GBM) samples, but holds importance in terms of prognosis. Typically occurring within hypoxic environments, particularly in perinecrotic regions, endothelial transdifferentiation is influenced by the secretome of neighboring cells, which orchestrates the activation of various signaling pathways including Notch during endothelial lineage commitment, PI3K/AKT, Wnt/β-catenin and epithelial-mesenchymal transition (EMT) during both commitment and maturation. Initially, GSCs organize into vascular-like channels resembling vasculogenic mimicry and express CD144; however, this signature diminishes as endothelial maturation progresses. GSC-derived endothelial cells (ECs) eventually integrate with normal ECs from the tumor periphery, yielding a mosaic pattern. Endothelial transdifferentiation plays a role in response to standard treatments such as temozolomide chemotherapy and radiotherapy.</p>
<section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Glioma stem cells, Transdifferentiation, Vasculogenic mimicry, Endothelial cells</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par63">Glioblastoma (GBM) is the most frequent primary malignant tumor of the central nervous system. Despite the latest advancements in translational research, GBM still carries a poor prognosis. Surgical resection combined with radiation therapy (RT) offers a median overall survival (mOS) of 12 months, and the addition of temozolomide (TMZ), the standard chemotherapeutic drug, extends mOS to just 14.6 months [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. Therapeutic alternatives such as anti-vascular endothelial growth factor (VEGF) antibodies, alkylating agents (lomustine, carmustine) or tumor treatment fields (strategy that utilizes alternating electric fields to interfere with mitosis) may be used in recurrent GBM, but with modest benefits [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. In this context, the mechanisms that contribute to recurrence and resistance are fundamental to our understanding of GBM biology. Over the last decade, the tumor heterogeneity received extended attention. GBM is an intricate ecosystem in which tumor clones recruit non-tumor cells (astrocytes, oligodendrocytes, microglia, macrophages, endothelial cells etc.) and convert them into a pro-tumor phenotype [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Within this heterogeneous environment, glioma stem cells (GSCs) represent a particular subpopulation that is widely recognized for its pivotal role in resistance and recurrence.</p>
<p id="Par64">Two models have been proposed to explain the origin of glioma stem cells (GSCs). Firstly, GBM cells can dedifferentiate and reprogram to the pluripotent state of GSCs under cellular insults (hypoxia, chemotherapy, radiotherapy) even in the presence of differentiation conditions [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. Secondly, neural stem cells (NSCs) in the subventricular zone (SVZ) acquire driver mutations and transform into GSCs that will eventually migrate and develop into GBM tumors [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. In addition to these, stemness and differentiation are just the extremities of a continuous gradient of cellular states [<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>], where GSCs and non-GSCs are interconvertible states among GBM cells [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p>
<p id="Par65">Similar to NSCs residing in specialized niches in the SVZ, GSCs nest in particular areas and often display a metabolic plasticity in accordance with the conditions imposed by the surrounding microenvironment. For instance, in the perivascular niche, GSCs resemble a proneural phenotype, highly proliferative and dependent on oxidative phosphorylation metabolism, whereas in hypoxic conditions such as the perinecrotic areas, GSCs recapitulate a mesenchymal phenotype with a glycolytic metabolism and a quiescent, but migratory behavior [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>, <a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>]. While some authors define the perivascular niche as the direct contact between GSCs and endothelial cells (ECs) [<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>], this should exclude larger transport vessels that cannot function as exchange vessels and consequently create the same hypoxic conditions as in the perinecrotic niche [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. All in all, even these states are interchangeable without genetic mutations, but rather epigenetic, transcriptional and post-transcriptional reprograming under external influences [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>, <a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>].</p>
<p id="Par66">Hence, defining GSCs proves a challenging assignment. The mandatory features of GSCs include self-renewal, persistent proliferation and tumor initiation upon transplantation. However, GSCs can also exhibit differences in multipotency, frequency within the tumor and stemness-associated markers (Table <a href="#Tab1" class="usa-link">1</a>) [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. The aforementioned represent a molecular repertoire that altogether orchestrates the differentiation-stemness switch and the interactions within the microenvironment. CD133 (Prominin-1) is a well-known stemness marker crucial for neurodevelopment. It activates the Wnt/β-catenin signaling pathway, promoting proliferation and differentiation towards the neural lineage [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. In GBM, CD133 is linked not only to the Wnt/β-catenin pathway but also to the Notch, Sonic Hedgehog (SHH), c-Jun N-terminal kinase (JNK), and phosphatidylinositol 3-kinase (PI3K)/AKT pathways [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Nonetheless, CD133- GSCs were also described as a distinct subpopulation [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Other markers include intermediate filament proteins such as nestin, vimentin, and glial fibrillary acidic protein (GFAP) [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Nestin is a cytoskeletal protein expressed not only in neuroepithelial stem cells, but also in various non-neural stem and progenitor cells, including endothelial progenitor cells (EPCs); however, although it is an unreliable marker for distinguishing between stem cells, nestin is not expressed in mature ECs [<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>]. Vimentin is the primary intermediate filament in oligodendrocyte precursor cells (OPCs) and immature astrocytes. In mature astrocytes, vimentin is replaced by GFAP as the main cytoskeletal protein, though it can be re-expressed in reactive astrocytes. Another frequently used stemness marker is SRY (sex determining region Y)-box 2 (SOX2), a key transcription factor that contributes to the neuroepithelial fate of stem cells and to the epithelial-mesenchymal transition (EMT) in cancers [<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]. Both SOX2 and octamer transcription factor 4 (OCT4) are essential for tumorigenicity and TMZ resistance [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. Additionally, ATP-binding cassette sub-family G member 2 (ABCG2) is highly expressed in GSCs, while normal astrocytes lack its expression [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. This protein is involved in self-renewal and the acquisition of stemness markers [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>].</p>
<section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Stemness markers</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Marker</th>
<th align="left" colspan="1" rowspan="1">Definition</th>
<th align="left" colspan="1" rowspan="1">Cell populations</th>
<th align="left" colspan="1" rowspan="1">Downstream targets and functions</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">CD133</td>
<td align="left" colspan="1" rowspan="1">Pentaspan transmembrane glycoprotein predominantly localized to lipid rafts within the plasma membrane</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>NSCs</p>
<p>GSCs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>CD133 phosphorylation → PI3K/AKT activation → GSK-3/β-catenin → self-renewal, proliferation, survival;</p>
<p>Src phosphorylation → EMT → migration;</p>
<p>Stem-cell-adjacent cell interactions;</p>
<p>Regulation of microvilli structure and dynamics;</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>] [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>] [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nestin</td>
<td align="left" colspan="1" rowspan="1">Class VI intermediate filament protein involved in cytoskeletal organization</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>NSCs</p>
<p>GSCs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Stabilization of βII-tubulin → G2/M progression → proliferation, survival;</p>
<p>Regulation of actin polymerization, looser interaction with the ECM → migration;</p>
<p>PI3K/AKT activation → self-renewal, proliferation, survival;</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>] [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]</p>
<p>[<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Vimentin</td>
<td align="left" colspan="1" rowspan="1">Class III intermediate filament protein involved in cytoskeletal organization</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>NSCs</p>
<p>GSCs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Cell-ECM adhesions: interaction with integrins → Ccd42 activation → cytoskeletal reorganization → motility;</p>
<p>Vimentin phosphorylation → Jagged1 interaction → Notch activation → vascular wall remodeling;</p>
<p>Regulation of TGF-β1/Slug/EMT signaling → ECM remodeling;</p>
<p>MT1-MMP translocation to plasma membrane → ECM remodeling;</p>
<p>ERK phosphorylation → proliferation;</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GFAP</td>
<td align="left" colspan="1" rowspan="1">Class III intermediate filament protein</td>
<td align="left" colspan="1" rowspan="1">
<p>NSCs</p>
<p>GSCs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Focal adhesion, cell: ECM interaction;</p>
<p>Proliferation;</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SOX2</td>
<td align="left" colspan="1" rowspan="1">High-mobility group transcription factor involved in embryonic development and cell fate determination</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>NSCs</p>
<p>GSCs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Transcriptional activator and repressor → pluripotency;</p>
<p>Wnt/β-catenin activation → self-renewal, proliferation, survival;</p>
<p>Notch regulation → self-renewal;</p>
<p>PI3K/AKT/mTOR activation → self-renewal, proliferation, survival;</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]</p>
<p>[<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]</p>
<p>[<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OCT4</td>
<td align="left" colspan="1" rowspan="1">Homeodomain transcription factor of the Pit-Oct-Unc family</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>NSCs</p>
<p>GSCs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Maintenance of stemness;</p>
<p>Control of pluripotency;</p>
<p>Self-renewal, proliferation;</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>, <a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>, <a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ABCG2</td>
<td align="left" colspan="1" rowspan="1">ATP-binding cassette (ABC) transporter</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>NSCs</p>
<p>GSCs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Maintenance of undifferentiated state;</p>
<p>Efflux pump involved in cellular protection for toxic substances, multidrug resistance;</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p61"><p><em>ABCG2</em> ATP-binding cassette subfamily G member 2, <em>Cdc42</em> cell division control protein 42 homolog, <em>ECM</em> extracellular matrix, <em>EMT</em> epithelial-to-mesenchymal transition, <em>EPCs</em> endothelial progenitor cells, <em>ERK</em> extracellular signal-regulated kinase, <em>GFAP</em> glial fibrillary acidic protein, <em>GSCs</em> glioblastoma stem cells, <em>GSK-3</em> glycogen synthase kinase 3, <em>HSPCs</em> hematopoietic stem and progenitor cells, <em>MT1-MMP</em> membrane type 1 matrix metalloproteinase, <em>mTOR</em> mammalian target of rapamycin, <em>NSCs</em> neural stem cells, <em>OCT4</em> octamer-binding transcription factor 4, <em>PI3K</em> phosphoinositide 3-kinase, <em>SOX2</em> SRY-box transcription factor 2, <em>TGF-β</em> transforming growth factor beta, <em>VEGFR2</em> vascular endothelial growth factor receptor 2</p></div></div></section><p id="Par67">Many of these markers are also critical for NSCs, reinforcing the hypothesis that GSCs originate in the SVZ. Differentiating between GSCs, NSCs, OPCs, and EPCs proves to be laborious due to the major overlap between the stemness markers in these populations. For example, GSCs and NSCs/OPCs cannot be distinguished based solely on stemness marker expression, as they share similar markers. Their differences are functional, driven by genetic alterations. Compared to NSCs, GSCs sustain proliferative signals (EGFR and PDGFRα overexpression), resist growth suppression (<em>TP53</em> mutations), evade apoptosis (<em>PTEN</em> mutations), and exhibit limitless replicative potential (<em>TERT</em> promoter mutations) [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>].</p>
<p id="Par68">Stemness markers and their localization within specific niches (perinecrotic, perivascular) are commonly employed for recognition of GSCs in vivo, although their identification should be further validated by the presence of genetic abnormalities characteristic of GBM cells. Isolation of GSCs by flow cytometry based on surface markers does not ensure the purity of the GSC population and may overlook GSCs with tumorigenic potential that do not express the putative markers [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>]. These surface markers mediate interactions within the TME, and once dissociated from the tumor microenvironment, GSCs start to lose their informational content [<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>]. After serum treatment, GSCs differentiate towards a neural lineage by up-regulating β-III tubulin (TUJ1), microtubule-associated protein 2 (MAP2) and GFAP, while downregulating CD133 [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. For this reason, GSCs are usually cultured in media enriched in epithelial growth factor (EGF) and basic fibroblast growth factor (bFGF) to inhibit their spontaneous differentiation. However, this can favor the selection of subpopulations with a biased receptor profile, which likely restricts the original tumor’s heterogeneity [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>, <a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>]. Additionally, long-term passaged GSCs are susceptible to genetic drift and selection of proliferative populations, leading to variations in phenotypic marker expression and behavior [<a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>]. It is very difficult to reproduce the complexity of the niche conditions in which bone morphogenetic proteins (BMPs), Wnt, Notch and SHH pathways maintain the behavior of the stem cell pool. Standard in vitro studies of GSCs neglect the interaction with GBM cells, ECs, immune cells, ECM components, and fail to reproduce nutrient and hypoxic gradients [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>]. Thus, in vitro data should not be over-interpreted in terms of phenotypic marker expression and cell behavior.</p>
<p id="Par69">GSCs-derived ECs and host ECs can collaborate to influence the histological features of GBM vasculature. Histologically, GBM is characterized by hypercellularity, nuclear atypia and palisading necrosis [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. The vascular network is composed of disorganized, glomeruloid and tortuous blood vessels, which exhibit high permeability, disruptions in the basement membrane, and abnormal pericyte coverage [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Poor perfusion caused by this abnormal vasculature leads to both hypoxia and reduced drug delivery. While hypoxia drives the development of treatment-resistant phenotypes, suboptimal drug concentrations further limit treatment efficacy [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]. Several mechanisms contribute to GBM vascularization. Firstly, tumor cells can migrate along the blood vessels, surround the blood–brain barrier (BBB) without detaching the pericytes, or perturb the BBB and attach to ECs, thus incorporating the pre-existing vasculature into the tumor [<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>]. In addition to this vessel co-option mechanism, GBM utilizes sprouting angiogenesis, where branches of the pre-existing vasculature grow towards the tumor mass [<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>]. During this process, the loss of pericyte-EC contact destabilizes the basement membrane and prompts ECs to adopt a mesenchymal phenotype [<a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>]. These migratory and proteolytic ECs (‘tip’ cells) navigate the vascular path, while proliferative ECs (‘stalk’ cells) assemble the neovessel. Vasculogenesis is similar to sprouting angiogenesis, but involves blood vessel formation by bone marrow-derived circulating endothelial progenitors (EPCs) [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Another mechanism is vessel intussusception where pre-existing vessels enlarge and bifurcate [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Lastly, vasculogenic mimicry (VM) involves GBM cells rearranging to form functional, vascular-like channels that eventually connect to the existing network.</p>
<p id="Par70">Despite the general view that ECs originate from the mesoderm [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>], NSCs were demonstrated to differentiate towards an endothelial phenotype both in vitro and in vivo [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>]<em>.</em> This important observation led to the investigation of a similar behavior in GSCs, known as endothelial transdifferentiation (endo-transdifferentiation). Since transdifferentiation is usually defined as an irreversible conversion between two differentiated cells [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>], GSCs constitute an intermediary phase between GBM cells and GBM-derived ECs. One of the main stimuli for GBM cell dedifferentiation is hypoxia, which induces CD133, CD15, Nestin, SOX2, Oct4 and Nanog in GBM cells [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>]. Additionally, CD133- GBMs cultured in differentiation media acquire CD133 expression following TMZ treatment [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. Similar to hypoxia, TMZ increases the expression of both HIF-1α and HIF-2α. HIF knockdown inhibits the interconversion between non-stem GBM cells and GSCs [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. Radiotherapy also contributes to dedifferentiation. Patient-derived differentiated GBM cells exposed to subtoxic RT doses (3 Gy) upregulate stemness markers (CD133, Nanog, Olig2, SHH, EZH2) via survivin, an anti-apoptotic protein. Notably, this effect was observed only in cells cultured in stem cell medium, but not in differentiation medium, arguing that RT alone is insufficient for dedifferentiation [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. GSCs are localized within specialized niches, such as the perinecrotic and perivascular niches. In the perinecrotic area, hypoxia promotes generation of proangiogenic factors, promoting GSC involvement in neovessel formation. In the perivascular niche, both hypoxia and direct interactions with ECs may enhance GSC recruitment into the vasculature. Although endothelial transdifferentiation and VM are distinct processes, they share some similar pathogenetic mechanisms, leading to occasional misuse of the terms. As recently illustrated by Maddison et al., endothelial transdifferentiation should be demonstrated by the presence of endothelial markers (CD31, CD34) [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>].</p>
<p id="Par71">In general, ECs can be identified based on their cobblestone morphology in monolayer cultures and the presence of several endothelial markers (Table <a href="#Tab2" class="usa-link">2</a>) including von Willebrand factor (vWF), endothelial nitric oxide synthase (eNOS) or CD31 (PECAM-1) [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. CD34 is also found on the surface of mature ECs as well as on EPCs and hematopoietic cells [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Another commonly used marker for ECs is CD144 (CDH5/VE-cadherin), which is located at intercellular junctions and regulates vascular permeability, proliferation, and modulation of the VEGFR2 functions [<a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>]. While VEGFR2 (KDR/Flk-1) and Tie receptors (Tie1, Tie2) are critical for the endothelial homeostasis, they are not EC-specific, being also expressed by GBM cells [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>] and pericytes [<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>]. Endoglin (CD105), a receptor of the transforming growth factor beta (TGF-β) family, is expressed by proliferating, active ECs that form disorganized vessels, as seen in GBM [<a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>]. Complementary to these surface markers, ECs display notable functions such as tube formation or uptake of acetylated-low density lipoprotein (acLDL).</p>
<section class="tw xbox font-sm" id="Tab2"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Molecular markers of the endothelial lineage</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Marker</th>
<th align="left" colspan="1" rowspan="1">Cells</th>
<th align="left" colspan="1" rowspan="1">Location</th>
<th align="left" colspan="1" rowspan="1">Function and known downstream pathways</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">CD34</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>Mature ECs (microvascular)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Resting ECs: apical</p>
<p>Activated ECs: EC-EC junction, filopodia</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Proliferation and blocking of differentiation in HSPCs</p>
<p>Adhesion of HSPCs to BM endothelium via E/P-selectin</p>
<p>Maintaining quiescence in mature ECs</p>
<p>Adhesion of naïve lymphocytes to mature ECs via L-selectin</p>
<p>Resting ECs: apical localization → prevents opposing ECs adhesion</p>
<p>Activated ECs: EC-EC junctions → permeability</p>
<p>Cytoskeletal remodeling (filopodia) → migration</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>, <a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>] [<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>] [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]</p>
<p>[<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD31</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>Mature ECs</p>
<p>Leukocytes, Platelets</p>
</td>
<td align="left" colspan="1" rowspan="1">EC-EC junction</td>
<td align="left" colspan="1" rowspan="1">
<p>EC-EC junction → barrier function</p>
<p>Homophillic interaction with leukocytes → transmigration</p>
<p>EC-ECM interactions</p>
<p>CD31/SHP-2 complex dephosphorylates FAK, paxillin → EC migration</p>
<p>CD31/SHP-2 complex dephosphorylates β-catenin → β-catenin signaling; formation of adherens junctional complexes</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>] [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>] [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>] [<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD144</td>
<td align="left" colspan="1" rowspan="1">
<p>EPCs</p>
<p>Mature ECs</p>
</td>
<td align="left" colspan="1" rowspan="1">EC-EC junction</td>
<td align="left" colspan="1" rowspan="1">
<p>EC-EC junction → barrier function</p>
<p>Binds and maintains VEGFR2/FGFR1 dephosphorylated → quiescence, survival</p>
<p>Binds TGF-βR2 → activates ALK5/Smad2/3 → inhibits migration, proliferation</p>
<p>Connects to the actin cytoskeleton via β-catenin</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>] [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>] [<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD105</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs (minor subset)</p>
<p>Mature ECs</p>
</td>
<td align="left" colspan="1" rowspan="1">Cell surface</td>
<td align="left" colspan="1" rowspan="1">Inhibits TGF-β1/Smad3 → proliferation</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>] [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VEGFR2</td>
<td align="left" colspan="1" rowspan="1">
<p>ECs</p>
<p>EPCs</p>
</td>
<td align="left" colspan="1" rowspan="1">Cell surface</td>
<td align="left" colspan="1" rowspan="1">
<p>Very strong mitotic signals</p>
<p>cPKC/RAF/MEK/ERK1/2 → migration/proliferation</p>
<p>SRC/FAK/Paxillin → Permeability</p>
<p>CD144 internalization → Permeability</p>
<p>PI3K/AKT/mTOR → survival, vasodilation (via eNOS)</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>] [<a href="#CR123" class="usa-link" aria-describedby="CR123">123</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VEGFR1</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>Mature ECs</p>
</td>
<td align="left" colspan="1" rowspan="1">Cell surface</td>
<td align="left" colspan="1" rowspan="1">Higher affinity for VEGF, but very weak mitotic signal</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tie2</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>Mature ECs</p>
<p>M2 monocytes</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Resting ECs: EC-EC junction</p>
<p>Migrating EC: EC-ECM</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Ang1 interaction → AKT activation → survival, quiescence, barrier integrity</p>
<p>Inflamed endothelium: Ang2 is antagonist for Tie2 → actin stress fibers → destabilize endothelial monolayers</p>
<p>Non-inflamed endothelium: Ang2 is weak agonist for Tie2</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tie1</td>
<td align="left" colspan="1" rowspan="1">
<p>HSPCs</p>
<p>EPCs</p>
<p>Mature ECs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Resting ECs: EC-EC junction</p>
<p>Migrating EC: EC-ECM</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Orphan receptor (lacks a known ligand)</p>
<p>Co-receptor for Tie2: required for full activation of Tie2 by Ang proteins</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>] [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">vWF</td>
<td align="left" colspan="1" rowspan="1">
<p>EPCs</p>
<p>Mature ECs</p>
<p>Megakaryocytes</p>
</td>
<td align="left" colspan="1" rowspan="1">Weibel-Palade bodies</td>
<td align="left" colspan="1" rowspan="1">Binds fVIII, GP Ib, GP IIb/IIIa, heparin, collagen → hemostasis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p129"><p><em>ALK5</em> activin receptor-like kinase 5, <em>Ang</em> angiopoietin, <em>BM</em> bone marrow, <em>cPKC</em> conventional protein kinase C, <em>EC</em> endothelial cell, <em>ECM</em> extracellular matrix, <em>EPC</em> endothelial progenitor cell, <em>ERK1/2</em> extracellular signal-regulated kinase 1/2 <em>FAK</em>, focal adhesion kinase, <em>fVIII</em>, coagulation factor VIII, <em>FGFR1</em> fibroblast growth factor receptor 1, <em>GP</em> glycoprotein, <em>HSPC</em> hematopoietic stem and progenitor cell, <em>MEK</em> mitogen-activated protein kinase kinase, <em>mTOR</em>, mammalian target of rapamycin, <em>PI3K</em> phosphoinositide 3-kinase, <em>RAF</em>, rapidly accelerated fibrosarcoma kinase, <em>SHP-2</em> Src homology region 2-containing protein tyrosine phosphatase-2, <em>TGF-β1</em> transforming growth factor beta 1, <em>TGF-βR2</em> transforming growth factor beta receptor 2, <em>Tie1</em> tyrosine kinase with immunoglobulin-like and EGF-like domains 1, Tie2 <em>TEK</em> receptor tyrosine kinase, <em>VEGFR</em> vascular endothelial growth factor receptor, <em>vWF</em> von Willebrand factor</p></div></div></section><p id="Par72">The concomitant presence of stemness and endothelial antigens (Table <a href="#Tab3" class="usa-link">3</a>) is suggestive of transdifferentiation, but can be misleading due to the co-expression of CD133, CD34 and VEGFR2 in EPCs [<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>]. Typically, early EPCs in the bone marrow or shortly after entering the circulation are CD133 + /CD34 + /VEGFR2 + , while circulating EPCs are CD34 + /CD31 + /CD144 + /VEGFR2 + , start expressing vWF and may lose CD133 [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. In the mouse lung, a population of resident EPCs identified as CD45-/CD31 + /VEGFR2- was able to differentiate to CD45-/CD31 + /VEGFR2 + cells and then to ECs, suggesting that VEGFR‐2 marks a later stage of endothelial progenitor development [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>]. During neovessel formation in adults, Patel et al. identified a subpopulation of EPCs as quiescent CD31-low/VEGFR2-/CD105- cells and definitive differentiated ECs as CD31 + /VEGFR2 + /CD105 + cells [<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>]. Regarding the expression of other stemness markers, vimentin plays a crucial role in EPCs, as its knockout in embryonic stem cells (ESCs) impairs spontaneous endothelial differentiation by disrupting the sequential acquisition of key markers. These include the early mesodermal marker Brachy-T, the lateral plate mesodermal marker VEGFR2, and endothelial-specific markers such as Tie2, CD31, and CD144 [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Endothelial nestin expression is observed in undifferentiated EPCs before they exit the cell cycle and is downregulated as EPCs mature into ECs in vitro [<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>]. Isolated circulating mesangioblasts express pluripotency markers Klf4 and c-Myc, low levels of Oct3/4, but lack Sox2; however, lentiviral transduction of Sox2 enhances their ability to differentiate into ECs in vitro [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]<em>.</em> During in vitro endothelial differentiation of ESCs, the endothelial markers CD31, CD144, and VEGFR2, CD144 appeared to coincide with an increase in SOX2 expression, suggesting that SOX2 may be present in EPCs. Finally, ABCG2 is expressed not only in GSCs and NSCs but also in EPCs and mature ECs participating in the formation of the BBB [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>, <a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>]. However, the presence of glioma-specific genetic aberrations in intratumoral ECs (monosomy 10/heterozygous PTEN deletion, polysomy 7/EGFR amplification) can distinguish GSC-derived ECs from their bone marrow-derived counterparts [<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>].</p>
<section class="tw xbox font-sm" id="Tab3"><h3 class="obj_head">Table 3.</h3>
<div class="caption p"><p>Immunophenotypes corresponding to GSC-derived ECs</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Immunophenotypes</th>
<th align="left" colspan="1" rowspan="1">Cell characteristics</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Nestin + /CD31 + </td>
<td align="left" colspan="1" rowspan="1">
<p>In vitro<em>:</em> Can be generated by exposing Nestin + /CD133 + cells to hypoxia; confers chemoresistance to neighboring GSCs; can revert to GSC by culturing in stem cell medium</p>
<p>Human GBM samples: represent 85% ECs in hypoxic regions; frequently co-expressed with ETV2 + ; high CD31 expression mostly associated with low Nestin expression; low CD31 expression mostly associated with high Nestin expression</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]</p>
<p>[<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nestin + /ABCG2 + </td>
<td align="left" colspan="1" rowspan="1">Human GBM samples: present in tumor vessel wall</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nestin + /CD105 + </td>
<td align="left" colspan="1" rowspan="1">Human GBM samples: CD105 and Nestin localized in different regions of the same ECs in the tumor area; overlapped immunoreactivity in the peritumor area</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD133 + /VEGFR2 + </td>
<td align="left" colspan="1" rowspan="1">
<p>In vitro<em>:</em> co-express EphA2, CD144, laminin5γ2</p>
<p>In vivo<em>:</em> co-implanting with GSCs results in larger and more vascularized tumors; can initiate tumors whose vasculature is mainly derived from tumor cells</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]</p>
<p>[<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD133 + /CD31 + </td>
<td align="left" colspan="1" rowspan="1">Human GBM samples: localize near SOX2-/CD31 + , SOX2-/CD105 + , CD133-/CD31 + ECs, in glomeruloid tufts, microvascular proliferations, invasive front; high CD31 expression mostly associated with low C133 expression; low CD31 expression mostly associated with high CD31 expression; co-express nestin, lipocalin2, selectin, endothelin 1 and 3, VEGF-C, eNOS</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>] [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]</p>
<p>[<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD133 + /CD34 + </td>
<td align="left" colspan="1" rowspan="1">In vitro<em>:</em> cell population increased by TMZ</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD133 + /CD144 + </td>
<td align="left" colspan="1" rowspan="1">In vitro<em>:</em> Can be generated by exposing CD133 + /CD144- cells to the GBM secretome; cultivation in endothelial medium results in downregulation of CD144 and upregulation of CD105, CD31, CD34, VEGFR2; can revert to GSC by culturing in stem cell medium; cell population increased by TMZ</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]</p>
<p>[<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>] [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GFAP + /CD31 + </td>
<td align="left" colspan="1" rowspan="1">
<p>In vitro<em>:</em> display tumorigenic activity; cultivation in endothelial medium results in the loss of tumorigenic activity</p>
<p>Human GBM samples: represent 18% of the total vascularization; co-express vWF, CD144</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]</p>
<p>[<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GFAP + /CD34 + </td>
<td align="left" colspan="1" rowspan="1">
<p>In vitro<em>:</em> can be generated as small population after cultivation of CD133 + GSCs in transdifferentiation medium</p>
<p>Human GBM samples: represent 14% of the total vascularization</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]</p>
<p>[<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SOX2 + /CD31 + </td>
<td align="left" colspan="1" rowspan="1">Human GBM samples: tend to localize near SOX2-/CD31 + , SOX2-/CD105 + , CD133-/CD31 + ECs</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SOX2 + /CD34 + </td>
<td align="left" colspan="1" rowspan="1">In vitro<em>:</em> cell population increased by TMZ</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SOX2 + /CD105 + </td>
<td align="left" colspan="1" rowspan="1">
<p>In vitro<em>:</em> cell population increased by TMZ</p>
<p>Human GBM samples: tend to localize near SOX2-/CD31 + , SOX2-/CD105 + , CD133-/CD31 + ECs</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>[<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]</p>
<p>[<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD105 + </td>
<td align="left" colspan="1" rowspan="1">
<p>In vitro: co-express CD31, VEGFR2, vWF</p>
<p>Human GBM samples: similar genetic aberrations (<em>EGFR</em> amplification, Cep7) as the parent tumors; form glomeruloid-like structures</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ABCG2 + /CD34 + </td>
<td align="left" colspan="1" rowspan="1">Human GBM samples: appeared in tumor vessel wall in clinical GBM specimens</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p158"><p><em>ABCG2</em> ATP-binding cassette sub-family G member 2, <em>CD</em> cluster of differentiation, <em>Cep7</em> chromosome 7 centromere amplification, <em>EC</em> endothelial cell, <em>EGFR</em> epidermal growth factor receptor, <em>eNOS</em> endothelial nitric oxide synthase, <em>EphA2</em> ephrin type-A receptor 2, <em>ETV2</em> ETS variant transcription factor 2, <em>GBM</em> glioblastoma, <em>GFAP</em> glial fibrillary acidic protein, <em>GSC</em> glioblastoma stem cell, <em>Laminin5γ2</em> laminin subunit gamma 2, <em>SOX2</em> SRY-box transcription factor 2, <em>TMZ</em> temozolomide, <em>VEGF-C</em> vascular endothelial growth factor C, <em>VEGFR2</em> vascular endothelial growth factor receptor 2, <em>vWF</em> von Willebrand factor</p></div></div></section><p id="Par73">In this review, we collected data from the literature on the effect of endothelial transdifferentiation in the formation of vascular structures in glioblastoma. We identify the signaling pathways involved in this mechanism and delineate with regards to the phases of endo-transdifferentiation. Additionally, we addressed contradictory findings, highlight gaps in the literature, and suggest possible directions for future research.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Endothelial cells in GBM: tumoral and non-tumoral</h2>
<p id="Par74">The isolation of patient-derived GSCs using a clonogenic assay involves culturing enzymatically dissociated GBM cells in stem cell medium to promote the formation of tumor spheres. These cells are heterogeneous, containing both CD133 + and CD133- populations. While both populations have similar tumorigenic potential, CD133 + GSCs tend to form more vascularized tumors [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Differentiated GBM cells cannot generate ECs in culture media optimized for EC, whereas GSCs (CD133 + /CD31- cells) transdifferentiate into functional GBM-derived ECs capable of tube formation, LDL uptake and eNOS expression [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. Under hypoxic and endothelial conditions, GSCs gain higher expression of endothelial markers [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Once acquiring an endothelial signature, CD34<sup>high</sup> GSCs generate more proliferative, necrotic, undifferentiated tumors compared to CD34<sup>low/−</sup> GSCs. Ultrastructural analysis of these GSC-derived ECs using transmission electron microscopy reveals a flat phenotype with few rough endoplasmic reticula, developed Golgi bodies, numerous lysosomes, mitochondria, glycogenosomes, and pinocytosis vesicles [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>]. Endothelial transdifferentiation appears to be irreversible beyond a certain point, as GBM-derived ECs (CD34 + /CD31 + /CD133-) retain their endothelial markers and functions even when cultivated back in stem cell medium [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. However, Nestin + /CD31 + cells can revert to the GSC state in serum-free culture, suggesting the existence of intermediate states with phenotypic plasticity [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. These seemingly contradictory findings underscore the need for comprehensive studies to fully decipher the molecular signature of these cells.</p>
<p id="Par75">In GBM, necrotic areas arise due to vessel occlusions or the imbalance between highly proliferative GBM cells and the ECs bearing a lower proliferation rate [<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>]. Tumor-derived ECs preferentially form in these hypoxic cores, activating molecular pathways that promote an endothelial fate. In a co-culture system, Zheng et al. demonstrated that GSCs transdifferentiate into Nestin + /CD31 + cells under hypoxia [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. Moreover, GSC-derived ECs influence neighboring GSCs, resulting in larger spheres and more generations compared to GSCs in mono-culture or when co-cultured with normal ECs. In a mouse model, Ding et al. managed to isolate VEGFR2 + /CD133 + cells and VEGFR2 + /CD133- cells and co-implanting VEGFR2 + /CD133 + ECs with GSCs in a tumor-naïve mouse resulted in larger tumors with more developed vascularization [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Therefore, transdifferentiated ECs provide conditions that support the generation of a stem cell pool, which can be further recruited into the vascular network.</p>
<p id="Par76">Normal ECs seem to play context-dependent roles in the endo-transdifferentiation process. Co-cultivation of GBM cells with human brain microvascular ECs (HBMECs) induces downregulation of VEGF receptor 1 (VEGFR1), Notch4, FGF1, FGF2, TGFβR1, and matrix metalloproteinases (MMPs), indicating that normal ECs might inhibit transdifferentiation [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. Conversely, co-cultivation of GBM cells with human umbilical vein ECs (HUVECs) resulted in EC-derived vascular branches that later englobed GBM cells into the vascular network [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>]. In this setting, while ECs expressed both Tie2 and VEGFR2, the recruited U251 cells did not. Notably, inhibition of Tie2 and VEGFR2 prevents the formation of GBM-derived blood channels, suggesting the role of the VEGF pathway in the recruitment of the neighboring tumor cells by ECs. The observed differences in GBM cell and EC behavior across these studies may be attributed to variations in experimental conditions. Smith et al. cultured KNS42 cells in DMEM/F12 and HBMECs in RPMI-1640, whereas Shaifer et al. co-cultured U251 cells with HUVECs in Matrigel with EGM. Smith et al. proposed that a high EC-to-GBM cell ratio inhibited GBM cell recruitment by reducing selection pressure for neovessel formation [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. However, the findings of Shaifer et al., who employed a 4:1 HUVEC-to-U251 ratio, contradicted this hypothesis [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>]<strong>.</strong> A more plausible explanation is the difference in culture media, as RPMI-1640 was originally formulated for non-adherent cells, such as hematopoietic cells, whereas Matrigel with EGM more accurately recapitulates the physiological environment required for EC culture.</p>
<p id="Par77">Carlson et al. found that ECs associated with the tumor are extremely heterogenous, comprising five distinct clusters with particular endothelial markers [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Another research group also identified five distinct clusters with varying tumor tissue localization and functional characteristics. Two clusters were found at the tumor periphery, exhibiting either a quiescent or immune-activated profile, while three clusters were located within the tumor core, displaying proangiogenic, intermediate, or immune-activated phenotypes [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]. Understanding how these individual clusters interact with GBM cells, particularly GSCs, is crucial for comprehending the interplay between ECs and GSCs.</p></section><section id="Sec3"><h2 class="pmc_sec_title">Endothelial state: a continuous maturation gradient</h2>
<p id="Par78">Due to the inter- and intratumor heterogeneity, endothelial transdifferentiation varies in extent among patients. For instance, in <em>EGFR</em>-amplified GBM specimens, El Hallani et al. found that ECs carrying <em>EGFR</em> amplifications were present in only 3 out of 10 GBM samples [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. However, in GBM specimens with mutant <em>TP53</em>, Ricci-Vitiani et al. showed that 20–90% of cells lining the vascular lumen shared the same genetic abnormalities as the tumor cells [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. As a potential explanation for these differences, <em>TP53</em> mutations and <em>EGFR</em> amplifications are generally considered mutually exclusive, with studies reporting a limited co-occurrence of these alterations ranging from 20.7% to 42.8% [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>, <a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. The circumscribing cells described by Ricci-Vitiani et al. were positive for CD31 and variably co-expressed GFAP (10–76%) [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. Mei and colleagues reported that CD34 + /GFAP + and CD31 + /GFAP + cells were absent in more than half of GBM samples, but in 70% of positive co-staining specimens, these cells formed vascular structures and comprised 14–18% of the total vascularization [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. In a CRISPR/Cas9-mediated native GBM model (<em>PTEN</em>, <em>TP53</em>, and <em>NF1</em> deletion), vessel morphometry showed that the host vessels density and branching points are unchanged throughout time [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Instead, CD31 + GBM-derived cells are dynamically involved in the vascularization. Isolating GBM-derived from host-derived ECs showed that the transdifferentiated ECs contribute to less than 1% of the total population. In vitro<em>,</em> patient-derived CD133 + GSCs cultured in transdifferentiation medium predominantly exhibits a CD34 + /GFAP- signature, while the number of CD34 + /GFAP + and CD34-/GFAP + is reduced [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. This indicates that these endothelial/glial hybrids could be GBM-derived ECs retaining glial markers, but the hypothesis of a common precursor for both endothelial and glial lineages cannot be totally excluded. Data from larger GBM cohorts may offer us a broader image of these endothelial/glial phenotypes and more complex in vitro models could elucidate the dynamics of these potential intermediate states over time.</p>
<p id="Par79">Strikingly, when taking stemness into consideration, CD31 co-localizes with CD133 and Nestin, but stemness expression is inversely proportional to the endothelial signature [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. CD144 is expressed in both tumor and vascular cells in most GBM samples, showing scattered and clustered patterns in tumor cells [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. The endothelial signature progressively increases from differentiated GBM cells (CD133 − /CD144 −) to GSCs (CD133 + /CD144 −) to GSC-derived ECs (CD133 + /CD144 +) and finally to CD133 − /CD144 + cells [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. Co-cultivation of GBM cells with CD133 + /CD144- cells results in the switch of the latter mentioned towards CD133 + /CD144 + cells, implicating the GBM secretome in the initiation of lineage commitment [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>].</p>
<p id="Par80">In human GBM specimens, Yao et al. observed Periodic acid-Schiff (PAS) + lumina containing red blood cells and lined by two distinct cell populations: CD34 + cells and Nestin + /CD34- cells [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. A similar pattern of CD34 + and CD34- anastomosis was also noticed by Chen et al. [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Another study investigated the presence of ABCG2 in GBM samples and found its co-localization with CD34 or Nestin in the intimal layer of vessels [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. While ABCG2 + /Nestin + cells lacking CD34 are more likely to be GSCs, ABCG2 + /CD34 + cells cannot be definitively identified as GSC-derived ECs, as this marker signature is also observed in EPCs. All in all, these findings suggests that GSCs group into vascular channels and assemble the basement membrane even before the expression of endothelial markers. Therefore, vasculogenic mimicry could be in fact an intermediary step during transdifferentiation.</p>
<p id="Par81">Additionally, SOX2 + /CD31 + , CD133 + /CD31 + , and SOX2 + /CD105 + ECs tend to localize near SOX2-/CD31 + , SOX2-/CD105 + , and CD133-/CD31 + ECs [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. This phenomenon can be explained by GBM-derived ECs recruiting normal ECs, with evidence supporting both the recruitment of regular ECs into the tumor vasculature and the co-option of GSCs by regular ECs [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>, <a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>]. However, another explanation could be the complete loss of stemness in GSC-derived ECs. While SOX2-/CD31 + and CD133-/CD31 + cells could indeed be normal ECs, SOX2-/CD105 + cells are more likely tumor-derived proliferating ECs. This is supported by the fact that, beside the endothelial morphology and signature (CD31, VEGFR2, vWF), the majority of CD105 + cells display similar genetic aberrations (<em>EGFR</em> amplification, Cep7) as the parent tumors [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. In other tumors, CD105 was demonstrated to be a marker of activated, proliferating ECs, which is why normal brains lack CD105 [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Cultivating CD133 + /CD144 + GSCs in endothelial medium results in the downregulation of CD144 and upregulation of CD105, CD31, CD34, and VEGFR2, suggesting that GSCs transdifferentiate towards an endothelial precursor that later on will become an active, proliferating, mature EC [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>].</p>
<p id="Par82">Within the perinecrotic area, both GBM cells and CD31 + ECs express hypoxia-inducible factor (HIF)-1α, and 85% of ECs in the hypoxic regions are Nestin + /CD31 + [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. In vitro, Zheng et al. revealed that Nestin + GSCs co-localize with Nestin + /CD31 + cells in a hypoxic co-culture system mimicking the perivascular niche [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>] and Smith et al. found that CD105 is expressed at the interface between the hypoxic/necrotic core and the proliferative area [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. Different surface markers are associated with various vascularization behaviors; for example, CD133-/CD144 + cells form capillary-like vascular structures in 3D gel, while primary CD105 + cells form glomeruloid-like structures, reflecting the vascularization patterns observed in GBM samples [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. In a mouse model, Ding et al. observed that CD133 + /CD31 + cells were located in the glomeruloid tufts, microvascular proliferation areas and the invasive front [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>].</p>
<p id="Par83">In rodent models with human GSC-derived tumors, 70% of the CD31 + cells in the tumor core were GBM-derived, while almost all CD31 + cells in the periphery were host-derived [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. Additionally, Yao et al. found that 34% of CD31 + cells in GSC-derived tumors were of human origin, compared to almost all CD31 + cells being host-derived in tumors formed by U87 cells [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. However, in a lentivirus murine model, Soda et al. found that 10–25% of ECs are tumor-derived, participating in up to 37% of the vascularization in the central area and in 2–12% vessels from the periphery. A mosaic pattern was noticed, in which GBM-derived ECs and host ECs cooperate to form vessels. This is supported by Wang et al. who showed that some CD31 + cells and CD144 + /CD133- cells are genotypically normal, therefore representing normal ECs [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. However, nestin is expressed in both GBM-derived ECs and host-derived ECs [<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>], probably as a marker of EPCs recruited to participate in the vessel formation. Chen et al. also proved this phenomenon in rats harboring C6 tumors by injecting magnetically-labeled EPCs that formed vessels from the periphery to the center of the tumor [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Thus, the vascular network generated by GSCs in hypoxic niches are partially tumoral in origin and connects with the periphery vessels which originated from sprouting angiogenesis or vasculogenesis. Notably, tumoral and non-tumoral ECs do not fuse in vivo [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>, <a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>].</p>
<p id="Par84">Taken together, these data suggest that under the process of transdifferentiation, GSCs progressively lose their stemness signature (CD133, Nestin, SOX2) while enriching endothelial markers (CD31, CD34, CD105) via an immature EC progenitor state (CD144 +). The co-expression of these markers recapitulates a maturation gradient (Fig. <a href="#Fig1" class="usa-link">1</a>). Indeed, gene-expression analysis revealed that the GBM-derived ECs situate between GBM cells and normal ECs [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. In a GEMM (<em>PTEN, TP53, NF1</em> deletion), tumor-associated ECs (co-opted vessels) and tumor-derived ECs presented over 400 differentially expressed genes [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. In GSC-derived ECs, there was an enrichment in migratory genes associated with a more infiltrative and angiogenic phenotype. Additionally, compared to CD133-/CD31 + , isolated CD133 + /CD31 + cells are enriched in nestin, lipocalin2, selectin, endothelin 1 and 3, VEGF-C, and eNOS, possible meditators of GBM tumorigenicity [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>].</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372203_40478_2025_2031_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d3/12372203/4a09cdd7d791/40478_2025_2031_Fig1_HTML.jpg" loading="lazy" id="MO1" height="562" width="784" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The maturation gradient of GBM-derived ECs. Under the influence of GBM cells, GSC progressively transdifferentiate to an immature EC-like phenotype (CD133 + /CD144 +) that will further maturate into an active EC (CD105 +). The active ECs proliferate and migrate in order to connect the transdifferentiated network with the pre-existing vessels in a mosaic pattern. <em>CD</em> cluster of differentiation, <em>EC</em> endothelial cell, <em>GBM</em> glioblastoma, <em>GSC</em> glioma stem cell, <em>SOX2</em> SRY (sex determining region Y)-box 2, <em>VEGFR2</em> vascular endothelial growth factor receptor 2, <em>Wnt5A</em> Wnt family member 5A</p></figcaption></figure><p id="Par85">In a single cell RNA sequencing of neurosurgical samples (4 GBMs, 3 low grade gliomas, 7 non-malignant), Xie et al. magnetically sorted cells for CD45 + leukocytes depletion and enrichment of CD31 + ECs and PDGFRβ + MCs [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. Cells were separated in 10 major clusters, including ECs, tumor cells and a small cluster labeled as “proliferating cells”. While the authors concluded that ECs could not be generated by GBM cells, based on the absence of genomic alterations in the EC cluster, there are several arguments supporting that GSC-derived ECs could in fact be identified in the proliferating cluster. Firstly, dot-plot heatmaps indicate that the proliferative cluster possess an intermediate endothelial signature (<em>CLDN5</em>, <em>ABCG2</em>, <em>FLT1</em>, <em>SLC2A1</em>, <em>PECAM1</em>) situated between tumor cells and ECs, while no other cluster presented this property. Secondly, uniform manifold approximation and projection (UMAP) reveals a subpopulation in the proliferative cluster with similar expression of CD144 and CD31 as the EC cluster. Thirdly, 19.5% of the cells in the proliferative cluster presented genomic alterations as the tumor cluster, while in other clusters this phenomenon was nearly absent. Lastly, the signature of the proliferating cluster as revealed by the dot-plot heatmap was marked by upregulation of <em>MKI67</em>, <em>TOP2A</em>, <em>CENPF</em>. Another group isolated 9520 ECs from 19 tissues in healthy domestic pigs and separated 21 EC clusters, with a small EC cluster harboring proliferation genes (<em>CENPF, CENPE, TOP2A, TPX2</em>) [<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>]. Further research is needed to study this proliferative cluster, as it may contain the GSC-derived ECs.</p>
<p id="Par86">GBM-derived ECs are capable of tumor initiation given purified CD31 + /CD144 + cells can be grafted and give rise to vascularized anaplastic tumors, but if cultured in endothelial medium, they fully differentiate and lose tumorigenicity [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. Therefore, GBM-derived ECs are distinct from normal mature ECs, but a complete differentiation could lead to a <em>bona fide</em> EC phenotype, at least unable to generate tumors. What are the precise moment and signature of the GSC-derived ECs when they are irreversibly transformed remains an unanswered question.</p></section><section id="Sec4"><h2 class="pmc_sec_title">Molecular pathways involved in endothelial transdifferentiation</h2>
<p id="Par87">Endothelial transdifferentiation occurs in two phases: endothelial lineage commitment and endothelial maturation. Lineage commitment represents the initial decision of the GSC to adopt an endothelial identity, marked by early endothelial-specific gene expression, while maturation is the functional refinement of the ECs, allowing them to participate in angiogenesis.</p>
<p id="Par88">In GBM, Wang et al. demonstrated that the conversion of CD133 + /CD144- to CD133 + /CD144 + cells (lineage commitment) is reduced by γ-secretase inhibition or <em>NOTCH1</em> knockdown, whereas the progression from CD133 + /CD144 + to CD105 + ECs (endothelial maturation) is blocked by anti-VEGF antibodies or <em>VEGFR2</em> knockdown [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. Additionally, VEGF stimulation of a SOX2 + /CD133 + patient-derived subpopulation of GSCs results in the formation of a confluent monolayer of spindle-shaped cells that lose SOX2 and CD133 expression, while gaining CD34 immuno-positivity, suggesting a role for VEGF in the final phase of transdifferentiation [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. Although these cells exhibit stemness markers, the CD144 signature was not studied, leaving open the possibility that the studied SOX2 + /CD133 + GSCs might harbor an intermediary endothelial identity that responds to VEGF and consequently assumes the mature EC signature. Indeed, isolated GSCs from U87 cells can already express several EC markers such as CD144, VEGFR2, laminin5γ2, and Ephrin Receptor A2 (EphA2) [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. In these GSCs, VEGF stimulation induces Y1175 phosphorylation in addition to the constitutive auto-phosphorylation of VEGFR2 at the Y1059 position, resulting in the activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinases (ERK1,2) and PI3K/AKT pathways [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. This behavior is similar to normal ECs, in which Y1059 phosphorylation enhances VEGFR2 kinase activity, while Y1175 phosphorylation is involved in proliferation, migration, and cell permeability [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. VEGF stimulation also upregulates VEGFR2 and CD144, while <em>VEGFR2</em> knockdown reduces CD144 expression and tube formation despite VEGF stimulation, suggesting a role for VEGF in the early phase of lineage commitment [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. Lastly, MAPK/ERK1,2 and PI3K/AKT can be activated by other growth factors, such as insulin-like growth factor 2 (IGF2) or FGF [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]. Smith et al. showed that VEGF inhibition results in a mild reduction of tube formation, while FGFR inhibition leads to a severe impairment of the vascular structures [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. In this model, U87 cells presented upregulated FGFR1, VEGFR1, TGFβR1, and overexpressed ligands including angiopoietin 1 (ANG1), hepatocyte growth factor (HGF), VEGF-C and IGF1 [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. Since Notch and VEGF signaling pathways are not mutually exclusive, it is challenging to delineate these phases based on their stimuli alone. Therefore, we distinguished these phases according to CD144 expression (Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<section id="Sec5"><h3 class="pmc_sec_title">Molecular pathways involved in the endothelial commitment</h3>
<p id="Par89">The primary trigger of endothelial commitment on the way to transdifferentiation is hypoxia. Interestingly, hypoxia induces both CD133 and a disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1) in U87, U251, U373, but not in T98G cells [<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>]. HIF-1 binds to the ADAMTS1 promoter, increasing its expression [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. While CD133 suggests the acquisition of stemness features, ADAMTS1 is correlated with the endothelial signature since <em>ADAMTS1</em> knockdown leads to downregulation of CD144, EphA2, VEGFR1 and VEGFR2. Moreover, co-culturing U87, U251 or U373 with HUVECS results in a predominantly GBM-derived vascular network, while T98G-HUVECs co-culture develops a HUVEC-based vascularization. ADAMTS1 mediates transdifferentiation through its proteolytic activity against insulin-like growth factor binding protein 2 (IGFBP2) [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. In GBM cell cultures, both full-length IGFBP2 and its C- and N-terminal fragments are present. However, in tumor samples, only the N-terminal fragment is constantly expressed. IGFBP2 binds to integrin α5β1, activating the focal adhesion kinase (FAK)/ERK pathway, which will further activate the specificity protein 1 (SP1) transcription factor. Then, SP1 interacts with the CD144 promoter and stimulates its transcription. Consequently, GBM cells overexpressing IGFBP2 form more vascular tubes, show higher migratory and invasive abilities, and express higher levels of CD144 and MMP2 [<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>]. ADAMTS1 cleaves IGFBP2, releasing IGF2, which binds to IGF1R and enhances GBM cell migration [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. In physiological conditions, IGF signaling increases the number of endothelial progenitors and enhances ECs migratory and tube-forming abilities [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. In GBM cells, IGF1R phosphorylation modulates the activity of PI3K/AKT pathway [<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>]. However, ADAMTS1 also inhibits proliferation, migration and angiogenesis in HUVECs [<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>]. Besides HIF-1, VEGF can induce ADAMTS1 overexpression in ECs [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>], and ADAMTS1 binds to VEGF, blocking VEGFR2 phosphorylation [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>], participating in a negative loop in the modulation of the angiogenic activity. Based on this data, ADAMTS1 likely contributes to the endothelial lineage commitment while maintaining an inactive, quiescent state of the ECs. Further studies are needed to understand the role of IGF1R in the endothelial transdifferentiation.</p>
<p id="Par90">Hypoxia may also trigger the ETS variant transcription factor 2 (ETV2) overexpression, as ETV2-positive cells are more abundant in the hypoxic tumor core [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. In embryonic stem cells, HIF-1α binds to the ETV2 promoter, leading to its upregulation, followed by Notch1 signaling [<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>], which is consistent with Notch1’s role as shown by Wang et al. [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. ETV2 overexpression in GBM cells results in the cells acquiring endothelial-like morphology and higher expression of VEGFR2, CD144 and CD31 [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. This process is independent of VEGF-A, bFGF and EGF, although these factors can double the number of GBM-derived ECs in vitro. In human samples, ETV2 is often co-expressed with stemness and endothelial markers, as well as EGFR amplification. Additionally, <em>ETV2</em> knockdown in patient-derived GBM tumor cells is associated with smaller tumors and the absence of proliferative GSC-derived ECs (hCD31 + /Ki67 +) in murine models. Although ETV2 is a downstream target of Notch, Wnt, BMP, and VEGF pathways, the mechanism of its upregulation in GBM remains unexplored [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>]. ETV2 downregulates Wnt family member 3 (WNT3) and Glycogen synthase kinase 1 (GSK1), both responsible for the neural lineage commitment, and upregulates of FLI1A, VEGFR2, Tie2, CD34 and CD144, suggestive of transdifferentiation towards the intermediate EC phenotype. Other studies have shown that LIM Domain Only 2 (LMO2), Delta Like Canonical Notch Ligand 4 (DLL4) and Notch1 are also possible downstream target genes of ETV2 [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>].</p>
<p id="Par91">Compared to CD133- cells, CD133 + cells exhibit higher expression of LMO2 [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>]. Induction of patient-derived GSCs differentiation with serum-containing media significantly downregulates LMO2, while overexpression of LMO2 in premalignant astrocytes leads to increased levels of CyclinD1, Nestin and CD133, suggesting the adoption of a stemness signature. LMO2 overexpression activates both <em>JAG1</em> (encoding Jagged canonical Notch ligand 1) and CD144 promoters, facilitating their transcription. Consequently, LMO2 overexpression results in the upregulation of VEGFR2, CD144, CD34 and vWF. The exact mechanism of how LMO2 form a transcriptional complex in this context remains unknown. Hypoxia also directly stimulates CD144 expression via HIF-1α and HIF-2α, which bind to the promoter of CD144 [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. Additionally, C6 cells cultured in endothelial medium under hypoxic conditions show upregulation of HIF-1α, Notch1, VEGFR2 and its phosphorylated form [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Thus, hypoxia promotes endothelial commitment, in part via LMO2, which acts both directly by regulating the CD144 promoter, and indirectly by activating the Jag1/Notch signaling pathway.</p>
<p id="Par92">As previously mentioned, GSCs group into vascular-like channels prior to expressing an EC signature. MMP production and the presence of the basement membrane suggest that extracellular matrix (ECM) remodeling is an early event in the process of transdifferentiation [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>, <a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]. Collagen, a major component of the basement membrane, plays a significant role in transdifferentiation. For instance, collagen-VI-alpha-1 (COL6A1), a marker of high-grade glioma, is mainly located in the perivascular areas [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>]. In vitro studies show that <em>COL6A1</em> knockdown decreases CD31 expression in GSC-derived ECs under hypoxic conditions [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. Collagen-IV is also expressed in the perivascular regions of GBM [<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. Prolyl 4-hydroxylase (P4H), a critical enzyme for collagen synthesis, is upregulated by hypoxia (via HIF-1α) in GBM cells, leading to the overexpression of EMT markers (Snail, Vimentin, MMP2, MMP9) [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>, <a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]. In human samples, P4HA1, a key component of P4H, positively correlates with glioma grade, proliferation, microvessel density, and endothelial markers (CD31, CD34, VEGF-A, VEGF-B, VEGFR2), while negatively impacting survival [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>, <a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. <em>P4HA1</em> knockdown in GSCs reduces collagen IV and VI levels, as well as tube formation and length. How collagen influences endothelial transdifferentiation is not known, but studies on another P4H isoenzyme, namely P4HA2, demonstrate that its knockdown inactivates the PI3K/AKT pathway and downregulates EMT markers (Snail, Slug, Twist1) [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>].</p>
<p id="Par93">A small proportion of induced GSCs (via transduction of dominant-negative <em>TP53</em> and constitutively activated <em>AKT</em> in c-Myc immortalized NSCs) expressed CD144 despite NSC maintenance conditions [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. AKT is critical for GSCs acquiring CD144, as p53DN-AKT-Myc-NSCs adopt a CD133 + /CD144 + signature, while p53DN-Myc-NSCs only express CD133. These CD133 + /CD144 + cells also express CD31, CD34, CD105, Tie2, VEGFR2, and vWF, indicating a role for PI3K/AKT in both lineage commitment and maturation. Additionally, inhibition of mammalian target of rapamycin (<strong>mTOR</strong>) decreases the CD133 + /CD144 + population and their endothelial functions. Moreover, silencing of mTOR, downstream of AKT, downregulates HIF-1α, MMP2, and MMP14, and inhibits VM under both normoxic and hypoxic conditions [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. In comparison, mTOR inhibition in endothelial precursors represses CD144 and vWF [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>], although the exact mechanism by which mTOR contributes to the overexpression of CD144 remains to be determined.</p>
<p id="Par94">AKT activation also triggers the epigenetic activation of distal-less homeobox 5 (DLX5) and suppression of paired box 6 (PAX6), both collaborating to induce transcriptional activation of the WNT5A locus [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. ChIP-seq analysis revealed a transition from H3K27 trimethylation to acetylation for WNT5A and DLX5, while PAX6 exhibited increased repressive H3K27me3 marks. WNT5A expression strongly correlates with the mTOR/S6K pathway but is inversely associated with neural and stemness markers. Furthermore, WNT5A downregulates CD133 and ALDH1A1 through the GSK3β/β-catenin/EMT signaling pathway, although the precise mechanism remains unclear. WNT5A secretion is higher in GSC-derived ECs compared to undifferentiated GSCs, and its knockdown results in reduced tube formation, migration, and downregulation of CD31, CD34, MMP9, and MMP14 [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. In vivo studies demonstrate that WNT5A blockade decreases vessel density and Ki67 + GSC-derived ECs. Additionally, co-culturing GSCs with shWNT5A-GSC-derived ECs results in reduced tube formation, lower levels of EC markers and higher levels of stemness markers in the GSCs, suggesting that GSC-derived ECs are recruiting GSCs. WNT5A binding to Frizzled 4 (FZD4) activates GSK3β/β-catenin pathway, enhancing EC signature and migration markers in GSC-derived ECs. Blocking FZD4 reduces mesenchymal markers (Vimentin, Snail, Twist) and increases E-cadherin expression while maintaining a stem-like morphology.</p>
<p id="Par95">The roles of PI3K/AKT and MAPK/ERK1/2 were also revealed by treating GBM cells with BMP9, which deactivates these pathways and consequently downregulates the stemness signature (CD133, Nestin, SOX2) [<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>]. During endothelial transdifferentiation, BMP9 diminishes the number, migratory potential and tube-formation ability of GSC-derived ECs. PI3K/AKT and Ras/MAPK pathways also target ETV4, a transcription factor that cooperates with SP1 to promote the expression of β1,4-Galactosyltransferase 5 (β4Gal-T5) [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>], which positively correlates with the intranuclear Notch intracellular domain (NICD) [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Notch1 is β1,4-galactosylated by β4Gal-T5, facilitating the interaction between Notch1 and Galectin-3. This galactose-dependent interaction activates NICD and promotes its nuclear translocation [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. Furthermore, <em>B4GALT5</em> knockdown in patient-derived GSCs inhibits tube formation, decreases tube length and CD31 expression in vitro, and reduces tumor dimensions and increases survival in an orthotopic mouse model.</p>
<p id="Par96">Transducing GSCs with the activated form of Notch1 results in the upregulation of TAL1-PP22, a truncated isoform of TAL1, whereas the full-length isoform is normally expressed in HUVECs [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. Overexpression of TAL1-PP22 is associated with a decline in the GSC growth, independent of SOX2 and OLIG2, suggestive of a role in differentiation. TAL1 + GSCs resemble an endothelial phenotype, expressing CD31 and CD144. Although co-immunoprecipitation reveals an interaction between TAL1-PP22 and LMO2, the importance of this interaction is yet to be elucidated. TAL1-PP22 lacks the transcriptional domain, and there are indications from other studies that this isoform might inhibit the transcriptional activity of the formed complex [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>].</p>
<p id="Par97">In sprouting angiogenesis, ‘tip’ cells express DLL4, which activates Notch1 signaling in ‘stalk’ cells. This DLL4-Notch1 pathway inhibits VEGFR2 expression, preventing the acquisition of the ‘tip’ phenotype [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Conversely, ‘stalk’ cells express Jag1, which counteracts DLL4-Notch1 signaling and enhances VEGFR2 expression. Notch1 is critical for the vascular hierarchy, as its inactivation disrupts tube formation and stable junctions. Thus, Notch1 maintains a balance between proliferative ‘stalk’ and proteolytic, migratory ‘tip’ phenotypes. It is possible that the Jag1-Notch1 interaction upregulates VEGFR2 in neighboring cells, promoting a migratory phenotype, while further VEGF stimulation leads to the active, proliferating CD105 + signature. ‘Stalk’/’tip’ EC polarization has not been explored in endothelial transdifferentiation of GSCs. However, Zheng et al. found that Jag1 and DDL4 are widely expressed in hypoxic/necrotic areas of GBM samples [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. In hypoxic conditions, co-culturing GSCs with both tumor and non-tumor ECs results in higher expression of both Jag1 and DLL4 in ECs, more so in GSC-derived ECs than in HBMECs. Blocking Jag1 and DDL4 also reduces proliferation and sphere formation ability of the neighboring GSCs. Although Jag1 and DDL4 are also present in soluble form, suggesting an autocrine activation of Notch, the impact upon GSC-derived ECs was not studied.</p>
<p id="Par98">Therefore, Notch1 significantly contributes to endothelial commitment, but growth factors may also play a crucial role, especially with the rise in VEGFR2 expression (Fig. <a href="#Fig2" class="usa-link">2</a>). Once more, isolating GSCs solely based on CD133-positivity could select GSCs already undergoing transdifferentiation. Thus, employing a broader array of markers alongside quantitative techniques is imperative to isolate "pure" GSCs (CD133 + /CD144-) and differentiate them from endothelial-committed CD133 + /CD144 + cells.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372203_40478_2025_2031_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d3/12372203/988403ac2032/40478_2025_2031_Fig2_HTML.jpg" loading="lazy" id="MO2" height="591" width="783" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Major pathways involved in the endothelial lineage commitment of GSCs. <em>ADAMTS1</em> a disintegrin and metalloproteinase with thrombospondin motif 1, <em>AKT</em> AKT serine/threonine kinase, <em>β4Gal-T5</em> beta-1,4-galactosyltransferase 5, <em>CD144</em> cluster of differentiation 144, <em>DLL4</em> delta like canonical Notch ligand 4, <em>ERK</em> extracellular regulated MAP kinase, <em>ETV</em> ETS variant transcription factor, <em>FAK</em> focal adhesion kinase, <em>HIF-1α</em> hypoxia-inducible factor 1-alpha, <em>IGF2</em> insulin-like growth factor 2, <em>IGFBP2</em> insulin like growth factor binding protein 2, <em>IGFR1</em> insulin-like growth factor receptor 1, <em>Jag1</em> jagged canonical Notch ligand 1, <em>LMO2</em> LIM domain only 2, <em>MAPK</em> mitogen-activated protein kinase, <em>mTOR</em> mammalian target of rapamycin, <em>P4HA1</em> prolyl 4-hydroxylase A1, <em>PI3K</em> phosphatidylinositol 3-kinase, <em>VEGF</em> vascular endothelial growth factor, <em>VEGFR2</em> vascular endothelial growth factor receptor 2</p></figcaption></figure></section><section id="Sec6"><h3 class="pmc_sec_title">Molecular pathways involved in the endothelial maturation</h3>
<p id="Par99">Endothelial maturation is the transition from a CD133 + /CD144 + progenitor state to an active CD105 + mature phenotype, characterized by downregulation of CD133, CD144 and upregulation of CD31, CD34, VEGFR2, CD105 [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. CD133 + /CD144- and CD133 + /CD144 + cells show no difference in the expression level of CD105, suggesting that CD105 upregulation is a hallmark of maturation [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. Since CD31, CD34 and VEGFR2 are also upregulated during endothelial commitment, it is likely that some similar pathways continue to be active during maturation. Additionally, pathways involved in endothelial maturation could also be seen during lineage commitment but activated to a lesser degree due to the different receptor signature. Notably, in vitro conversion of CD133 + /CD144 + to CD105 + ECs was observed after cultivation in endothelial medium (supplemented with VEGF) and it was inhibited by the VEGF/VEGFR2 blockade [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>, <a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. Therefore, the enrichment in VEGFR2 is responsible for entering maturation. Once GSC-derived ECs lose their stemness markers, this process became irreversible, and cells retain their endothelial signature even if cultured back in stem cell medium [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>].</p>
<p id="Par100">Some mechanisms observed in normal angiogenesis can explain the crosstalk between VEGFR2, CD144 and CD105. Firstly, CD144 normally keeps VEGFR2 in an unphosphorylated state, maintaining the cell quiescence [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. Additionally, CD144 loss activates FGFR, which upregulates the expression of VEGFR2. Thus, loss of CD144 leads to an increase of both total VEGFR2 and phosphorylated VEGFR2 levels. Activated VEGFR2 further enhances the internalization of CD144, contributing to a feedback loop that sustains its own activation. VEGFR2 promotes cell proliferation and MMPs secretion via the MAPK/ERK1/2 pathway. Loss of CD144 and gain of CD105 also promote a switch in TGF-β signaling from an antiproliferative to a proliferative effect [<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>].</p>
<p id="Par101">Another explanation for CD144 loss is the activation of the EMT program. As previously mentioned, PI3K/AKT/mTOR drives WNT5A expression that will further activate GSK3β/β-catenin/EMT signaling pathway via FZD4 [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. In GBM cells, TGF-β and ERK pathways also contributes to EMT [<a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>]. Consequently, these signaling cascades activate transcription factors which promote the synthesis of Snail1/2, Slug and Twist. The EC signature is likely driven by Snail1 (targeting CD31 and CD34) and Twist (targeting MMP9 and MMP14). Both Snail and Twist bind to the CD144 promoter, downregulating its transcription [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>]. Additionally, MMP14 cleaves CD144 in the EC membrane.</p>
<p id="Par102">These observations suggest that PI3K/AKT and WNT/β-catenin/EMT are key effectors of endothelial maturation, too (Fig. <a href="#Fig3" class="usa-link">3</a>). Since CD105 is a primary marker for active ECs, further studies should investigate the role of WNT5A in CD105 expression. Notably, rapamycin reduces CD105 expression, indicating a possible involvement of mTOR. While embryonic stem cells in 3D cultures express CD105, NSCs in the same conditions do not, although OCT4 overexpression in NSCs induces CD105 expression [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. In liver cancer, OCT4 activates the AKT/Nuclear factor kappa B (NF-κB) p65 pathway, and silencing of OCT4B1 reduces CD105 expression [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>]. Notch inhibition in GBM explants decreases CD105 + cells, though this does not rule out Notch's early role in transdifferentiation [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. In a U87-based 3D culture model, CD105 expression was unaffected by VEGF or FGFR inhibition, suggesting that this mechanism may become VEGF-independent and other paracrine factors in the GBM secretome can contribute to endothelial maturation [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. In summary, VEGF induces CD105 expression and downregulates CD144, with potential signaling pathways involved including PI3K/AKT and EMT; however, these pathways can be activated by various other upstream signals [<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>].</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372203_40478_2025_2031_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d3/12372203/4302040af97a/40478_2025_2031_Fig3_HTML.jpg" loading="lazy" id="MO3" height="532" width="784" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The interplay between epigenetic mechanisms and epithelial-to-mesenchymal (EMT) pathway in endothelial maturation. <em>AKT</em> AKT serine/threonine kinase, <em>Ang1</em> angiopoietin 1, <em>CD</em> cluster of differentiation, <em>DLX5</em> Distal-Less Homeobox 5, <em>FZD4</em> Frizzled class receptor 4, <em>GSK-3β</em> glycogen synthase kinase 3, <em>H3K27-me3/-ac</em> trimethylation/ acetylation of lysine 27 on histone, <em>HIF-1α</em> hypoxia-inducible factor 1-alpha, <em>LRP</em> low density lipoprotein receptor-related protein, <em>MMP</em> matrix metalloproteinase, <em>mTOR</em> mammalian target of rapamycin, <em>PAX</em> Paired Box, <em>PI3K</em> phosphatidylinositol 3-kinase, <em>VEGF</em> vascular endothelial growth factor, <em>VEGFR2</em> vascular endothelial growth factor receptor 2, <em>Wnt5A</em> Wnt family member 5A</p></figcaption></figure></section></section><section id="Sec7"><h2 class="pmc_sec_title">VEGFR2 controversy: not all GSCs act in the same manner</h2>
<p id="Par103">The main issue with the definition of endothelial maturation in the context of GSC transdifferentiation is that this process was firstly observed in vitro where is driven by VEGF/VEGFR2 signaling pathway. In several GBM patient samples and in vivo GBM models, many cells with a typical endothelial signature and localization do not express VEGFR2, which casts doubt on the role of VEGFR2 in maturation. The main explanation is related to the TME, which includes various other growth factors or cytokines with a role in angiogenesis.</p>
<p id="Par104">In a lentiviral murine model (constitutively activated <em>HRAS</em> and <em>AKT</em> in <em>TP53</em><sup>+/−</sup> transgenic mice), Soda et al. found that VEGFR1, VEGFR2 and VEGFR3 were absent in most GBM-derived ECs, while VEGFR2 was present in the majority of host ECs. Additionally, FGFR1 was expressed in all subsets of both GBM-derived and host ECs [<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>]. GSCs from this model secreted a basal level of VEGF when cultured in NSC medium, but under differentiation conditions, they secreted three times more VEGF in normoxia and up to ten times more in hypoxia. In GSCs, hypoxia also elevated the expression of endothelial markers (vWF, CD31, and VEGFR2 in a limited subpopulation), promoted the adoption of an EC-like morphology, and enhanced tube formation. VEGF is a potent chemotactic signal, proportional to the VEGFR2 expression [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. Thus, the VEGF secretion of GSC-derived ECs could stimulate the VEGFR2-expressing host ECs and the few VEGFR2 + GSC-derived EC to migrate and contribute to the mosaic pattern of the neovessels. Similarly, Deshors et al. cultured patient-derived GSC lines in endothelial medium (EGM-2), where cells exhibited increased CD31 expression and loss of stemness, with significantly higher levels of VEGFR2 observed only in GSC-derived ECs from one of the three lines tested [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Despite variations in VEGFR2 expression, all GSC-derived ECs displayed tube formation similar to HUVECs, LDL uptake, and enhanced migration towards a VEGF gradient, suggesting the potential presence of an alternative receptor for integrating VEGF chemotactic signals. Compared to Wang et al. that originally discovered the role of VEGFR2 in maturation using sorted CD133 + /CD144 + cells, Deshors et al. used sphere-formation assay to isolate GSCs, which can generate a more heterogeneous cell population. Thus, the divergence in results can be attributed to the use of distinct cell lines from various patients, highlighting both intra- and intertumoral heterogeneity as factors contributing to the discrepant behavior of different cell populations.</p>
<p id="Par105">To comprehend the emergence of the divergent VEGFR2 + and VEGFR2- populations, several mechanisms observed in GBM vascular networks require elucidation. Huang et al. observed that CD31 + ECs isolated from GBM samples exhibit decreased VEGFR2 levels but increased expression of N-cadherin, alpha smooth muscle actin (α-SMA), and fibroblast-specific protein 1 (FSP-1) [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. Therefore, the absence of VEGFR2 may indicate an EC transition towards a mesenchymal phenotype characterized by disruptions of intercellular junctions and increased vascular permeability, as well as cytoskeletal remodeling to promote a migratory and invasive behavior [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>]. Exposure of ECs to the GBM secretome triggers c-Met phosphorylation, leading to the activation of downstream targets NF-κB and ETS-1, the latter being expressed irrespective of hypoxia [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]. Similarly, ECs in GBM secrete platelet-derived growth factor (PDGF) that acts in an autocrine manner upon PDGFR-α and PDGFR-β, leading to NF-κB activation [<a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. Both NF-κB and ETS-1 promote FSP-1 overexpression, although the underlying mechanisms remain unclear [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. Additionally, NF-κB binds to the <em>SNAIL</em> promoter and upregulates Snail, which binds to the VEGFR2 promoter, inhibiting its expression [<a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. Indeed, exposure of HBMECs to glioma conditioned medium induces a phenotypic transition towards a disorganized architecture of spindle-shaped cells, endothelial marker reduction, mesenchymal signature upregulation, intercellular protein loss and increased HGF levels [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>, <a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. Functionally, these cells exhibit increased proliferation, migration, and monolayer permeability, characteristics retained upon re-culture in normal medium, indicating an irreversible transformation possibly mediated by the autocrine feed-back loops. Despite adopting a mesenchymal phenotype, these ECs maintain endothelial functions (tube formation and LDL uptake). In rodent models, deletion of c-Met or PDGFR-β does not affect tumor growth but promotes vascular network normalization (reduced tortuosity, minimal hemorrhagic necrosis, pericyte coverage) [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>, <a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. Although endothelial-to-mesenchymal transition has not been studied in transdifferentiated ECs, the involvement of similar EMT transcription factors in both processes provides a potential explanation for how VEGFR2 may be lost during this transition [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>].</p>
<p id="Par106">On the other hand, hypoxia and nutrient deprivation could trigger the production of reactive oxygen species (ROS) in tumor cells and consequently induce autophagy. In vivo, bevacizumab decreases vessel density, but promotes the formation of VM channels, while chloroquine (used as autophagy inhibitor) reduces VM channels without altering vessel density [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]. Therefore, VEGF is critical for angiogenesis, but not for VM. Instead, ROS promote the overexpression of autophagy protein 5 (ATG5), which is positively correlated with both VM and pVEGFR2 in GBM samples. Indeed, knocking down <em>ATG5</em> results not only in reduced levels of VEGFR2, but also in diminished phosphorylation at Y1175 position. This is in line with previous research showing that VEGFR2 activation could contribute to lineage commitment, although other pathways such as Notch are more important [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>].</p></section><section id="Sec8"><h2 class="pmc_sec_title">Transdifferentiation in relation to GBM treatment</h2>
<p id="Par107">The importance of endothelial transdifferentiation was illustrated in a 3D mathematical model proposed by Yan et al., which predicted that targeting GSC-derived ECs is critical for the development of novel combinatorial regimens aimed at tumor eradication [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>]. Current treatment strategies not only fail to address transdifferentiation but may also exacerbate its occurrence.</p>
<p id="Par108">Following radiation exposure, GSC-derived ECs exhibit Tie2 overexpression without alterations in CD31 or stemness/neural markers, thereby enhancing migratory capabilities towards VEGF and tube formation [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Since mRNA and protein levels of ANG1 and ANG2 in GSC-derived ECs are not influenced by radiotherapy, Tie2 is not activated in an autocrine manner. Several GBM cell lines (U87, ADF) express angiopoietins and induce in vitro angiogenesis when co-cultivated with HUVECs, suggesting that GBM itself could provide ligands for Tie2 activation in irradiated GSC-derived ECs [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Tie2 primarily acts through the PI3K/AKT pathway rather than the MAPK/ERK signaling pathway. As explained above, PI3K/AKT is crucial for endothelial transdifferentiation. Inhibition of Tie2 signaling by regorafenib decreases CD31 expression and tube formation in irradiated patient-derived GSCs [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Additionally, Notch inhibition has been demonstrated to enhance the efficacy of RT, with the combination of RT and γ-secretase inhibition resulting in reduced proliferation, neurosphere formation, and CD133 + cells compared to either treatment alone, although no effect upon transdifferentiation was investigated [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>].</p>
<p id="Par109">TMZ induces the generation of CD133 + /CD144 + cells not only in CD133 + cells, but also in CD133- cells, outlining its role in both dedifferentiation and endothelial fate [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Moreover, TMZ increases CD133 + /CD34 + and SOX2 + /CD34 + cell populations, and under therapeutical stress, there is a notable co-expression of SOX2 + and CD105 + , suggesting the development of activated, proliferating ECs. In vivo, TMZ exposure induces the endothelial signature in a time- and dose-dependent manner. In hypoxic conditions, GSCs display a higher survival rate to TMZ when co-cultivated with Nestin + /CD31 + cells or HBMECs, indicating endothelial transdifferentiation confers chemoresistance to the neighboring GSCs [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>].</p>
<p id="Par110">Since hypoxia plays an important role in lineage commitment, therapeutic strategies that combat this mechanism could inhibit endothelial transdifferentiation. However, the main problem is that hypoxic areas are either avascular or characterized by leaky vasculature, which prevents active drug concentrations from reaching these areas. In a phase II clinical trial involving 24 patients with recurrent GBM, small-molecule PT2385 (an HIF-2α inhibitor) did not achieve objective radiographic responses, had a modest impact on outcomes (mOS, 7.7 months), and demonstrated high variability in pharmacokinetics between patients [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>]. Another significant pathway involved in transdifferentiation is Notch. Targeting Notch signaling with the γ-secretase inhibitor RO4929097 also proved ineffective in a phase II trial involving 47 patients with recurrent GBM, yielding a 6-month progression-free survival (PFS) rate of only 4% [<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>]. Disappointing results were also observed when attempting to target the PI3K/AKT/mTOR pathway. In a phase II study of the oral PI3K inhibitor PX-866 in recurrent GBM, 73% of patients experienced disease progression [<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]. To date, the only FDA-approved targeted therapy with a possible role in transdifferentiation is the VEGF inhibitor bevacizumab. In a randomized clinical trial, newly diagnosed GBM patients were treated with concomitant chemoradiotherapy followed by either bevacizumab or placebo. While PFS was longer in the bevacizumab arm, no significant difference in mOS was noted (15.7 vs. 16.1 months) [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. Although these molecules have failed to bring major benefits, strategies to normalize vascularization, multidrug combinations, and strategies for better drug penetration into tumor tissue are necessary to combat transdifferentiation in GBM.</p></section><section id="Sec9"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par111">Endothelial transdifferentiation, wherein GSCs assume an endothelial phenotype to facilitate tumor neovascularization, is influenced by the tumor microenvironment, notably hypoxic conditions in perinecrotic regions and the secretome of neighboring cells. This process is not constant in GBM, but many associated markers indicate a poor prognosis. Given that current treatments can promote endothelial transdifferentiation, it is more likely to occur in recurrent GBM. Initially, GSCs form vascular-like channels that integrate into the vascular network, accompanied by a gradual reduction in the stemness signature and an increase in endothelial markers and functions. During the initial phase of endothelial commitment, GSCs upregulate CD144 expression, which is subsequently downregulated in a maturation phase. These processes are tightly regulated by Notch, PI3K/AKT/mTOR, MAPK/ERK, and EMT pathways. Notch appears pivotal in lineage commitment, while PI3K/AKT/mTOR and Wnt/β-catenin/EMT are involved in both phases, though specific activation mechanisms remain incompletely understood. The shift in balance between phases could be attributed to alterations in growth factor receptors, and the quantitative impact of these pathways. Conflicting findings due to tumor heterogeneity necessitate clarification through more sophisticated disease models and larger patient cohorts.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ABCG2</dt>
<dd><p id="Par2">ATP-binding cassette sub-family G member 2</p></dd>
<dt>acLDL</dt>
<dd><p id="Par3">Acetylated-low density lipoprotein</p></dd>
<dt>ADAMTS1</dt>
<dd><p id="Par4">A disintegrin and metalloproteinase with thrombospondin motifs 1</p></dd>
<dt>ANG</dt>
<dd><p id="Par5">Angiopoietin</p></dd>
<dt>ATG5</dt>
<dd><p id="Par6">Autophagy protein 5</p></dd>
<dt>BBB</dt>
<dd><p id="Par7">Blood–brain barrier</p></dd>
<dt>bFGF</dt>
<dd><p id="Par8">Basic fibroblast growth factor</p></dd>
<dt>BMP</dt>
<dd><p id="Par9">Bone morphogenetic protein</p></dd>
<dt>COL6A1</dt>
<dd><p id="Par10">Collagen-VI-alpha-1</p></dd>
<dt>DLL4</dt>
<dd><p id="Par11">Delta like canonical notch ligand 4</p></dd>
<dt>DLX5</dt>
<dd><p id="Par12">Distal-less homeobox 5</p></dd>
<dt>EC</dt>
<dd><p id="Par13">Endothelial cell</p></dd>
<dt>EGF</dt>
<dd><p id="Par14">Epithelial growth factor</p></dd>
<dt>EMT</dt>
<dd><p id="Par15">Epithelial-mesenchymal transition</p></dd>
<dt>eNOS</dt>
<dd><p id="Par16">Endothelial nitric oxide synthase</p></dd>
<dt>EPC</dt>
<dd><p id="Par17">Endothelial progenitor</p></dd>
<dt>EphA2</dt>
<dd><p id="Par18">Ephrin receptor A2</p></dd>
<dt>ERK</dt>
<dd><p id="Par19">Extracellular signal-regulated kinases</p></dd>
<dt>ETV</dt>
<dd><p id="Par20">ETS Variant transcription factor</p></dd>
<dt>FAK</dt>
<dd><p id="Par21">Focal adhesion kinase</p></dd>
<dt>FSP-1</dt>
<dd><p id="Par22">Fibroblast-specific protein 1</p></dd>
<dt>FZD4</dt>
<dd><p id="Par23">Frizzled 4</p></dd>
<dt>GBM</dt>
<dd><p id="Par24">Glioblastoma</p></dd>
<dt>GFAP</dt>
<dd><p id="Par25">Glial fibrillary acidic protein</p></dd>
<dt>GSC</dt>
<dd><p id="Par26">Glioma stem cell</p></dd>
<dt>GSK</dt>
<dd><p id="Par27">Glycogen synthase kinase</p></dd>
<dt>HBMEC</dt>
<dd><p id="Par28">Human brain microvascular endothelial cell</p></dd>
<dt>HGF</dt>
<dd><p id="Par29">Hepatocyte growth factor</p></dd>
<dt>HIF</dt>
<dd><p id="Par30">Hypoxia-inducible factor</p></dd>
<dt>HUVEC</dt>
<dd><p id="Par31">Human umbilical vein endothelial cell</p></dd>
<dt>IGF</dt>
<dd><p id="Par32">Insulin-like growth factor</p></dd>
<dt>IGFBP2</dt>
<dd><p id="Par33">Insulin-like growth factor binding protein 2</p></dd>
<dt>JNK</dt>
<dd><p id="Par34">c-Jun N-terminal kinase</p></dd>
<dt>LMO2</dt>
<dd><p id="Par35">LIM domain only 2</p></dd>
<dt>MAP2</dt>
<dd><p id="Par36">Microtubule-associated protein 2</p></dd>
<dt>MAPK</dt>
<dd><p id="Par37">Mitogen-activated protein kinase</p></dd>
<dt>MMP</dt>
<dd><p id="Par38">Matrix metalloproteinase</p></dd>
<dt>mTOR</dt>
<dd><p id="Par39">Mammalian target of rapamycin</p></dd>
<dt>NF-κB</dt>
<dd><p id="Par40">Nuclear factor kappa B</p></dd>
<dt>NICD</dt>
<dd><p id="Par41">Notch intracellular domain</p></dd>
<dt>NSC</dt>
<dd><p id="Par42">Neural stem cell</p></dd>
<dt>OCT4</dt>
<dd><p id="Par43">Octamer transcription factor 4</p></dd>
<dt>P4H</dt>
<dd><p id="Par44">Prolyl 4-hydroxylase</p></dd>
<dt>PAX6</dt>
<dd><p id="Par45">Paired box 6</p></dd>
<dt>PDGF</dt>
<dd><p id="Par46">Platelet-derived growth factor</p></dd>
<dt>PI3K</dt>
<dd><p id="Par47">Phosphatidylinositol 3-kinase</p></dd>
<dt>PTEN</dt>
<dd><p id="Par48">Phosphatase and tensin homolog</p></dd>
<dt>ROS</dt>
<dd><p id="Par49">Reactive oxygen species</p></dd>
<dt>RT</dt>
<dd><p id="Par50">Radiation therapy</p></dd>
<dt>SHH</dt>
<dd><p id="Par51">Sonic Hedgehog</p></dd>
<dt>SOX2</dt>
<dd><p id="Par52">SRY (sex determining region Y)-box 2</p></dd>
<dt>SP1</dt>
<dd><p id="Par53">Specificity protein 1</p></dd>
<dt>SVZ</dt>
<dd><p id="Par54">Subventricular zone</p></dd>
<dt>TGF-β</dt>
<dd><p id="Par55">Transforming growth factor beta</p></dd>
<dt>TMZ</dt>
<dd><p id="Par56">Temozolomide</p></dd>
<dt>TUJ1</dt>
<dd><p id="Par57">β-III tubulin</p></dd>
<dt>VEGF</dt>
<dd><p id="Par58">Vascular endothelial growth factor</p></dd>
<dt>VM</dt>
<dd><p id="Par59">Vasculogenic mimicry</p></dd>
<dt>vWF</dt>
<dd><p id="Par60">Von Willebrand factor</p></dd>
<dt>α-SMA</dt>
<dd><p id="Par61">Alpha smooth muscle actin</p></dd>
<dt>β4Gal-T5</dt>
<dd><p id="Par62">β1,4-Galactosyltransferase 5</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>A.B. and S.S. designed the study. A.B., S.I.F., A.I.F., O.S. and S.S. participated in writing and editing the manuscript. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research received no external funding.</p></section><section id="notes3"><h2 class="pmc_sec_title">Availability of data and materials</h2>
<p>Not applicable.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par112">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par113">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par114">The authors declare that they have no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Aderetti DA, Hira VVV, Molenaar RJ, van Noorden CJF (2018) The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma. Biochimica et Biophysica Acta (BBA)–Rev Cancer 1869(2):346–354. 10.1016/j.bbcan.2018.04.008</cite> [<a href="https://doi.org/10.1016/j.bbcan.2018.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29684521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aderetti%20DA,%20Hira%20VVV,%20Molenaar%20RJ,%20van%20Noorden%20CJF%20(2018)%20The%20hypoxic%20peri-arteriolar%20glioma%20stem%20cell%20niche,%20an%20integrated%20concept%20of%20five%20types%20of%20niches%20in%20human%20glioblastoma.%20Biochimica%20et%20Biophysica%20Acta%20(BBA)%E2%80%93Rev%20Cancer%201869(2):346%E2%80%93354.%2010.1016/j.bbcan.2018.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Akil A, Gutiérrez-García AK, Rachael Guenter J, Rose B, Beck AW, Chen H, Ren B (2021) Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective. Front Cell Dev Biol. 10.3389/fcell.2021.642352
</cite> [<a href="https://doi.org/10.3389/fcell.2021.642352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7928398/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33681228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Akil%20A,%20Guti%C3%A9rrez-Garc%C3%ADa%20AK,%20Rachael%20Guenter%20J,%20Rose%20B,%20Beck%20AW,%20Chen%20H,%20Ren%20B%20(2021)%20Notch%20signaling%20in%20vascular%20endothelial%20cells,%20angiogenesis,%20and%20tumor%20progression:%20an%20update%20and%20prospective.%20Front%20Cell%20Dev%20Biol.%2010.3389/fcell.2021.642352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Arakelian L, Lion J, Churlaud G, Bargui R, Thierry B, Mutabazi E, Bruneval P, Alberdi AJ, Doliger C, Veyssiere M, Larghero J, Mooney N (2023) Endothelial CD34 expression and regulation of immune cell response in-vitro. Sci Rep 13:13512. 10.1038/s41598-023-40622-7
</cite> [<a href="https://doi.org/10.1038/s41598-023-40622-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10439936/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37598252/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arakelian%20L,%20Lion%20J,%20Churlaud%20G,%20Bargui%20R,%20Thierry%20B,%20Mutabazi%20E,%20Bruneval%20P,%20Alberdi%20AJ,%20Doliger%20C,%20Veyssiere%20M,%20Larghero%20J,%20Mooney%20N%20(2023)%20Endothelial%20CD34%20expression%20and%20regulation%20of%20immune%20cell%20response%20in-vitro.%20Sci%20Rep%2013:13512.%2010.1038/s41598-023-40622-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Ardizzone A, Scuderi SA, Giuffrida D, Colarossi C, Puglisi C, Campolo M, Cuzzocrea S, Esposito E, Paterniti I (2020) Role of fibroblast growth factors receptors (FGFRs) in brain tumors. Focus Astrocytoma Glioblastoma Cancers 12:3825. 10.3390/cancers12123825
</cite> [<a href="https://doi.org/10.3390/cancers12123825" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7766440/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33352931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ardizzone%20A,%20Scuderi%20SA,%20Giuffrida%20D,%20Colarossi%20C,%20Puglisi%20C,%20Campolo%20M,%20Cuzzocrea%20S,%20Esposito%20E,%20Paterniti%20I%20(2020)%20Role%20of%20fibroblast%20growth%20factors%20receptors%20(FGFRs)%20in%20brain%20tumors.%20Focus%20Astrocytoma%20Glioblastoma%20Cancers%2012:3825.%2010.3390/cancers12123825" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Audero E, Cascone I, Zanon I, Previtali SC, Piva R, Schiffer D, Bussolino F (2001) Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: in vivo and in vitro studies. Arterioscler Thromb Vasc Biol 21:536–541. 10.1161/01.atv.21.4.536
</cite> [<a href="https://doi.org/10.1161/01.atv.21.4.536" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11304469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Audero%20E,%20Cascone%20I,%20Zanon%20I,%20Previtali%20SC,%20Piva%20R,%20Schiffer%20D,%20Bussolino%20F%20(2001)%20Expression%20of%20angiopoietin-1%20in%20human%20glioblastomas%20regulates%20tumor-induced%20angiogenesis:%20in%20vivo%20and%20in%20vitro%20studies.%20Arterioscler%20Thromb%20Vasc%20Biol%2021:536%E2%80%93541.%2010.1161/01.atv.21.4.536" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Auffinger B, Spencer D, Pytel P, Ahmed AU, Lesniak MS (2015) The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother 15:741. 10.1586/14737175.2015.1051968
</cite> [<a href="https://doi.org/10.1586/14737175.2015.1051968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4830899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26027432/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Auffinger%20B,%20Spencer%20D,%20Pytel%20P,%20Ahmed%20AU,%20Lesniak%20MS%20(2015)%20The%20role%20of%20glioma%20stem%20cells%20in%20chemotherapy%20resistance%20and%20glioblastoma%20multiforme%20recurrence.%20Expert%20Rev%20Neurother%2015:741.%2010.1586/14737175.2015.1051968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Bach LA (2015) Endothelial cells and the IGF system. J Mol Endocrinol 54:R1-13. 10.1530/JME-14-0215
</cite> [<a href="https://doi.org/10.1530/JME-14-0215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25351818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bach%20LA%20(2015)%20Endothelial%20cells%20and%20the%20IGF%20system.%20J%20Mol%20Endocrinol%2054:R1-13.%2010.1530/JME-14-0215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Baisiwala S, Auffinger B, Caragher SP, Shireman JM, Ahsan R, Lee G, Hasan T, Park C, Saathoff MR, Christensen AC, Ahmed AU (2019) Chemotherapeutic stress induces transdifferentiation of glioblastoma cells to endothelial cells and promotes vascular mimicry. Stem Cells Int 2019:6107456. 10.1155/2019/6107456
</cite> [<a href="https://doi.org/10.1155/2019/6107456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6604352/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31316566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baisiwala%20S,%20Auffinger%20B,%20Caragher%20SP,%20Shireman%20JM,%20Ahsan%20R,%20Lee%20G,%20Hasan%20T,%20Park%20C,%20Saathoff%20MR,%20Christensen%20AC,%20Ahmed%20AU%20(2019)%20Chemotherapeutic%20stress%20induces%20transdifferentiation%20of%20glioblastoma%20cells%20to%20endothelial%20cells%20and%20promotes%20vascular%20mimicry.%20Stem%20Cells%20Int%202019:6107456.%2010.1155/2019/6107456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Bakhshinyan D, Savage N, Salim SK, Venugopal C, Singh SK (2021) The strange case of jekyll and hyde: parallels between neural stem cells and glioblastoma-initiating cells. Front Oncol 10:603738. 10.3389/fonc.2020.603738
</cite> [<a href="https://doi.org/10.3389/fonc.2020.603738" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7820896/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33489908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bakhshinyan%20D,%20Savage%20N,%20Salim%20SK,%20Venugopal%20C,%20Singh%20SK%20(2021)%20The%20strange%20case%20of%20jekyll%20and%20hyde:%20parallels%20between%20neural%20stem%20cells%20and%20glioblastoma-initiating%20cells.%20Front%20Oncol%2010:603738.%2010.3389/fonc.2020.603738" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Barzegar Behrooz A, Syahir A, Ahmad S (2019) CD133: beyond a cancer stem cell biomarker. J Drug Target 27:257–269. 10.1080/1061186X.2018.1479756
</cite> [<a href="https://doi.org/10.1080/1061186X.2018.1479756" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29911902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barzegar%20Behrooz%20A,%20Syahir%20A,%20Ahmad%20S%20(2019)%20CD133:%20beyond%20a%20cancer%20stem%20cell%20biomarker.%20J%20Drug%20Target%2027:257%E2%80%93269.%2010.1080/1061186X.2018.1479756" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Baumann N, Pham-dinh D (2002) Astrocytes. In: Encyclopedia of the human brain. Elsevier, pp 251–268</cite>
</li>
<li id="CR12">
<span class="label">12.</span><cite>Beier CP (2011) CD133 negative cancer stem cells in glioblastoma. Front Biosci E3:701–710. 10.2741/e280</cite> [<a href="https://doi.org/10.2741/e280" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21196345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Beier%20CP%20(2011)%20CD133%20negative%20cancer%20stem%20cells%20in%20glioblastoma.%20Front%20Biosci%20E3:701%E2%80%93710.%2010.2741/e280" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Biswas P, Canosa S, Schoenfeld D, Schoenfeld J, Li P, Cheas LC, Zhang J, Cordova A, Sumpio B, Madri JA (2006) PECAM-1 affects GSK-3β-mediated β-catenin phosphorylation and degradation. Am J Pathol 169:314–324. 10.2353/ajpath.2006.051112
</cite> [<a href="https://doi.org/10.2353/ajpath.2006.051112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1698776/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16816383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Biswas%20P,%20Canosa%20S,%20Schoenfeld%20D,%20Schoenfeld%20J,%20Li%20P,%20Cheas%20LC,%20Zhang%20J,%20Cordova%20A,%20Sumpio%20B,%20Madri%20JA%20(2006)%20PECAM-1%20affects%20GSK-3%CE%B2-mediated%20%CE%B2-catenin%20phosphorylation%20and%20degradation.%20Am%20J%20Pathol%20169:314%E2%80%93324.%2010.2353/ajpath.2006.051112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Boraas LC, Ahsan T (2016) Lack of vimentin impairs endothelial differentiation of embryonic stem cells. Sci Rep 6:30814. 10.1038/srep30814
</cite> [<a href="https://doi.org/10.1038/srep30814" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4969593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27480130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Boraas%20LC,%20Ahsan%20T%20(2016)%20Lack%20of%20vimentin%20impairs%20endothelial%20differentiation%20of%20embryonic%20stem%20cells.%20Sci%20Rep%206:30814.%2010.1038/srep30814" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Breier G, Grosser M, Rezaei M (2014) Endothelial cadherins in cancer. Cell Tissue Res 355:523–527. 10.1007/s00441-014-1851-7
</cite> [<a href="https://doi.org/10.1007/s00441-014-1851-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24619142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Breier%20G,%20Grosser%20M,%20Rezaei%20M%20(2014)%20Endothelial%20cadherins%20in%20cancer.%20Cell%20Tissue%20Res%20355:523%E2%80%93527.%2010.1007/s00441-014-1851-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Brooks LJ, Parrinello S (2017) Vascular regulation of glioma stem-like cells: a balancing act. Curr Opin Neurobiol 47:8–15. 10.1016/j.conb.2017.06.008
</cite> [<a href="https://doi.org/10.1016/j.conb.2017.06.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28732340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brooks%20LJ,%20Parrinello%20S%20(2017)%20Vascular%20regulation%20of%20glioma%20stem-like%20cells:%20a%20balancing%20act.%20Curr%20Opin%20Neurobiol%2047:8%E2%80%9315.%2010.1016/j.conb.2017.06.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Buccarelli M, D’Alessandris QG, Matarrese P, Mollinari C, Signore M, Cappannini A, Martini M, D’Aliberti P, De Luca G, Pedini F, Boe A, Biffoni M, Pallini R, Ricci-Vitiani L (2021) Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth. J Exp Clin Cancer Res 40:228. 10.1186/s13046-021-02031-4
</cite> [<a href="https://doi.org/10.1186/s13046-021-02031-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8273992/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34253243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Buccarelli%20M,%20D%E2%80%99Alessandris%20QG,%20Matarrese%20P,%20Mollinari%20C,%20Signore%20M,%20Cappannini%20A,%20Martini%20M,%20D%E2%80%99Aliberti%20P,%20De%20Luca%20G,%20Pedini%20F,%20Boe%20A,%20Biffoni%20M,%20Pallini%20R,%20Ricci-Vitiani%20L%20(2021)%20Elesclomol-induced%20increase%20of%20mitochondrial%20reactive%20oxygen%20species%20impairs%20glioblastoma%20stem-like%20cell%20survival%20and%20tumor%20growth.%20J%20Exp%20Clin%20Cancer%20Res%2040:228.%2010.1186/s13046-021-02031-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Buruiană A, Florian Ștefan I, Florian AI, Timiș T-L, Mihu CM, Miclăuș M, Oșan S, Hrapșa I, Cataniciu RC, Farcaș M, Șușman S (2020) The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive negotiations. Int J Mol Sci. 10.3390/ijms21061950
</cite> [<a href="https://doi.org/10.3390/ijms21061950" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7139390/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32178454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Buruian%C4%83%20A,%20Florian%20%C8%98tefan%20I,%20Florian%20AI,%20Timi%C8%99%20T-L,%20Mihu%20CM,%20Micl%C4%83u%C8%99%20M,%20O%C8%99an%20S,%20Hrap%C8%99a%20I,%20Cataniciu%20RC,%20Farca%C8%99%20M,%20%C8%98u%C8%99man%20S%20(2020)%20The%20roles%20of%20miRNA%20in%20glioblastoma%20tumor%20cell%20communication:%20diplomatic%20and%20aggressive%20negotiations.%20Int%20J%20Mol%20Sci.%2010.3390/ijms21061950" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Butzal M, Loges S, Schweizer M, Fischer U, Gehling UM, Hossfeld DK, Fiedler W (2004) Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. Exp Cell Res 300:65–71. 10.1016/j.yexcr.2004.07.002
</cite> [<a href="https://doi.org/10.1016/j.yexcr.2004.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15383315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Butzal%20M,%20Loges%20S,%20Schweizer%20M,%20Fischer%20U,%20Gehling%20UM,%20Hossfeld%20DK,%20Fiedler%20W%20(2004)%20Rapamycin%20inhibits%20proliferation%20and%20differentiation%20of%20human%20endothelial%20progenitor%20cells%20in%20vitro.%20Exp%20Cell%20Res%20300:65%E2%80%9371.%2010.1016/j.yexcr.2004.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Carlson JC, Cantu Gutierrez M, Lozzi B, Huang-Hobbs E, Turner WD, Tepe B, Zhang Y, Herman AM, Rao G, Creighton CJ, Wythe JD, Deneen B (2021) Identification of diverse tumor endothelial cell populations in malignant glioma. Neuro Oncol 23:932–944. 10.1093/neuonc/noaa297
</cite> [<a href="https://doi.org/10.1093/neuonc/noaa297" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8168823/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33367832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carlson%20JC,%20Cantu%20Gutierrez%20M,%20Lozzi%20B,%20Huang-Hobbs%20E,%20Turner%20WD,%20Tepe%20B,%20Zhang%20Y,%20Herman%20AM,%20Rao%20G,%20Creighton%20CJ,%20Wythe%20JD,%20Deneen%20B%20(2021)%20Identification%20of%20diverse%20tumor%20endothelial%20cell%20populations%20in%20malignant%20glioma.%20Neuro%20Oncol%2023:932%E2%80%93944.%2010.1093/neuonc/noaa297" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Chen L, Shi L, Wang W, Zhou Y (2017) ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin. Oncotarget 8:43237–43247. 10.18632/oncotarget.18018
</cite> [<a href="https://doi.org/10.18632/oncotarget.18018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5522142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28591733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20L,%20Shi%20L,%20Wang%20W,%20Zhou%20Y%20(2017)%20ABCG2%20downregulation%20in%20glioma%20stem%20cells%20enhances%20the%20therapeutic%20efficacy%20of%20demethoxycurcumin.%20Oncotarget%208:43237%E2%80%9343247.%2010.18632/oncotarget.18018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Chen T, Zhang F, Liu J, Huang Z, Zheng Y, Deng S, Liu Y, Wang J, Sun X (2021) Dual role of WNT5A in promoting endothelial differentiation of glioma stem cells and angiogenesis of glioma derived endothelial cells. Oncogene 40:5081–5094. 10.1038/s41388-021-01922-2
</cite> [<a href="https://doi.org/10.1038/s41388-021-01922-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34188250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20T,%20Zhang%20F,%20Liu%20J,%20Huang%20Z,%20Zheng%20Y,%20Deng%20S,%20Liu%20Y,%20Wang%20J,%20Sun%20X%20(2021)%20Dual%20role%20of%20WNT5A%20in%20promoting%20endothelial%20differentiation%20of%20glioma%20stem%20cells%20and%20angiogenesis%20of%20glioma%20derived%20endothelial%20cells.%20Oncogene%2040:5081%E2%80%935094.%2010.1038/s41388-021-01922-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Chen X, Fang J, Wang S, Liu H, Du X, Chen J, Li X, Yang Y, Zhang B, Zhang W (2014) A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells. Oncotarget 5:1955–1968. 10.18632/oncotarget.1885
</cite> [<a href="https://doi.org/10.18632/oncotarget.1885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4039108/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24722469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20X,%20Fang%20J,%20Wang%20S,%20Liu%20H,%20Du%20X,%20Chen%20J,%20Li%20X,%20Yang%20Y,%20Zhang%20B,%20Zhang%20W%20(2014)%20A%20new%20mosaic%20pattern%20in%20glioma%20vascularization:%20exogenous%20endothelial%20progenitor%20cells%20integrating%20into%20the%20vessels%20containing%20tumor-derived%20endothelial%20cells.%20Oncotarget%205:1955%E2%80%931968.%2010.18632/oncotarget.1885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Chen Y, Jing Z, Luo C, Zhuang M, Xia J, Chen Z, Wang Y (2012) Vasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo study. Med Oncol 29:324–331. 10.1007/s12032-010-9765-z
</cite> [<a href="https://doi.org/10.1007/s12032-010-9765-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21161444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20Y,%20Jing%20Z,%20Luo%20C,%20Zhuang%20M,%20Xia%20J,%20Chen%20Z,%20Wang%20Y%20(2012)%20Vasculogenic%20mimicry-potential%20target%20for%20glioblastoma%20therapy:%20an%20in%20vitro%20and%20in%20vivo%20study.%20Med%20Oncol%2029:324%E2%80%93331.%2010.1007/s12032-010-9765-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Chetty SC, Rost MS, Enriquez JR, Schumacher JA, Baltrunaite K, Rossi A, Stainier DYR, Sumanas S (2017) Vegf signaling promotes vascular endothelial differentiation by modulating etv2 expression. Dev Biol 424:147. 10.1016/j.ydbio.2017.03.005
</cite> [<a href="https://doi.org/10.1016/j.ydbio.2017.03.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5419721/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28279709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chetty%20SC,%20Rost%20MS,%20Enriquez%20JR,%20Schumacher%20JA,%20Baltrunaite%20K,%20Rossi%20A,%20Stainier%20DYR,%20Sumanas%20S%20(2017)%20Vegf%20signaling%20promotes%20vascular%20endothelial%20differentiation%20by%20modulating%20etv2%20expression.%20Dev%20Biol%20424:147.%2010.1016/j.ydbio.2017.03.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Cheung KCP, Fanti S, Mauro C, Wang G, Nair AS, Fu H, Angeletti S, Spoto S, Fogolari M, Romano F, Aksentijevic D, Liu W, Li B, Cheng L, Jiang L, Vuononvirta J, Poobalasingam TR, Smith DM, Ciccozzi M, Solito E, Marelli-Berg FM (2020) Preservation of microvascular barrier function requires CD31 receptor-induced metabolic reprogramming. Nat Commun 11:3595. 10.1038/s41467-020-17329-8
</cite> [<a href="https://doi.org/10.1038/s41467-020-17329-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7367815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32681081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheung%20KCP,%20Fanti%20S,%20Mauro%20C,%20Wang%20G,%20Nair%20AS,%20Fu%20H,%20Angeletti%20S,%20Spoto%20S,%20Fogolari%20M,%20Romano%20F,%20Aksentijevic%20D,%20Liu%20W,%20Li%20B,%20Cheng%20L,%20Jiang%20L,%20Vuononvirta%20J,%20Poobalasingam%20TR,%20Smith%20DM,%20Ciccozzi%20M,%20Solito%20E,%20Marelli-Berg%20FM%20(2020)%20Preservation%20of%20microvascular%20barrier%20function%20requires%20CD31%20receptor-induced%20metabolic%20reprogramming.%20Nat%20Commun%2011:3595.%2010.1038/s41467-020-17329-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Chiao M-T, Yang Y-C, Cheng W-Y, Shen C-C, Ko J-L (2011) CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo. Curr Neurovasc Res 8:210–219. 10.2174/156720211796558023
</cite> [<a href="https://doi.org/10.2174/156720211796558023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21675958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chiao%20M-T,%20Yang%20Y-C,%20Cheng%20W-Y,%20Shen%20C-C,%20Ko%20J-L%20(2011)%20CD133+%20glioblastoma%20stem-like%20cells%20induce%20vascular%20mimicry%20in%20vivo.%20Curr%20Neurovasc%20Res%208:210%E2%80%93219.%2010.2174/156720211796558023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Clavreul A, Pourbaghi-Masouleh M, Roger E, Menei P (2019) Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far. IJN 14:2497–2513. 10.2147/IJN.S194858
</cite> [<a href="https://doi.org/10.2147/IJN.S194858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6461002/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31040671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clavreul%20A,%20Pourbaghi-Masouleh%20M,%20Roger%20E,%20Menei%20P%20(2019)%20Nanocarriers%20and%20nonviral%20methods%20for%20delivering%20antiangiogenic%20factors%20for%20glioblastoma%20therapy:%20the%20story%20so%20far.%20IJN%2014:2497%E2%80%932513.%2010.2147/IJN.S194858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Cribaro GP, Saavedra-López E, Romarate L, Mitxitorena I, Díaz LR, Casanova PV, Roig-Martínez M, Gallego JM, Perez-Vallés A, Barcia C (2021) Three-dimensional vascular microenvironment landscape in human glioblastoma. Acta Neuropathol Commun 9:24. 10.1186/s40478-020-01115-0
</cite> [<a href="https://doi.org/10.1186/s40478-020-01115-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7879533/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33579378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cribaro%20GP,%20Saavedra-L%C3%B3pez%20E,%20Romarate%20L,%20Mitxitorena%20I,%20D%C3%ADaz%20LR,%20Casanova%20PV,%20Roig-Mart%C3%ADnez%20M,%20Gallego%20JM,%20Perez-Vall%C3%A9s%20A,%20Barcia%20C%20(2021)%20Three-dimensional%20vascular%20microenvironment%20landscape%20in%20human%20glioblastoma.%20Acta%20Neuropathol%20Commun%209:24.%2010.1186/s40478-020-01115-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Cui C, Chen X, Liu Y, Cao B, Xing Y, Liu C, Yang F, Li Y, Yang T, Hua L, Tian M, Wei Y, Gong Y, Jiang J (2018) β1,4-Galactosyltransferase V activates Notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells. J Biol Chem 293:2219–2230. 10.1074/jbc.RA117.000682
</cite> [<a href="https://doi.org/10.1074/jbc.RA117.000682" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5808780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29269413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cui%20C,%20Chen%20X,%20Liu%20Y,%20Cao%20B,%20Xing%20Y,%20Liu%20C,%20Yang%20F,%20Li%20Y,%20Yang%20T,%20Hua%20L,%20Tian%20M,%20Wei%20Y,%20Gong%20Y,%20Jiang%20J%20(2018)%20%CE%B21,4-Galactosyltransferase%20V%20activates%20Notch1%20signaling%20in%20glioma%20stem-like%20cells%20and%20promotes%20their%20transdifferentiation%20into%20endothelial%20cells.%20J%20Biol%20Chem%20293:2219%E2%80%932230.%2010.1074/jbc.RA117.000682" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Dahan P, Martinez Gala J, Delmas C, Monferran S, Malric L, Zentkowski D, Lubrano V, Toulas C, Cohen-Jonathan Moyal E, Lemarie A (2014) Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance. Cell Death Dis 5:e1543. 10.1038/cddis.2014.509
</cite> [<a href="https://doi.org/10.1038/cddis.2014.509" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4260760/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25429620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dahan%20P,%20Martinez%20Gala%20J,%20Delmas%20C,%20Monferran%20S,%20Malric%20L,%20Zentkowski%20D,%20Lubrano%20V,%20Toulas%20C,%20Cohen-Jonathan%20Moyal%20E,%20Lemarie%20A%20(2014)%20Ionizing%20radiations%20sustain%20glioblastoma%20cell%20dedifferentiation%20to%20a%20stem-like%20phenotype%20through%20survivin:%20possible%20involvement%20in%20radioresistance.%20Cell%20Death%20Dis%205:e1543.%2010.1038/cddis.2014.509" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>D’Alessio A, Proietti G, Sica G, Scicchitano BM (2019) Pathological and molecular features of glioblastoma and its peritumoral tissue. Cancers. 10.3390/cancers11040469
</cite> [<a href="https://doi.org/10.3390/cancers11040469" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6521241/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30987226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?D%E2%80%99Alessio%20A,%20Proietti%20G,%20Sica%20G,%20Scicchitano%20BM%20(2019)%20Pathological%20and%20molecular%20features%20of%20glioblastoma%20and%20its%20peritumoral%20tissue.%20Cancers.%2010.3390/cancers11040469" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Dallas NA, Samuel S, Xia L, Fan F, Gray MJ, Lim SJ, Ellis LM (2008) Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 14:1931–1937. 10.1158/1078-0432.CCR-07-4478
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-07-4478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18381930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dallas%20NA,%20Samuel%20S,%20Xia%20L,%20Fan%20F,%20Gray%20MJ,%20Lim%20SJ,%20Ellis%20LM%20(2008)%20Endoglin%20(CD105):%20a%20marker%20of%20tumor%20vasculature%20and%20potential%20target%20for%20therapy.%20Clin%20Cancer%20Res%2014:1931%E2%80%931937.%2010.1158/1078-0432.CCR-07-4478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Dejana E, Hirschi KK, Simons M (2017) The molecular basis of endothelial cell plasticity. Nat Commun 8:14361. 10.1038/ncomms14361
</cite> [<a href="https://doi.org/10.1038/ncomms14361" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5309780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28181491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dejana%20E,%20Hirschi%20KK,%20Simons%20M%20(2017)%20The%20molecular%20basis%20of%20endothelial%20cell%20plasticity.%20Nat%20Commun%208:14361.%2010.1038/ncomms14361" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Delgado-López PD, Corrales-García EM (2016) Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol 18:1062–1071. 10.1007/s12094-016-1497-x
</cite> [<a href="https://doi.org/10.1007/s12094-016-1497-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26960561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Delgado-L%C3%B3pez%20PD,%20Corrales-Garc%C3%ADa%20EM%20(2016)%20Survival%20in%20glioblastoma:%20a%20review%20on%20the%20impact%20of%20treatment%20modalities.%20Clin%20Transl%20Oncol%2018:1062%E2%80%931071.%2010.1007/s12094-016-1497-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Deshors P, Arnauduc F, Boëlle B, Cohen-Jonathan Moyal E, Courtade-Saïdi M, Evrard SM (2022) Impact of regorafenib on endothelial transdifferentiation of glioblastoma stem-like cells. Cancers (Basel) 14:1551. 10.3390/cancers14061551
</cite> [<a href="https://doi.org/10.3390/cancers14061551" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8946617/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35326702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deshors%20P,%20Arnauduc%20F,%20Bo%C3%ABlle%20B,%20Cohen-Jonathan%20Moyal%20E,%20Courtade-Sa%C3%AFdi%20M,%20Evrard%20SM%20(2022)%20Impact%20of%20regorafenib%20on%20endothelial%20transdifferentiation%20of%20glioblastoma%20stem-like%20cells.%20Cancers%20(Basel)%2014:1551.%2010.3390/cancers14061551" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Deshors P, Toulas C, Arnauduc F, Malric L, Siegfried A, Nicaise Y, Lemarié A, Larrieu D, Tosolini M, Cohen-Jonathan Moyal E, Courtade-Saidi M, Evrard SM (2019) Ionizing radiation induces endothelial transdifferentiation of glioblastoma stem-like cells through the Tie2 signaling pathway. Cell Death Dis 10:1–15. 10.1038/s41419-019-2055-6</cite> [<a href="https://doi.org/10.1038/s41419-019-2055-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6817826/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31659157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deshors%20P,%20Toulas%20C,%20Arnauduc%20F,%20Malric%20L,%20Siegfried%20A,%20Nicaise%20Y,%20Lemari%C3%A9%20A,%20Larrieu%20D,%20Tosolini%20M,%20Cohen-Jonathan%20Moyal%20E,%20Courtade-Saidi%20M,%20Evrard%20SM%20(2019)%20Ionizing%20radiation%20induces%20endothelial%20transdifferentiation%20of%20glioblastoma%20stem-like%20cells%20through%20the%20Tie2%20signaling%20pathway.%20Cell%20Death%20Dis%2010:1%E2%80%9315.%2010.1038/s41419-019-2055-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Ding B-S, James D, Iyer R, Falciatori I, Hambardzumyan D, Wang S, Butler JM, Rabbany SY, Hormigo A (2013) Prominin 1/CD133 endothelium sustains growth of proneural glioma. PLoS ONE 8:e62150. 10.1371/journal.pone.0062150
</cite> [<a href="https://doi.org/10.1371/journal.pone.0062150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3636202/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23637986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ding%20B-S,%20James%20D,%20Iyer%20R,%20Falciatori%20I,%20Hambardzumyan%20D,%20Wang%20S,%20Butler%20JM,%20Rabbany%20SY,%20Hormigo%20A%20(2013)%20Prominin%201/CD133%20endothelium%20sustains%20growth%20of%20proneural%20glioma.%20PLoS%20ONE%208:e62150.%2010.1371/journal.pone.0062150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Ding LN, Yu YY, Ma CJ, Lei CJ, Zhang HB (2023) SOX2-associated signaling pathways regulate biological phenotypes of cancers. Biomed Pharmacother 160:114336. 10.1016/j.biopha.2023.114336
</cite> [<a href="https://doi.org/10.1016/j.biopha.2023.114336" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36738502/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ding%20LN,%20Yu%20YY,%20Ma%20CJ,%20Lei%20CJ,%20Zhang%20HB%20(2023)%20SOX2-associated%20signaling%20pathways%20regulate%20biological%20phenotypes%20of%20cancers.%20Biomed%20Pharmacother%20160:114336.%2010.1016/j.biopha.2023.114336" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Dong J, Zhao Y, Huang Q, Fei X, Diao Y, Shen Y, Xiao H, Zhang T, Lan Q, Gu X (2011) Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation. Stem Cell Rev and Rep 7:141–152. 10.1007/s12015-010-9169-7
</cite> [<a href="https://doi.org/10.1007/s12015-010-9169-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20697979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dong%20J,%20Zhao%20Y,%20Huang%20Q,%20Fei%20X,%20Diao%20Y,%20Shen%20Y,%20Xiao%20H,%20Zhang%20T,%20Lan%20Q,%20Gu%20X%20(2011)%20Glioma%20stem/progenitor%20cells%20contribute%20to%20neovascularization%20via%20transdifferentiation.%20Stem%20Cell%20Rev%20and%20Rep%207:141%E2%80%93152.%2010.1007/s12015-010-9169-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>El Hallani S, Colin C, El Houfi Y, Idbaih A, Boisselier B, Marie Y, Ravassard P, Labussière M, Mokhtari K, Thomas J-L, Delattre J-Y, Eichmann A, Sanson M (2014) Tumor and endothelial cell hybrids participate in glioblastoma vasculature. Biomed Res Int 2014:1–9. 10.1155/2014/827327</cite> [<a href="https://doi.org/10.1155/2014/827327" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4017715/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24868550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?El%20Hallani%20S,%20Colin%20C,%20El%20Houfi%20Y,%20Idbaih%20A,%20Boisselier%20B,%20Marie%20Y,%20Ravassard%20P,%20Labussi%C3%A8re%20M,%20Mokhtari%20K,%20Thomas%20J-L,%20Delattre%20J-Y,%20Eichmann%20A,%20Sanson%20M%20(2014)%20Tumor%20and%20endothelial%20cell%20hybrids%20participate%20in%20glioblastoma%20vasculature.%20Biomed%20Res%20Int%202014:1%E2%80%939.%2010.1155/2014/827327" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Fisher JP, Adamson DC (2021) Current FDA-approved therapies for high-grade malignant gliomas. Biomedicines. 10.3390/biomedicines9030324
</cite> [<a href="https://doi.org/10.3390/biomedicines9030324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8004675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33810154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fisher%20JP,%20Adamson%20DC%20(2021)%20Current%20FDA-approved%20therapies%20for%20high-grade%20malignant%20gliomas.%20Biomedicines.%2010.3390/biomedicines9030324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Giannotta M, Trani M, Dejana E (2013) VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell 26:441–454. 10.1016/j.devcel.2013.08.020
</cite> [<a href="https://doi.org/10.1016/j.devcel.2013.08.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24044891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Giannotta%20M,%20Trani%20M,%20Dejana%20E%20(2013)%20VE-cadherin%20and%20endothelial%20adherens%20junctions:%20active%20guardians%20of%20vascular%20integrity.%20Dev%20Cell%2026:441%E2%80%93454.%2010.1016/j.devcel.2013.08.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, Brachman DG, Werner-Wasik M, Tremont-Lukats IW, Sulman EP, Aldape KD, Curran WJJ, Mehta MP (2014) A Randomized trial of bevacizumab for newly diagnosed glioblastoma. In: The New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa1308573. Accessed 26 Mar 2025</cite> [<a href="https://doi.org/10.1056/NEJMoa1308573" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4201043/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24552317/" class="usa-link">PubMed</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Goncharov NV, Nadeev AD, Jenkins RO, Avdonin PV (2017) Markers and biomarkers of endothelium: when something is rotten in the state. Oxidat Med Cell Longev. 10.1155/2017/9759735</cite> [<a href="https://doi.org/10.1155/2017/9759735" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5733214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29333215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goncharov%20NV,%20Nadeev%20AD,%20Jenkins%20RO,%20Avdonin%20PV%20(2017)%20Markers%20and%20biomarkers%20of%20endothelium:%20when%20something%20is%20rotten%20in%20the%20state.%20Oxidat%20Med%20Cell%20Longev.%2010.1155/2017/9759735" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Guardia GDA, Correa BR, Araujo PR, Qiao M, Burns S, Penalva LOF, Galante PAF (2020) Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles. npj Genom Med 5:1–12. 10.1038/s41525-019-0108-5
</cite> [<a href="https://doi.org/10.1038/s41525-019-0108-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6965107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31969990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guardia%20GDA,%20Correa%20BR,%20Araujo%20PR,%20Qiao%20M,%20Burns%20S,%20Penalva%20LOF,%20Galante%20PAF%20(2020)%20Proneural%20and%20mesenchymal%20glioma%20stem%20cells%20display%20major%20differences%20in%20splicing%20and%20lncRNA%20profiles.%20npj%20Genom%20Med%205:1%E2%80%9312.%2010.1038/s41525-019-0108-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Guelfi S, Orsetti B, Deleuze V, Rigau V, Bauchet L, Duffau H, Rothhut B, Hugnot J-P (2021) SLUG and truncated TAL1 reduce glioblastoma stem cell growth downstream of notch1 and define distinct vascular subpopulations in glioblastoma multiforme. Cancers 13:5393. 10.3390/cancers13215393
</cite> [<a href="https://doi.org/10.3390/cancers13215393" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8582547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34771555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guelfi%20S,%20Orsetti%20B,%20Deleuze%20V,%20Rigau%20V,%20Bauchet%20L,%20Duffau%20H,%20Rothhut%20B,%20Hugnot%20J-P%20(2021)%20SLUG%20and%20truncated%20TAL1%20reduce%20glioblastoma%20stem%20cell%20growth%20downstream%20of%20notch1%20and%20define%20distinct%20vascular%20subpopulations%20in%20glioblastoma%20multiforme.%20Cancers%2013:5393.%2010.3390/cancers13215393" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Guo B, Slevin M, Li C, Parameshwar S, Liu D, Kumar P, Bernabeu C, Kumar S (2004) CD105 inhibits transforming growth factor-beta-Smad3 signalling. Anticancer Res 24:1337–1345
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/15274293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20B,%20Slevin%20M,%20Li%20C,%20Parameshwar%20S,%20Liu%20D,%20Kumar%20P,%20Bernabeu%20C,%20Kumar%20S%20(2004)%20CD105%20inhibits%20transforming%20growth%20factor-beta-Smad3%20signalling.%20Anticancer%20Res%2024:1337%E2%80%931345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Han X, Wang Q, Fang S, Wang J, Liu F, Zhang J, Jin G (2022) P4HA1 regulates CD31 via COL6A1 in the transition of glioblastoma stem-like cells to tumor endothelioid cells. Front Oncol 12:836511. 10.3389/fonc.2022.836511
</cite> [<a href="https://doi.org/10.3389/fonc.2022.836511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9044633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35494018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han%20X,%20Wang%20Q,%20Fang%20S,%20Wang%20J,%20Liu%20F,%20Zhang%20J,%20Jin%20G%20(2022)%20P4HA1%20regulates%20CD31%20via%20COL6A1%20in%20the%20transition%20of%20glioblastoma%20stem-like%20cells%20to%20tumor%20endothelioid%20cells.%20Front%20Oncol%2012:836511.%2010.3389/fonc.2022.836511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Hardee ME, Zagzag D (2012) Mechanisms of glioma-associated neovascularization. Am J Pathol 181:1126–1141. 10.1016/j.ajpath.2012.06.030
</cite> [<a href="https://doi.org/10.1016/j.ajpath.2012.06.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3463636/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22858156/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hardee%20ME,%20Zagzag%20D%20(2012)%20Mechanisms%20of%20glioma-associated%20neovascularization.%20Am%20J%20Pathol%20181:1126%E2%80%931141.%2010.1016/j.ajpath.2012.06.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Hassn Mesrati M, Behrooz AB, Y. Abuhamad A, Syahir A (2020) Understanding glioblastoma biomarkers: knocking a mountain with a hammer. Cells 9:1236. 10.3390/cells9051236
</cite> [<a href="https://doi.org/10.3390/cells9051236" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7291262/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32429463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hassn%20Mesrati%20M,%20Behrooz%20AB,%20Y.%20Abuhamad%20A,%20Syahir%20A%20(2020)%20Understanding%20glioblastoma%20biomarkers:%20knocking%20a%20mountain%20with%20a%20hammer.%20Cells%209:1236.%2010.3390/cells9051236" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Hatipoglu OF, Hirohata S, Cilek MZ, Ogawa H, Miyoshi T, Obika M, Demircan K, Shinohata R, Kusachi S, Ninomiya Y (2009) ADAMTS1 is a unique hypoxic early response gene expressed by endothelial cells*. J Biol Chem 284:16325–16333. 10.1074/jbc.M109.001313
</cite> [<a href="https://doi.org/10.1074/jbc.M109.001313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2713541/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19349275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hatipoglu%20OF,%20Hirohata%20S,%20Cilek%20MZ,%20Ogawa%20H,%20Miyoshi%20T,%20Obika%20M,%20Demircan%20K,%20Shinohata%20R,%20Kusachi%20S,%20Ninomiya%20Y%20(2009)%20ADAMTS1%20is%20a%20unique%20hypoxic%20early%20response%20gene%20expressed%20by%20endothelial%20cells*.%20J%20Biol%20Chem%20284:16325%E2%80%9316333.%2010.1074/jbc.M109.001313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Heddleston JM, Hitomi M, Venere M, Flavahan WA, Yan K, Kim Y, Minhas S, Rich JN, Hjelmeland AB (2011) Glioma stem cell maintenance: the role of the microenvironment. Curr Pharm Des 17:2386
</cite> [<a href="https://doi.org/10.2174/138161211797249260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3615428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21827414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heddleston%20JM,%20Hitomi%20M,%20Venere%20M,%20Flavahan%20WA,%20Yan%20K,%20Kim%20Y,%20Minhas%20S,%20Rich%20JN,%20Hjelmeland%20AB%20(2011)%20Glioma%20stem%20cell%20maintenance:%20the%20role%20of%20the%20microenvironment.%20Curr%20Pharm%20Des%2017:2386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Hovinga KE, Shimizu F, Wang R, Panagiotakos G, Van Der Heijden M, Moayedpardazi H, Correia AS, Soulet D, Major T, Menon J, Tabar V (2010) Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells 28:1019–1029. 10.1002/stem.429
</cite> [<a href="https://doi.org/10.1002/stem.429" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5532884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20506127/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hovinga%20KE,%20Shimizu%20F,%20Wang%20R,%20Panagiotakos%20G,%20Van%20Der%20Heijden%20M,%20Moayedpardazi%20H,%20Correia%20AS,%20Soulet%20D,%20Major%20T,%20Menon%20J,%20Tabar%20V%20(2010)%20Inhibition%20of%20notch%20signaling%20in%20glioblastoma%20targets%20cancer%20stem%20cells%20via%20an%20endothelial%20cell%20intermediate.%20Stem%20Cells%2028:1019%E2%80%931029.%2010.1002/stem.429" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Hristov M, Erl W, Weber PC (2003) Endothelial progenitor cells. Arterioscler Thromb Vasc Biol 23:1185–1189. 10.1161/01.ATV.0000073832.49290.B5
</cite> [<a href="https://doi.org/10.1161/01.ATV.0000073832.49290.B5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12714439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hristov%20M,%20Erl%20W,%20Weber%20PC%20(2003)%20Endothelial%20progenitor%20cells.%20Arterioscler%20Thromb%20Vasc%20Biol%2023:1185%E2%80%931189.%2010.1161/01.ATV.0000073832.49290.B5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Hu B, Wang Q, Wang YA, Hua S, Sauvé C-EG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, Wang G, Liao W-T, Corley LJ, Yan H, Zhang J, You Y, Liu N, Cai L, Finocchiaro G, Phillips JJ, Berger MS, Spring DJ, Hu J, Sulman EP, Fuller GN, Chin L, Verhaak RGW, DePinho RA (2016) Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth. Cell 167:1281-1295.e18. 10.1016/j.cell.2016.10.039
</cite> [<a href="https://doi.org/10.1016/j.cell.2016.10.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5320931/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27863244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20B,%20Wang%20Q,%20Wang%20YA,%20Hua%20S,%20Sauv%C3%A9%20C-EG,%20Ong%20D,%20Lan%20ZD,%20Chang%20Q,%20Ho%20YW,%20Monasterio%20MM,%20Lu%20X,%20Zhong%20Y,%20Zhang%20J,%20Deng%20P,%20Tan%20Z,%20Wang%20G,%20Liao%20W-T,%20Corley%20LJ,%20Yan%20H,%20Zhang%20J,%20You%20Y,%20Liu%20N,%20Cai%20L,%20Finocchiaro%20G,%20Phillips%20JJ,%20Berger%20MS,%20Spring%20DJ,%20Hu%20J,%20Sulman%20EP,%20Fuller%20GN,%20Chin%20L,%20Verhaak%20RGW,%20DePinho%20RA%20(2016)%20Epigenetic%20activation%20of%20WNT5A%20drives%20glioblastoma%20stem%20cell%20differentiation%20and%20invasive%20growth.%20Cell%20167:1281-1295.e18.%2010.1016/j.cell.2016.10.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Huang M, Ke Y, Sun X, Yu L, Yang Z, Zhang Y, Du M, Wang J, Liu X, Huang S (2014) Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1α. Oncol Rep 32:1973–1980. 10.3892/or.2014.3454
</cite> [<a href="https://doi.org/10.3892/or.2014.3454" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25175735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20M,%20Ke%20Y,%20Sun%20X,%20Yu%20L,%20Yang%20Z,%20Zhang%20Y,%20Du%20M,%20Wang%20J,%20Liu%20X,%20Huang%20S%20(2014)%20Mammalian%20target%20of%20rapamycin%20signaling%20is%20involved%20in%20the%20vasculogenic%20mimicry%20of%20glioma%20via%20hypoxia-inducible%20factor-1%CE%B1.%20Oncol%20Rep%2032:1973%E2%80%931980.%2010.3892/or.2014.3454" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Huang M, Liu T, Ma P, Mitteer RA, Zhang Z, Kim HJ, Yeo E, Zhang D, Cai P, Li C, Zhang L, Zhao B, Roccograndi L, O’Rourke DM, Dahmane N, Gong Y, Koumenis C, Fan Y (2016) c-Met–mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Investig 126:1801–1814. 10.1172/JCI84876
</cite> [<a href="https://doi.org/10.1172/JCI84876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4855929/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27043280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20M,%20Liu%20T,%20Ma%20P,%20Mitteer%20RA,%20Zhang%20Z,%20Kim%20HJ,%20Yeo%20E,%20Zhang%20D,%20Cai%20P,%20Li%20C,%20Zhang%20L,%20Zhao%20B,%20Roccograndi%20L,%20O%E2%80%99Rourke%20DM,%20Dahmane%20N,%20Gong%20Y,%20Koumenis%20C,%20Fan%20Y%20(2016)%20c-Met%E2%80%93mediated%20endothelial%20plasticity%20drives%20aberrant%20vascularization%20and%20chemoresistance%20in%20glioblastoma.%20J%20Clin%20Investig%20126:1801%E2%80%931814.%2010.1172/JCI84876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Hughes MR, Canals Hernaez D, Cait J, Refaeli I, Lo BC, Roskelley CD, McNagny KM (2020) A sticky wicket: defining molecular functions for CD34 in hematopoietic cells. Exp Hematol 86:1–14. 10.1016/j.exphem.2020.05.004
</cite> [<a href="https://doi.org/10.1016/j.exphem.2020.05.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32422232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hughes%20MR,%20Canals%20Hernaez%20D,%20Cait%20J,%20Refaeli%20I,%20Lo%20BC,%20Roskelley%20CD,%20McNagny%20KM%20(2020)%20A%20sticky%20wicket:%20defining%20molecular%20functions%20for%20CD34%20in%20hematopoietic%20cells.%20Exp%20Hematol%2086:1%E2%80%9314.%2010.1016/j.exphem.2020.05.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Iruela-Arispe ML, Carpizo D, Luque A (2003) ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci 995:183–190. 10.1111/j.1749-6632.2003.tb03221.x
</cite> [<a href="https://doi.org/10.1111/j.1749-6632.2003.tb03221.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12814950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Iruela-Arispe%20ML,%20Carpizo%20D,%20Luque%20A%20(2003)%20ADAMTS1:%20a%20matrix%20metalloprotease%20with%20angioinhibitory%20properties.%20Ann%20N%20Y%20Acad%20Sci%20995:183%E2%80%93190.%2010.1111/j.1749-6632.2003.tb03221.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Ishiwata T, Teduka K, Yamamoto T, Kawahara K, Matsuda Y, Naito Z (2011) Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas. Oncol Rep 26:91–99. 10.3892/or.2011.1267
</cite> [<a href="https://doi.org/10.3892/or.2011.1267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21503585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ishiwata%20T,%20Teduka%20K,%20Yamamoto%20T,%20Kawahara%20K,%20Matsuda%20Y,%20Naito%20Z%20(2011)%20Neuroepithelial%20stem%20cell%20marker%20nestin%20regulates%20the%20migration,%20invasion%20and%20growth%20of%20human%20gliomas.%20Oncol%20Rep%2026:91%E2%80%9399.%2010.3892/or.2011.1267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Islam MO, Kanemura Y, Tajria J, Mori H, Kobayashi S, Hara M, Yamasaki M, Okano H, Miyake J (2005) Functional expression of ABCG2 transporter in human neural stem/progenitor cells. Neurosci Res 52:75–82. 10.1016/j.neures.2005.01.013
</cite> [<a href="https://doi.org/10.1016/j.neures.2005.01.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15811555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Islam%20MO,%20Kanemura%20Y,%20Tajria%20J,%20Mori%20H,%20Kobayashi%20S,%20Hara%20M,%20Yamasaki%20M,%20Okano%20H,%20Miyake%20J%20(2005)%20Functional%20expression%20of%20ABCG2%20transporter%20in%20human%20neural%20stem/progenitor%20cells.%20Neurosci%20Res%2052:75%E2%80%9382.%2010.1016/j.neures.2005.01.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Jiang J, Gu J (2010) Beta 1,4-galactosyltransferase V A growth regulator in glioma. Methods Enzymol 479:3–23. 10.1016/S0076-6879(10)79001-7
</cite> [<a href="https://doi.org/10.1016/S0076-6879(10)79001-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20816157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20J,%20Gu%20J%20(2010)%20Beta%201,4-galactosyltransferase%20V%20A%20growth%20regulator%20in%20glioma.%20Methods%20Enzymol%20479:3%E2%80%9323.%2010.1016/S0076-6879(10)79001-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Jin X, Kim LJY, Wu Q, Wallace LC, Prager BC, Sanvoranart T, Gimple RC, Wang X, Mack SC, Miller TE, Huang P, Valentim CL, Zhou Q, Barnholtz-Sloan JS, Bao S, Sloan AE, Rich JN (2017) Targeting glioma stem cells through combined BMI1 and EZH2 inhibition. Nat Med 23:1352. 10.1038/nm.4415
</cite> [<a href="https://doi.org/10.1038/nm.4415" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5679732/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29035367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin%20X,%20Kim%20LJY,%20Wu%20Q,%20Wallace%20LC,%20Prager%20BC,%20Sanvoranart%20T,%20Gimple%20RC,%20Wang%20X,%20Mack%20SC,%20Miller%20TE,%20Huang%20P,%20Valentim%20CL,%20Zhou%20Q,%20Barnholtz-Sloan%20JS,%20Bao%20S,%20Sloan%20AE,%20Rich%20JN%20(2017)%20Targeting%20glioma%20stem%20cells%20through%20combined%20BMI1%20and%20EZH2%20inhibition.%20Nat%20Med%2023:1352.%2010.1038/nm.4415" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Kang HG, Kim D-H, Kim S-J, Cho Y, Jung J, Jang W, Chun K-H (2016) Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain. Oncotarget 7:68229–68241. 10.18632/oncotarget.11920
</cite> [<a href="https://doi.org/10.18632/oncotarget.11920" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5356551/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27626163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kang%20HG,%20Kim%20D-H,%20Kim%20S-J,%20Cho%20Y,%20Jung%20J,%20Jang%20W,%20Chun%20K-H%20(2016)%20Galectin-3%20supports%20stemness%20in%20ovarian%20cancer%20stem%20cells%20by%20activation%20of%20the%20Notch1%20intracellular%20domain.%20Oncotarget%207:68229%E2%80%9368241.%2010.18632/oncotarget.11920" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Karnam S, Kottu R, Chowhan AK, Bodepati PC (2017) Expression of p53 &amp; epidermal growth factor receptor in glioblastoma. Indian J Med Res 146:738–745. 10.4103/ijmr.IJMR_1179_15
</cite> [<a href="https://doi.org/10.4103/ijmr.IJMR_1179_15" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5926345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29664032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Karnam%20S,%20Kottu%20R,%20Chowhan%20AK,%20Bodepati%20PC%20(2017)%20Expression%20of%20p53%20&amp;%20epidermal%20growth%20factor%20receptor%20in%20glioblastoma.%20Indian%20J%20Med%20Res%20146:738%E2%80%93745.%2010.4103/ijmr.IJMR_1179_15" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Kim KL, Shin I-S, Kim J-M, Choi J-H, Byun J, Jeon E-S, Suh W, Kim D-K (2006) Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells. Cardiovasc Res 72:394–402. 10.1016/j.cardiores.2006.08.002
</cite> [<a href="https://doi.org/10.1016/j.cardiores.2006.08.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17054925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20KL,%20Shin%20I-S,%20Kim%20J-M,%20Choi%20J-H,%20Byun%20J,%20Jeon%20E-S,%20Suh%20W,%20Kim%20D-K%20(2006)%20Interaction%20between%20Tie%20receptors%20modulates%20angiogenic%20activity%20of%20angiopoietin2%20in%20endothelial%20progenitor%20cells.%20Cardiovasc%20Res%2072:394%E2%80%93402.%2010.1016/j.cardiores.2006.08.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Kim S-H, Kim E-J, Hitomi M, Oh S-Y, Jin X, Jeon H-M, Beck S, Jin X, Kim J-K, Park CG, Chang S-Y, Yin J, Kim T, Jeon Y, Song J, Lim YC, Lathia JD, Nakano I, Kim H (2015) The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells. Cell Death Differ 22:1517–1525. 10.1038/cdd.2015.7
</cite> [<a href="https://doi.org/10.1038/cdd.2015.7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4532780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25721045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20S-H,%20Kim%20E-J,%20Hitomi%20M,%20Oh%20S-Y,%20Jin%20X,%20Jeon%20H-M,%20Beck%20S,%20Jin%20X,%20Kim%20J-K,%20Park%20CG,%20Chang%20S-Y,%20Yin%20J,%20Kim%20T,%20Jeon%20Y,%20Song%20J,%20Lim%20YC,%20Lathia%20JD,%20Nakano%20I,%20Kim%20H%20(2015)%20The%20LIM-only%20transcription%20factor%20LMO2%20determines%20tumorigenic%20and%20angiogenic%20traits%20in%20glioma%20stem%20cells.%20Cell%20Death%20Differ%2022:1517%E2%80%931525.%2010.1038/cdd.2015.7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Koessinger D, Albrecht V, Faber F, Jaehnert I, Schichor C (2018) ETS-1 expression is hypoxia-independent in glioblastoma-derived endothelial and mesenchymal stem-like cells. Anticancer Res 38:3347–3355. 10.21873/anticanres.12601
</cite> [<a href="https://doi.org/10.21873/anticanres.12601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29848683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koessinger%20D,%20Albrecht%20V,%20Faber%20F,%20Jaehnert%20I,%20Schichor%20C%20(2018)%20ETS-1%20expression%20is%20hypoxia-independent%20in%20glioblastoma-derived%20endothelial%20and%20mesenchymal%20stem-like%20cells.%20Anticancer%20Res%2038:3347%E2%80%933355.%2010.21873/anticanres.12601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Kormish JD, Sinner D, Zorn AM (2010) Interactions between SOX factors and Wnt/β-catenin signaling in development and disease. Dev Dyn 239:56–68. 10.1002/dvdy.22046
</cite> [<a href="https://doi.org/10.1002/dvdy.22046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3269784/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19655378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kormish%20JD,%20Sinner%20D,%20Zorn%20AM%20(2010)%20Interactions%20between%20SOX%20factors%20and%20Wnt/%CE%B2-catenin%20signaling%20in%20development%20and%20disease.%20Dev%20Dyn%20239:56%E2%80%9368.%2010.1002/dvdy.22046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Koyanagi M, Iwasaki M, Rupp S, Tedesco FS, Yoon C-H, Boeckel J-N, Trauth J, Schütz C, Ohtani K, Goetz R, Iekushi K, Bushoven P, Momma S, Mummery C, Passier R, Henschler R, Akintuerk H, Schranz D, Urbich C, Galvez BG, Cossu G, Zeiher AM, Dimmeler S (2010) Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts. Circ Res 106:1290–1302. 10.1161/CIRCRESAHA.109.206045
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.109.206045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20185800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koyanagi%20M,%20Iwasaki%20M,%20Rupp%20S,%20Tedesco%20FS,%20Yoon%20C-H,%20Boeckel%20J-N,%20Trauth%20J,%20Sch%C3%BCtz%20C,%20Ohtani%20K,%20Goetz%20R,%20Iekushi%20K,%20Bushoven%20P,%20Momma%20S,%20Mummery%20C,%20Passier%20R,%20Henschler%20R,%20Akintuerk%20H,%20Schranz%20D,%20Urbich%20C,%20Galvez%20BG,%20Cossu%20G,%20Zeiher%20AM,%20Dimmeler%20S%20(2010)%20Sox2%20transduction%20enhances%20cardiovascular%20repair%20capacity%20of%20blood-derived%20mesoangioblasts.%20Circ%20Res%20106:1290%E2%80%931302.%2010.1161/CIRCRESAHA.109.206045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR (2019) Vessel co-option in cancer. Nat Rev Clin Oncol 16:469–493. 10.1038/s41571-019-0181-9
</cite> [<a href="https://doi.org/10.1038/s41571-019-0181-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30816337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuczynski%20EA,%20Vermeulen%20PB,%20Pezzella%20F,%20Kerbel%20RS,%20Reynolds%20AR%20(2019)%20Vessel%20co-option%20in%20cancer.%20Nat%20Rev%20Clin%20Oncol%2016:469%E2%80%93493.%2010.1038/s41571-019-0181-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CLL, Rich JN (2015) Cancer stem cells in glioblastoma. Genes Dev 29:1203–1217. 10.1101/gad.261982.115
</cite> [<a href="https://doi.org/10.1101/gad.261982.115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4495393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26109046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lathia%20JD,%20Mack%20SC,%20Mulkearns-Hubert%20EE,%20Valentim%20CLL,%20Rich%20JN%20(2015)%20Cancer%20stem%20cells%20in%20glioblastoma.%20Genes%20Dev%2029:1203%E2%80%931217.%2010.1101/gad.261982.115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Lee G, Auffinger B, Guo D, Hasan T, Deheeger M, Tobias AL, Kim JY, Atashi F, Zhang L, Lesniak MS, James CD, Ahmed AU (2016) Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model. Mol Cancer Ther 15:3064–3076. 10.1158/1535-7163.MCT-15-0675
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-15-0675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5298928/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27765847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20G,%20Auffinger%20B,%20Guo%20D,%20Hasan%20T,%20Deheeger%20M,%20Tobias%20AL,%20Kim%20JY,%20Atashi%20F,%20Zhang%20L,%20Lesniak%20MS,%20James%20CD,%20Ahmed%20AU%20(2016)%20Dedifferentiation%20of%20glioma%20cells%20to%20glioma%20stem-like%20cells%20by%20therapeutic%20stress-induced%20HIF%20signaling%20in%20the%20recurrent%20GBM%20model.%20Mol%20Cancer%20Ther%2015:3064%E2%80%933076.%2010.1158/1535-7163.MCT-15-0675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, Um J-Y, Kim WK, Lee J-K, Park J, Kim EH, Lee J-H, Lee J-H, Chung W-S, Ju YS, Park S-H, Chang JH, Kang S-G, Lee JH (2018) Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature 560:243–247. 10.1038/s41586-018-0389-3
</cite> [<a href="https://doi.org/10.1038/s41586-018-0389-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30069053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20JH,%20Lee%20JE,%20Kahng%20JY,%20Kim%20SH,%20Park%20JS,%20Yoon%20SJ,%20Um%20J-Y,%20Kim%20WK,%20Lee%20J-K,%20Park%20J,%20Kim%20EH,%20Lee%20J-H,%20Lee%20J-H,%20Chung%20W-S,%20Ju%20YS,%20Park%20S-H,%20Chang%20JH,%20Kang%20S-G,%20Lee%20JH%20(2018)%20Human%20glioblastoma%20arises%20from%20subventricular%20zone%20cells%20with%20low-level%20driver%20mutations.%20Nature%20560:243%E2%80%93247.%2010.1038/s41586-018-0389-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Lee KS, Choe G, Nam KH, Seo AN, Yun S, Kim KJ, Cho HJ, Park SH (2013) Immunohistochemical classification of primary and secondary glioblastomas. Korean J Pathol 47:541–548. 10.4132/KoreanJPathol.2013.47.6.541
</cite> [<a href="https://doi.org/10.4132/KoreanJPathol.2013.47.6.541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3887156/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24421847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20KS,%20Choe%20G,%20Nam%20KH,%20Seo%20AN,%20Yun%20S,%20Kim%20KJ,%20Cho%20HJ,%20Park%20SH%20(2013)%20Immunohistochemical%20classification%20of%20primary%20and%20secondary%20glioblastomas.%20Korean%20J%20Pathol%2047:541%E2%80%93548.%2010.4132/KoreanJPathol.2013.47.6.541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Lin J, Jiang L, Wang X, Wei W, Song C, Cui Y, Wu X, Qiu G (2021) P4HA2 Promotes epithelial-to-mesenchymal transition and glioma malignancy through the collagen-dependent PI3K/AKT pathway. J Oncol 2021:1406853. 10.1155/2021/1406853
</cite> [<a href="https://doi.org/10.1155/2021/1406853" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8382519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34434233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20J,%20Jiang%20L,%20Wang%20X,%20Wei%20W,%20Song%20C,%20Cui%20Y,%20Wu%20X,%20Qiu%20G%20(2021)%20P4HA2%20Promotes%20epithelial-to-mesenchymal%20transition%20and%20glioma%20malignancy%20through%20the%20collagen-dependent%20PI3K/AKT%20pathway.%20J%20Oncol%202021:1406853.%2010.1155/2021/1406853" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Lin Y, Gil C-H, Banno K, Yokoyama M, Wingo M, Go E, Prasain N, Liu Y, Hato T, Naito H, Wakabayashi T, Sominskaia M, Gao M, Chen K, Geng F, Gomez Salinero JM, Chen S, Shelley WC, Yoshimoto M, Li Calzi S, Murphy MP, Horie K, Grant MB, Schreiner R, Redmond D, Basile DP, Rafii S, Yoder MC (2024) ABCG2-expressing clonal repopulating endothelial cells serve to form and maintain blood vessels. Circulation 150:451–465. 10.1161/CIRCULATIONAHA.122.061833
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.122.061833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11300167/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38682338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20Y,%20Gil%20C-H,%20Banno%20K,%20Yokoyama%20M,%20Wingo%20M,%20Go%20E,%20Prasain%20N,%20Liu%20Y,%20Hato%20T,%20Naito%20H,%20Wakabayashi%20T,%20Sominskaia%20M,%20Gao%20M,%20Chen%20K,%20Geng%20F,%20Gomez%20Salinero%20JM,%20Chen%20S,%20Shelley%20WC,%20Yoshimoto%20M,%20Li%20Calzi%20S,%20Murphy%20MP,%20Horie%20K,%20Grant%20MB,%20Schreiner%20R,%20Redmond%20D,%20Basile%20DP,%20Rafii%20S,%20Yoder%20MC%20(2024)%20ABCG2-expressing%20clonal%20repopulating%20endothelial%20cells%20serve%20to%20form%20and%20maintain%20blood%20vessels.%20Circulation%20150:451%E2%80%93465.%2010.1161/CIRCULATIONAHA.122.061833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Liu H-L, Tang H, Yang H, Deng T-T, Xu Y-P, Xu S-Q, Peng L, Wang Z, Fang Q, Kuang X-Y, Li Q-S (2020) Regulates the transition of cancer stem-like cells to tumor endothelial-like cells in human liver cancer. Front Cell Dev Biol. 10.3389/fcell.2020.563316
</cite> [<a href="https://doi.org/10.3389/fcell.2020.563316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7554317/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33102474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20H-L,%20Tang%20H,%20Yang%20H,%20Deng%20T-T,%20Xu%20Y-P,%20Xu%20S-Q,%20Peng%20L,%20Wang%20Z,%20Fang%20Q,%20Kuang%20X-Y,%20Li%20Q-S%20(2020)%20Regulates%20the%20transition%20of%20cancer%20stem-like%20cells%20to%20tumor%20endothelial-like%20cells%20in%20human%20liver%20cancer.%20Front%20Cell%20Dev%20Biol.%2010.3389/fcell.2020.563316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Liu J, Ji X, Li Z, Zheng H, Zheng W, Jia J, Shen H, Zhang Q, An J (2015) Nestin overexpression promotes the embryonic development of heart and brain through the regulation of cell proliferation. Brain Res 1610:1–11. 10.1016/j.brainres.2015.03.044
</cite> [<a href="https://doi.org/10.1016/j.brainres.2015.03.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25843934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20J,%20Ji%20X,%20Li%20Z,%20Zheng%20H,%20Zheng%20W,%20Jia%20J,%20Shen%20H,%20Zhang%20Q,%20An%20J%20(2015)%20Nestin%20overexpression%20promotes%20the%20embryonic%20development%20of%20heart%20and%20brain%20through%20the%20regulation%20of%20cell%20proliferation.%20Brain%20Res%201610:1%E2%80%9311.%2010.1016/j.brainres.2015.03.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Liu T, Ma W, Xu H, Huang M, Zhang D, He Z, Zhang L, Brem S, O’Rourke DM, Gong Y, Mou Y, Zhang Z, Fan Y (2018) PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma. Nat Commun 9:3439. 10.1038/s41467-018-05982-z
</cite> [<a href="https://doi.org/10.1038/s41467-018-05982-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6110798/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30150753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20T,%20Ma%20W,%20Xu%20H,%20Huang%20M,%20Zhang%20D,%20He%20Z,%20Zhang%20L,%20Brem%20S,%20O%E2%80%99Rourke%20DM,%20Gong%20Y,%20Mou%20Y,%20Zhang%20Z,%20Fan%20Y%20(2018)%20PDGF-mediated%20mesenchymal%20transformation%20renders%20endothelial%20resistance%20to%20anti-VEGF%20treatment%20in%20glioblastoma.%20Nat%20Commun%209:3439.%2010.1038/s41467-018-05982-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Liu Y, Li F, Yang YT, Xu XD, Chen JS, Chen TL, Chen HJ, Zhu YB, Lin JY, Li Y, Xie XM, Sun XL, Ke YQ (2019) IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma. Oncogene 38:1815–1831. 10.1038/s41388-018-0525-4
</cite> [<a href="https://doi.org/10.1038/s41388-018-0525-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30368528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Li%20F,%20Yang%20YT,%20Xu%20XD,%20Chen%20JS,%20Chen%20TL,%20Chen%20HJ,%20Zhu%20YB,%20Lin%20JY,%20Li%20Y,%20Xie%20XM,%20Sun%20XL,%20Ke%20YQ%20(2019)%20IGFBP2%20promotes%20vasculogenic%20mimicry%20formation%20via%20regulating%20CD144%20and%20MMP2%20expression%20in%20glioma.%20Oncogene%2038:1815%E2%80%931831.%2010.1038/s41388-018-0525-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Liu Y-R, Laghari ZA, Novoa CA, Hughes J, Webster JR, Goodwin PE, Wheatley SP, Scotting PJ (2014) Sox2 acts as a transcriptional repressor in neural stem cells. BMC Neurosci 15:95. 10.1186/1471-2202-15-95
</cite> [<a href="https://doi.org/10.1186/1471-2202-15-95" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4148960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25103589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y-R,%20Laghari%20ZA,%20Novoa%20CA,%20Hughes%20J,%20Webster%20JR,%20Goodwin%20PE,%20Wheatley%20SP,%20Scotting%20PJ%20(2014)%20Sox2%20acts%20as%20a%20transcriptional%20repressor%20in%20neural%20stem%20cells.%20BMC%20Neurosci%2015:95.%2010.1186/1471-2202-15-95" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Lopez D, Niu G, Huber P, Carter WB (2009) Tumor-induced upregulation of twist, snail, and slug represses the activity of the human VE-cadherin promoter. Arch Biochem Biophys 482:77–82. 10.1016/j.abb.2008.11.016
</cite> [<a href="https://doi.org/10.1016/j.abb.2008.11.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19046938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lopez%20D,%20Niu%20G,%20Huber%20P,%20Carter%20WB%20(2009)%20Tumor-induced%20upregulation%20of%20twist,%20snail,%20and%20slug%20represses%20the%20activity%20of%20the%20human%20VE-cadherin%20promoter.%20Arch%20Biochem%20Biophys%20482:77%E2%80%9382.%2010.1016/j.abb.2008.11.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Maddison K, Bowden NA, Graves MC, Tooney PA (2023) Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: a systematic review. BMC Cancer 23:185. 10.1186/s12885-023-10659-y
</cite> [<a href="https://doi.org/10.1186/s12885-023-10659-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9948311/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36823554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maddison%20K,%20Bowden%20NA,%20Graves%20MC,%20Tooney%20PA%20(2023)%20Characteristics%20of%20vasculogenic%20mimicry%20and%20tumour%20to%20endothelial%20transdifferentiation%20in%20human%20glioblastoma:%20a%20systematic%20review.%20BMC%20Cancer%2023:185.%2010.1186/s12885-023-10659-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Manoranjan B, Chokshi C, Venugopal C, Subapanditha M, Savage N, Tatari N, Provias JP, Murty NK, Moffat J, Doble BW, Singh SK (2020) A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells. Oncogene 39:1590–1599. 10.1038/s41388-019-1086-x
</cite> [<a href="https://doi.org/10.1038/s41388-019-1086-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31695152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Manoranjan%20B,%20Chokshi%20C,%20Venugopal%20C,%20Subapanditha%20M,%20Savage%20N,%20Tatari%20N,%20Provias%20JP,%20Murty%20NK,%20Moffat%20J,%20Doble%20BW,%20Singh%20SK%20(2020)%20A%20CD133-AKT-Wnt%20signaling%20axis%20drives%20glioblastoma%20brain%20tumor-initiating%20cells.%20Oncogene%2039:1590%E2%80%931599.%2010.1038/s41388-019-1086-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Mao XG, Xue XY, Wang L, Zhang X, Yan M, Tu YY, Lin W, Jiang XF, Ren HG, Zhang W, Song SJ (2013) CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia. Neuro-Oncol 15:865–879. 10.1093/neuonc/not029
</cite> [<a href="https://doi.org/10.1093/neuonc/not029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3688011/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23645533/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mao%20XG,%20Xue%20XY,%20Wang%20L,%20Zhang%20X,%20Yan%20M,%20Tu%20YY,%20Lin%20W,%20Jiang%20XF,%20Ren%20HG,%20Zhang%20W,%20Song%20SJ%20(2013)%20CDH5%20is%20specifically%20activated%20in%20glioblastoma%20stemlike%20cells%20and%20contributes%20to%20vasculogenic%20mimicry%20induced%20by%20hypoxia.%20Neuro-Oncol%2015:865%E2%80%93879.%2010.1093/neuonc/not029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Martino-Echarri E, Fernández-Rodríguez R, Bech-Serra JJ, del Carmen P-CM, Vidal N, Casal C, Colomé N, Seoane J, Canals F, Rodríguez-Manzaneque JC (2014) Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1. Oncotarget 5:4295–4304. 10.18632/oncotarget.2009
</cite> [<a href="https://doi.org/10.18632/oncotarget.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4147324/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24962328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Martino-Echarri%20E,%20Fern%C3%A1ndez-Rodr%C3%ADguez%20R,%20Bech-Serra%20JJ,%20del%20Carmen%20P-CM,%20Vidal%20N,%20Casal%20C,%20Colom%C3%A9%20N,%20Seoane%20J,%20Canals%20F,%20Rodr%C3%ADguez-Manzaneque%20JC%20(2014)%20Relevance%20of%20IGFBP2%20proteolysis%20in%20glioma%20and%20contribution%20of%20the%20extracellular%20protease%20ADAMTS1.%20Oncotarget%205:4295%E2%80%934304.%2010.18632/oncotarget.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Meacham CE, Morrison SJ (2013) Tumour heterogeneity and cancer cell plasticity. Nature 501:328–337. 10.1038/nature12624
</cite> [<a href="https://doi.org/10.1038/nature12624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4521623/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24048065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meacham%20CE,%20Morrison%20SJ%20(2013)%20Tumour%20heterogeneity%20and%20cancer%20cell%20plasticity.%20Nature%20501:328%E2%80%93337.%2010.1038/nature12624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Mei X, Chen Y-S, Chen F-R, Xi S-Y, Chen Z-P (2017) Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging. Neuro Oncol 19:1109–1118. 10.1093/neuonc/nox016
</cite> [<a href="https://doi.org/10.1093/neuonc/nox016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5570159/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28340100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mei%20X,%20Chen%20Y-S,%20Chen%20F-R,%20Xi%20S-Y,%20Chen%20Z-P%20(2017)%20Glioblastoma%20stem%20cell%20differentiation%20into%20endothelial%20cells%20evidenced%20through%20live-cell%20imaging.%20Neuro%20Oncol%2019:1109%E2%80%931118.%2010.1093/neuonc/nox016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Moeton M, Stassen OMJA, Sluijs JA, van der Meer VWN, Kluivers LJ, van Hoorn H, Schmidt T, Reits EAJ, van Strien ME, Hol EM (2016) GFAP isoforms control intermediate filament network dynamics, cell morphology, and focal adhesions. Cell Mol Life Sci 73:4101–4120. 10.1007/s00018-016-2239-5
</cite> [<a href="https://doi.org/10.1007/s00018-016-2239-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5043008/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27141937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moeton%20M,%20Stassen%20OMJA,%20Sluijs%20JA,%20van%20der%20Meer%20VWN,%20Kluivers%20LJ,%20van%20Hoorn%20H,%20Schmidt%20T,%20Reits%20EAJ,%20van%20Strien%20ME,%20Hol%20EM%20(2016)%20GFAP%20isoforms%20control%20intermediate%20filament%20network%20dynamics,%20cell%20morphology,%20and%20focal%20adhesions.%20Cell%20Mol%20Life%20Sci%2073:4101%E2%80%934120.%2010.1007/s00018-016-2239-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Mohiuddin IS, Wei S-J, Kang MH (2020) Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochimica et Biophysica Acta (BBA) Mol Basis Dis 1866(4):165432. 10.1016/j.bbadis.2019.03.005</cite> [<a href="https://doi.org/10.1016/j.bbadis.2019.03.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6754810/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30904611/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mohiuddin%20IS,%20Wei%20S-J,%20Kang%20MH%20(2020)%20Role%20of%20OCT4%20in%20cancer%20stem-like%20cells%20and%20chemotherapy%20resistance.%20Biochimica%20et%20Biophysica%20Acta%20(BBA)%20Mol%20Basis%20Dis%201866(4):165432.%2010.1016/j.bbadis.2019.03.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Moreno-Londoño AP, Robles-Flores M (2024) Functional roles of CD133: more than stemness associated factor regulated by the microenvironment. Stem Cell Rev and Rep 20:25–51. 10.1007/s12015-023-10647-6
</cite> [<a href="https://doi.org/10.1007/s12015-023-10647-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10799829/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37922108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moreno-Londo%C3%B1o%20AP,%20Robles-Flores%20M%20(2024)%20Functional%20roles%20of%20CD133:%20more%20than%20stemness%20associated%20factor%20regulated%20by%20the%20microenvironment.%20Stem%20Cell%20Rev%20and%20Rep%2020:25%E2%80%9351.%2010.1007/s12015-023-10647-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Mou Y, Yue Z, Wang X, Li W, Zhang H, Wang Y, Li R, Sun X (2016) OCT4 remodels the phenotype and promotes angiogenesis of HUVECs by changing the gene expression profile. Int J Med Sci 13:386–394. 10.7150/ijms.15057
</cite> [<a href="https://doi.org/10.7150/ijms.15057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4879770/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27226779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mou%20Y,%20Yue%20Z,%20Wang%20X,%20Li%20W,%20Zhang%20H,%20Wang%20Y,%20Li%20R,%20Sun%20X%20(2016)%20OCT4%20remodels%20the%20phenotype%20and%20promotes%20angiogenesis%20of%20HUVECs%20by%20changing%20the%20gene%20expression%20profile.%20Int%20J%20Med%20Sci%2013:386%E2%80%93394.%2010.7150/ijms.15057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Mu Q, Wang L, Yu F, Gao H, Lei T, Li P, Liu P, Zheng X, Hu X, Chen Y, Jiang Z, Sayari AJ, Shen J, Huang H (2015) Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway. Cancer Biol Ther 16:623–633. 10.1080/15384047.2015.1019185
</cite> [<a href="https://doi.org/10.1080/15384047.2015.1019185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4622833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25719943/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mu%20Q,%20Wang%20L,%20Yu%20F,%20Gao%20H,%20Lei%20T,%20Li%20P,%20Liu%20P,%20Zheng%20X,%20Hu%20X,%20Chen%20Y,%20Jiang%20Z,%20Sayari%20AJ,%20Shen%20J,%20Huang%20H%20(2015)%20Imp2%20regulates%20GBM%20progression%20by%20activating%20IGF2/PI3K/Akt%20pathway.%20Cancer%20Biol%20Ther%2016:623%E2%80%93633.%2010.1080/15384047.2015.1019185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Nielsen JS, Mcnagny KM (2009) CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation 16:487–496. 10.1080/10739680902941737
</cite> [<a href="https://doi.org/10.1080/10739680902941737" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19479621/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nielsen%20JS,%20Mcnagny%20KM%20(2009)%20CD34%20is%20a%20key%20regulator%20of%20hematopoietic%20stem%20cell%20trafficking%20to%20bone%20marrow%20and%20mast%20cell%20progenitor%20trafficking%20in%20the%20periphery.%20Microcirculation%2016:487%E2%80%93496.%2010.1080/10739680902941737" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Núñez-Gómez E, Pericacho M, Ollauri-Ibáñez C, Bernabéu C, López-Novoa JM (2017) The role of endoglin in post-ischemic revascularization. Angiogenesis 20:1–24. 10.1007/s10456-016-9535-4
</cite> [<a href="https://doi.org/10.1007/s10456-016-9535-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27943030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?N%C3%BA%C3%B1ez-G%C3%B3mez%20E,%20Pericacho%20M,%20Ollauri-Ib%C3%A1%C3%B1ez%20C,%20Bernab%C3%A9u%20C,%20L%C3%B3pez-Novoa%20JM%20(2017)%20The%20role%20of%20endoglin%20in%20post-ischemic%20revascularization.%20Angiogenesis%2020:1%E2%80%9324.%2010.1007/s10456-016-9535-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Ogawa K, Oguchi M, Nakashima Y, Yamabe H (1989) Distribution of collagen Type IV in brain tumors: an immunohistochemical study. J Neuro-Oncol 7:357–366. 10.1007/BF02147093</cite> [<a href="https://doi.org/10.1007/BF02147093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2585030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ogawa%20K,%20Oguchi%20M,%20Nakashima%20Y,%20Yamabe%20H%20(1989)%20Distribution%20of%20collagen%20Type%20IV%20in%20brain%20tumors:%20an%20immunohistochemical%20study.%20J%20Neuro-Oncol%207:357%E2%80%93366.%2010.1007/BF02147093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Oh S-Y, Kim JY, Park C (2015) The ETS factor, ETV2: a master regulator for vascular endothelial cell development. Mol Cells 38:1029. 10.14348/molcells.2015.0331
</cite> [<a href="https://doi.org/10.14348/molcells.2015.0331" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4696993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26694034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oh%20S-Y,%20Kim%20JY,%20Park%20C%20(2015)%20The%20ETS%20factor,%20ETV2:%20a%20master%20regulator%20for%20vascular%20endothelial%20cell%20development.%20Mol%20Cells%2038:1029.%2010.14348/molcells.2015.0331" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Oliveira MN, Breznik B, Pillat MM, Pereira RL, Ulrich H, Lah TT (2019) Kinins in glioblastoma microenvironment. Cancer Microenviron 12:77. 10.1007/s12307-019-00229-x
</cite> [<a href="https://doi.org/10.1007/s12307-019-00229-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6937362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31420805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oliveira%20MN,%20Breznik%20B,%20Pillat%20MM,%20Pereira%20RL,%20Ulrich%20H,%20Lah%20TT%20(2019)%20Kinins%20in%20glioblastoma%20microenvironment.%20Cancer%20Microenviron%2012:77.%2010.1007/s12307-019-00229-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Ollauri-Ibáñez C, Núñez-Gómez E, Egido-Turrión C, Silva-Sousa L, Díaz-Rodríguez E, Rodríguez-Barbero A, López-Novoa JM, Pericacho M (2020) Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis. Angiogenesis 23:231. 10.1007/s10456-019-09703-y
</cite> [<a href="https://doi.org/10.1007/s10456-019-09703-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7160077/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31897911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ollauri-Ib%C3%A1%C3%B1ez%20C,%20N%C3%BA%C3%B1ez-G%C3%B3mez%20E,%20Egido-Turri%C3%B3n%20C,%20Silva-Sousa%20L,%20D%C3%ADaz-Rodr%C3%ADguez%20E,%20Rodr%C3%ADguez-Barbero%20A,%20L%C3%B3pez-Novoa%20JM,%20Pericacho%20M%20(2020)%20Continuous%20endoglin%20(CD105)%20overexpression%20disrupts%20angiogenesis%20and%20facilitates%20tumor%20cell%20metastasis.%20Angiogenesis%2023:231.%2010.1007/s10456-019-09703-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Ostrowska-Podhorodecka Z, Ding I, Norouzi M, McCulloch CA (2022) Impact of vimentin on regulation of cell signaling and matrix remodeling. Front Cell Dev Biol. 10.3389/fcell.2022.869069
</cite> [<a href="https://doi.org/10.3389/fcell.2022.869069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8961691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35359446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ostrowska-Podhorodecka%20Z,%20Ding%20I,%20Norouzi%20M,%20McCulloch%20CA%20(2022)%20Impact%20of%20vimentin%20on%20regulation%20of%20cell%20signaling%20and%20matrix%20remodeling.%20Front%20Cell%20Dev%20Biol.%2010.3389/fcell.2022.869069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suvà ML, Regev A, Bernstein BE (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344:1396–1401. 10.1126/science.1254257
</cite> [<a href="https://doi.org/10.1126/science.1254257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4123637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24925914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel%20AP,%20Tirosh%20I,%20Trombetta%20JJ,%20Shalek%20AK,%20Gillespie%20SM,%20Wakimoto%20H,%20Cahill%20DP,%20Nahed%20BV,%20Curry%20WT,%20Martuza%20RL,%20Louis%20DN,%20Rozenblatt-Rosen%20O,%20Suv%C3%A0%20ML,%20Regev%20A,%20Bernstein%20BE%20(2014)%20Single-cell%20RNA-seq%20highlights%20intratumoral%20heterogeneity%20in%20primary%20glioblastoma.%20Science%20344:1396%E2%80%931401.%2010.1126/science.1254257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Patel J, Seppanen EJ, Rodero MP, Wong HY, Donovan P, Neufeld Z, Fisk NM, Francois M, Khosrotehrani K (2017) Functional definition of progenitors versus mature endothelial cells reveals key SoxF-Dependent differentiation process. Circulation 135:786–805. 10.1161/CIRCULATIONAHA.116.024754
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.116.024754" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27899395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel%20J,%20Seppanen%20EJ,%20Rodero%20MP,%20Wong%20HY,%20Donovan%20P,%20Neufeld%20Z,%20Fisk%20NM,%20Francois%20M,%20Khosrotehrani%20K%20(2017)%20Functional%20definition%20of%20progenitors%20versus%20mature%20endothelial%20cells%20reveals%20key%20SoxF-Dependent%20differentiation%20process.%20Circulation%20135:786%E2%80%93805.%2010.1161/CIRCULATIONAHA.116.024754" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Peereboom DM, Ye X, Mikkelsen T, Lesser GJ, Lieberman FS, Robins HI, Ahluwalia MS, Sloan AE, Grossman SA (2020) A phase II and pharmacodynamic trial of RO4929097 for patients with recurrent/progressive glioblastoma. Neurosurgery 88:246–251. 10.1093/neuros/nyaa412</cite> [<a href="https://doi.org/10.1093/neuros/nyaa412" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7919338/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33027815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peereboom%20DM,%20Ye%20X,%20Mikkelsen%20T,%20Lesser%20GJ,%20Lieberman%20FS,%20Robins%20HI,%20Ahluwalia%20MS,%20Sloan%20AE,%20Grossman%20SA%20(2020)%20A%20phase%20II%20and%20pharmacodynamic%20trial%20of%20RO4929097%20for%20patients%20with%20recurrent/progressive%20glioblastoma.%20Neurosurgery%2088:246%E2%80%93251.%2010.1093/neuros/nyaa412" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Pitz MW, Eisenhauer EA, MacNeil MV, Thiessen B, Easaw JC, Macdonald DR, Eisenstat DD, Kakumanu AS, Salim M, Chalchal H, Squire J, Tsao MS, Kamel-Reid S, Banerji S, Tu D, Powers J, Hausman DF, Mason WP (2015) Phase II study of PX-866 in recurrent glioblastoma. Neuro Oncol 17:1270–1274. 10.1093/neuonc/nou365
</cite> [<a href="https://doi.org/10.1093/neuonc/nou365" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4588751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25605819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pitz%20MW,%20Eisenhauer%20EA,%20MacNeil%20MV,%20Thiessen%20B,%20Easaw%20JC,%20Macdonald%20DR,%20Eisenstat%20DD,%20Kakumanu%20AS,%20Salim%20M,%20Chalchal%20H,%20Squire%20J,%20Tsao%20MS,%20Kamel-Reid%20S,%20Banerji%20S,%20Tu%20D,%20Powers%20J,%20Hausman%20DF,%20Mason%20WP%20(2015)%20Phase%20II%20study%20of%20PX-866%20in%20recurrent%20glioblastoma.%20Neuro%20Oncol%2017:1270%E2%80%931274.%2010.1093/neuonc/nou365" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Porcù E, Maule F, Boso D, Rampazzo E, Barbieri V, Zuccolotto G, Rosato A, Frasson C, Viola G, Della Puppa A, Basso G, Persano L (2018) BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma. Cell Death Differ 25:1808–1822. 10.1038/s41418-018-0149-9
</cite> [<a href="https://doi.org/10.1038/s41418-018-0149-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6180121/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29977042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Porc%C3%B9%20E,%20Maule%20F,%20Boso%20D,%20Rampazzo%20E,%20Barbieri%20V,%20Zuccolotto%20G,%20Rosato%20A,%20Frasson%20C,%20Viola%20G,%20Della%20Puppa%20A,%20Basso%20G,%20Persano%20L%20(2018)%20BMP9%20counteracts%20the%20tumorigenic%20and%20pro-angiogenic%20potential%20of%20glioblastoma.%20Cell%20Death%20Differ%2025:1808%E2%80%931822.%2010.1038/s41418-018-0149-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Rakocevic J, Orlic D, Mitrovic-Ajtic O, Tomasevic M, Dobric M, Zlatic N, Milasinovic D, Stankovic G, Ostojić M, Labudovic-Borovic M (2017) Endothelial cell markers from clinician’s perspective. Exp Mol Pathol 102:303–313. 10.1016/j.yexmp.2017.02.005
</cite> [<a href="https://doi.org/10.1016/j.yexmp.2017.02.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28192087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rakocevic%20J,%20Orlic%20D,%20Mitrovic-Ajtic%20O,%20Tomasevic%20M,%20Dobric%20M,%20Zlatic%20N,%20Milasinovic%20D,%20Stankovic%20G,%20Ostoji%C4%87%20M,%20Labudovic-Borovic%20M%20(2017)%20Endothelial%20cell%20markers%20from%20clinician%E2%80%99s%20perspective.%20Exp%20Mol%20Pathol%20102:303%E2%80%93313.%2010.1016/j.yexmp.2017.02.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468:824–828. 10.1038/nature09557
</cite> [<a href="https://doi.org/10.1038/nature09557" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21102434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ricci-Vitiani%20L,%20Pallini%20R,%20Biffoni%20M,%20Todaro%20M,%20Invernici%20G,%20Cenci%20T,%20Maira%20G,%20Parati%20EA,%20Stassi%20G,%20Larocca%20LM,%20De%20Maria%20R%20(2010)%20Tumour%20vascularization%20via%20endothelial%20differentiation%20of%20glioblastoma%20stem-like%20cells.%20Nature%20468:824%E2%80%93828.%2010.1038/nature09557" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Rosińska S, Gavard J (2021) Tumor vessels fuel the fire in glioblastoma. Int J Mol Sci 22:6514. 10.3390/ijms22126514
</cite> [<a href="https://doi.org/10.3390/ijms22126514" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8235363/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34204510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rosi%C5%84ska%20S,%20Gavard%20J%20(2021)%20Tumor%20vessels%20fuel%20the%20fire%20in%20glioblastoma.%20Int%20J%20Mol%20Sci%2022:6514.%2010.3390/ijms22126514" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Suzuki S, Namiki J, Shibata S, Mastuzaki Y, Okano H (2010) The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature. J Histochem Cytochem: Off J Histochem Soc. 10.1369/jhc.2010.955609</cite> [<a href="https://doi.org/10.1369/jhc.2010.955609" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2907277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20421592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suzuki%20S,%20Namiki%20J,%20Shibata%20S,%20Mastuzaki%20Y,%20Okano%20H%20(2010)%20The%20neural%20stem/progenitor%20cell%20marker%20nestin%20is%20expressed%20in%20proliferative%20endothelial%20cells,%20but%20not%20in%20mature%20vasculature.%20J%20Histochem%20Cytochem:%20Off%20J%20Histochem%20Soc.%2010.1369/jhc.2010.955609" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Saharinen P, Eklund L, Alitalo K (2017) Therapeutic targeting of the angiopoietin–TIE pathway. Nat Rev Drug Discov 16:635–661. 10.1038/nrd.2016.278
</cite> [<a href="https://doi.org/10.1038/nrd.2016.278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28529319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saharinen%20P,%20Eklund%20L,%20Alitalo%20K%20(2017)%20Therapeutic%20targeting%20of%20the%20angiopoietin%E2%80%93TIE%20pathway.%20Nat%20Rev%20Drug%20Discov%2016:635%E2%80%93661.%2010.1038/nrd.2016.278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Schaefer T, Lengerke C (2020) SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond. Oncogene 39:278–292. 10.1038/s41388-019-0997-x
</cite> [<a href="https://doi.org/10.1038/s41388-019-0997-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6949191/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31477842/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schaefer%20T,%20Lengerke%20C%20(2020)%20SOX2%20protein%20biochemistry%20in%20stemness,%20reprogramming,%20and%20cancer:%20the%20PI3K/AKT/SOX2%20axis%20and%20beyond.%20Oncogene%2039:278%E2%80%93292.%2010.1038/s41388-019-0997-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Schiffer D, Annovazzi L, Casalone C, Corona C, Mellai M (2018) Glioblastoma: microenvironment and niche concept. Cancers 11:5. 10.3390/cancers11010005
</cite> [<a href="https://doi.org/10.3390/cancers11010005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6357107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30577488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schiffer%20D,%20Annovazzi%20L,%20Casalone%20C,%20Corona%20C,%20Mellai%20M%20(2018)%20Glioblastoma:%20microenvironment%20and%20niche%20concept.%20Cancers%2011:5.%2010.3390/cancers11010005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Schulz JA, Hartz AMS, Bauer B (2023) ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery. Pharmacol Rev 75:815–853. 10.1124/pharmrev.120.000025
</cite> [<a href="https://doi.org/10.1124/pharmrev.120.000025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10441638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36973040/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schulz%20JA,%20Hartz%20AMS,%20Bauer%20B%20(2023)%20ABCB1%20and%20ABCG2%20regulation%20at%20the%20blood-brain%20barrier:%20potential%20new%20targets%20to%20improve%20brain%20drug%20delivery.%20Pharmacol%20Rev%2075:815%E2%80%93853.%2010.1124/pharmrev.120.000025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>Serrano-Garrido O, Peris-Torres C, Redondo-García S, Asenjo HG, Plaza-Calonge MD, Fernandez-Luna JL, Rodríguez-Manzaneque JC (2020) ADAMTS1 supports endothelial plasticity of glioblastoma cells with relevance for glioma progression. Biomolecules 11:44. 10.3390/biom11010044
</cite> [<a href="https://doi.org/10.3390/biom11010044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7823850/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33396280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Serrano-Garrido%20O,%20Peris-Torres%20C,%20Redondo-Garc%C3%ADa%20S,%20Asenjo%20HG,%20Plaza-Calonge%20MD,%20Fernandez-Luna%20JL,%20Rodr%C3%ADguez-Manzaneque%20JC%20(2020)%20ADAMTS1%20supports%20endothelial%20plasticity%20of%20glioblastoma%20cells%20with%20relevance%20for%20glioma%20progression.%20Biomolecules%2011:44.%2010.3390/biom11010044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Shaifer CA, Huang J, Lin PC (2010) Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance. Int J Cancer J Int Cancer 127:2063. 10.1002/ijc.25249</cite> [<a href="https://doi.org/10.1002/ijc.25249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2932815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20162571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shaifer%20CA,%20Huang%20J,%20Lin%20PC%20(2010)%20Glioblastoma%20cells%20incorporate%20into%20tumor%20vasculature%20and%20contribute%20to%20vascular%20radioresistance.%20Int%20J%20Cancer%20J%20Int%20Cancer%20127:2063.%2010.1002/ijc.25249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Shen C-N, Burke ZD, Tosh D (2004) Transdifferentiation, metaplasia and tissue regeneration. Organogenesis 1:36–44
</cite> [<a href="https://doi.org/10.4161/org.1.2.1409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2633984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19521559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20C-N,%20Burke%20ZD,%20Tosh%20D%20(2004)%20Transdifferentiation,%20metaplasia%20and%20tissue%20regeneration.%20Organogenesis%201:36%E2%80%9344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Shi L, Wang Z, Rong J, Fei X, Li X, He B, Gong W, Qian J (2023) Inhibition of TGF-β1-induced epithelial-mesenchymal transition in gliomas by DMC-HA. Aging 15:15183–15195. 10.18632/aging.205340
</cite> [<a href="https://doi.org/10.18632/aging.205340" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10781457/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38154100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20L,%20Wang%20Z,%20Rong%20J,%20Fei%20X,%20Li%20X,%20He%20B,%20Gong%20W,%20Qian%20J%20(2023)%20Inhibition%20of%20TGF-%CE%B21-induced%20epithelial-mesenchymal%20transition%20in%20gliomas%20by%20DMC-HA.%20Aging%2015:15183%E2%80%9315195.%2010.18632/aging.205340" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Shibao S, Minami N, Koike N, Fukui N, Yoshida K, Saya H, Sampetrean O (2018) Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model. Neuro Oncol 20:343–354. 10.1093/neuonc/nox170
</cite> [<a href="https://doi.org/10.1093/neuonc/nox170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5817950/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29016888/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shibao%20S,%20Minami%20N,%20Koike%20N,%20Fukui%20N,%20Yoshida%20K,%20Saya%20H,%20Sampetrean%20O%20(2018)%20Metabolic%20heterogeneity%20and%20plasticity%20of%20glioma%20stem%20cells%20in%20a%20mouse%20glioblastoma%20model.%20Neuro%20Oncol%2020:343%E2%80%93354.%2010.1093/neuonc/nox170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Sica G, Lama G, Anile C, Geloso MC, La Torre G, De Bonis P, Maira G, Lauriola L, Jhanwar-Uniyal M, Mangiola A (2011) Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol 38:41–49. 10.3892/ijo_00000822
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/21109924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sica%20G,%20Lama%20G,%20Anile%20C,%20Geloso%20MC,%20La%20Torre%20G,%20De%20Bonis%20P,%20Maira%20G,%20Lauriola%20L,%20Jhanwar-Uniyal%20M,%20Mangiola%20A%20(2011)%20Assessment%20of%20angiogenesis%20by%20CD105%20and%20nestin%20expression%20in%20peritumor%20tissue%20of%20glioblastoma.%20Int%20J%20Oncol%2038:41%E2%80%9349.%2010.3892/ijo_00000822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Siemerink MJ, Klaassen I, Vogels IMC, Griffioen AW, Van Noorden CJF, Schlingemann RO (2012) CD34 marks angiogenic tip cells in human vascular endothelial cell cultures. Angiogenesis 15:151–163. 10.1007/s10456-011-9251-z
</cite> [<a href="https://doi.org/10.1007/s10456-011-9251-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3274677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22249946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Siemerink%20MJ,%20Klaassen%20I,%20Vogels%20IMC,%20Griffioen%20AW,%20Van%20Noorden%20CJF,%20Schlingemann%20RO%20(2012)%20CD34%20marks%20angiogenic%20tip%20cells%20in%20human%20vascular%20endothelial%20cell%20cultures.%20Angiogenesis%2015:151%E2%80%93163.%2010.1007/s10456-011-9251-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Simons M, Gordon E, Claesson-Welsh L (2016) Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol 17:611–625. 10.1038/nrm.2016.87
</cite> [<a href="https://doi.org/10.1038/nrm.2016.87" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27461391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Simons%20M,%20Gordon%20E,%20Claesson-Welsh%20L%20(2016)%20Mechanisms%20and%20regulation%20of%20endothelial%20VEGF%20receptor%20signalling.%20Nat%20Rev%20Mol%20Cell%20Biol%2017:611%E2%80%93625.%2010.1038/nrm.2016.87" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Smith SJ, Ward JH, Tan C, Grundy RG, Rahman R (2015) Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response. Oncotarget 6:22191–22205. 10.18632/oncotarget.4339
</cite> [<a href="https://doi.org/10.18632/oncotarget.4339" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4673156/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26203665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Smith%20SJ,%20Ward%20JH,%20Tan%20C,%20Grundy%20RG,%20Rahman%20R%20(2015)%20Endothelial-like%20malignant%20glioma%20cells%20in%20dynamic%20three%20dimensional%20culture%20identifies%20a%20role%20for%20VEGF%20and%20FGFR%20in%20a%20tumor-derived%20angiogenic%20response.%20Oncotarget%206:22191%E2%80%9322205.%2010.18632/oncotarget.4339" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, Verma IM (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci 108:4274–4280. 10.1073/pnas.1016030108
</cite> [<a href="https://doi.org/10.1073/pnas.1016030108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3060261/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21262804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Soda%20Y,%20Marumoto%20T,%20Friedmann-Morvinski%20D,%20Soda%20M,%20Liu%20F,%20Michiue%20H,%20Pastorino%20S,%20Yang%20M,%20Hoffman%20RM,%20Kesari%20S,%20Verma%20IM%20(2011)%20Transdifferentiation%20of%20glioblastoma%20cells%20into%20vascular%20endothelial%20cells.%20Proc%20Natl%20Acad%20Sci%20108:4274%E2%80%934280.%2010.1073/pnas.1016030108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Strowd R, Ellingson B, Raymond C, Yao J, Wen PY, Ahluwalia M, Piotrowski A, Desai A, Clarke JL, Lieberman FS, Desideri S, Nabors LB, Ye X, Grossman S (2023) Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma. J Neurooncol 165:101–112. 10.1007/s11060-023-04456-7
</cite> [<a href="https://doi.org/10.1007/s11060-023-04456-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10863646/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37864646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Strowd%20R,%20Ellingson%20B,%20Raymond%20C,%20Yao%20J,%20Wen%20PY,%20Ahluwalia%20M,%20Piotrowski%20A,%20Desai%20A,%20Clarke%20JL,%20Lieberman%20FS,%20Desideri%20S,%20Nabors%20LB,%20Ye%20X,%20Grossman%20S%20(2023)%20Activity%20of%20a%20first-in-class%20oral%20HIF2-alpha%20inhibitor,%20PT2385,%20in%20patients%20with%20first%20recurrence%20of%20glioblastoma.%20J%20Neurooncol%20165:101%E2%80%93112.%2010.1007/s11060-023-04456-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, Dejana E (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10:923–934. 10.1038/ncb1752
</cite> [<a href="https://doi.org/10.1038/ncb1752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18604199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Taddei%20A,%20Giampietro%20C,%20Conti%20A,%20Orsenigo%20F,%20Breviario%20F,%20Pirazzoli%20V,%20Potente%20M,%20Daly%20C,%20Dimmeler%20S,%20Dejana%20E%20(2008)%20Endothelial%20adherens%20junctions%20control%20tight%20junctions%20by%20VE-cadherin-mediated%20upregulation%20of%20claudin-5.%20Nat%20Cell%20Biol%2010:923%E2%80%93934.%2010.1038/ncb1752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Teichert M, Milde L, Holm A, Stanicek L, Gengenbacher N, Savant S, Ruckdeschel T, Hasanov Z, Srivastava K, Hu J, Hertel S, Bartol A, Schlereth K, Augustin HG (2017) Pericyte-expressed Tie2 controls angiogenesis and vessel maturation. Nat Commun 8:16106. 10.1038/ncomms16106
</cite> [<a href="https://doi.org/10.1038/ncomms16106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5520106/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28719590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Teichert%20M,%20Milde%20L,%20Holm%20A,%20Stanicek%20L,%20Gengenbacher%20N,%20Savant%20S,%20Ruckdeschel%20T,%20Hasanov%20Z,%20Srivastava%20K,%20Hu%20J,%20Hertel%20S,%20Bartol%20A,%20Schlereth%20K,%20Augustin%20HG%20(2017)%20Pericyte-expressed%20Tie2%20controls%20angiogenesis%20and%20vessel%20maturation.%20Nat%20Commun%208:16106.%2010.1038/ncomms16106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Timmerman I, Daniel AE, Kroon J, Van Buul JD (2016) Leukocytes crossing the endothelium: a matter of communication. in: international review of cell and molecular biology. Elsevier, pp 281–329</cite> [<a href="https://doi.org/10.1016/bs.ircmb.2015.10.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26940521/" class="usa-link">PubMed</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>Tirrò E, Massimino M, Romano C, Martorana F, Pennisi MS, Stella S, Pavone G, Di Gregorio S, Puma A, Tomarchio C, Vitale SR, Manzella L, Vigneri P (2020) Prognostic and therapeutic roles of the insulin growth factor system in glioblastoma. Front Oncol 10:612385. 10.3389/fonc.2020.612385
</cite> [<a href="https://doi.org/10.3389/fonc.2020.612385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7885861/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33604294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tirr%C3%B2%20E,%20Massimino%20M,%20Romano%20C,%20Martorana%20F,%20Pennisi%20MS,%20Stella%20S,%20Pavone%20G,%20Di%20Gregorio%20S,%20Puma%20A,%20Tomarchio%20C,%20Vitale%20SR,%20Manzella%20L,%20Vigneri%20P%20(2020)%20Prognostic%20and%20therapeutic%20roles%20of%20the%20insulin%20growth%20factor%20system%20in%20glioblastoma.%20Front%20Oncol%2010:612385.%2010.3389/fonc.2020.612385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Torsvik A, Stieber D, Enger PØ, Golebiewska A, Molven A, Svendsen A, Westermark B, Niclou SP, Olsen TK, Chekenya Enger M, Bjerkvig R (2014) U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Med 3:812–824. 10.1002/cam4.219
</cite> [<a href="https://doi.org/10.1002/cam4.219" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4303149/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24810477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Torsvik%20A,%20Stieber%20D,%20Enger%20P%C3%98,%20Golebiewska%20A,%20Molven%20A,%20Svendsen%20A,%20Westermark%20B,%20Niclou%20SP,%20Olsen%20TK,%20Chekenya%20Enger%20M,%20Bjerkvig%20R%20(2014)%20U-251%20revisited:%20genetic%20drift%20and%20phenotypic%20consequences%20of%20long-term%20cultures%20of%20glioblastoma%20cells.%20Cancer%20Med%203:812%E2%80%93824.%2010.1002/cam4.219" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>Tsang KM, Hyun JS, Cheng KT, Vargas M, Mehta D, Ushio-Fukai M, Zou L, Pajcini KV, Rehman J, Malik AB (2017) Embryonic stem cell differentiation to functional arterial endothelial cells through sequential activation of ETV2 and NOTCH1 signaling by HIF1α. Stem Cell Reports 9:796–806. 10.1016/j.stemcr.2017.07.001
</cite> [<a href="https://doi.org/10.1016/j.stemcr.2017.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5599266/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28781077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsang%20KM,%20Hyun%20JS,%20Cheng%20KT,%20Vargas%20M,%20Mehta%20D,%20Ushio-Fukai%20M,%20Zou%20L,%20Pajcini%20KV,%20Rehman%20J,%20Malik%20AB%20(2017)%20Embryonic%20stem%20cell%20differentiation%20to%20functional%20arterial%20endothelial%20cells%20through%20sequential%20activation%20of%20ETV2%20and%20NOTCH1%20signaling%20by%20HIF1%CE%B1.%20Stem%20Cell%20Reports%209:796%E2%80%93806.%2010.1016/j.stemcr.2017.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Turtoi A, Blomme A, Bianchi E, Maris P, Vannozzi R, Naccarato AG, Delvenne P, De Pauw E, Bevilacqua G, Castronovo V (2014) Accessibilome of human glioblastoma: collagen-VI-alpha-1 is a new target and a marker of poor outcome. J Proteome Res 13:5660–5669. 10.1021/pr500657w
</cite> [<a href="https://doi.org/10.1021/pr500657w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25325876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Turtoi%20A,%20Blomme%20A,%20Bianchi%20E,%20Maris%20P,%20Vannozzi%20R,%20Naccarato%20AG,%20Delvenne%20P,%20De%20Pauw%20E,%20Bevilacqua%20G,%20Castronovo%20V%20(2014)%20Accessibilome%20of%20human%20glioblastoma:%20collagen-VI-alpha-1%20is%20a%20new%20target%20and%20a%20marker%20of%20poor%20outcome.%20J%20Proteome%20Res%2013:5660%E2%80%935669.%2010.1021/pr500657w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Vásquez X, Sánchez-Gómez P, Palma V (2021) Netrin-1 in glioblastoma neovascularization: the new partner in crime? IJMS 22:8248. 10.3390/ijms22158248
</cite> [<a href="https://doi.org/10.3390/ijms22158248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8348949/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34361013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?V%C3%A1squez%20X,%20S%C3%A1nchez-G%C3%B3mez%20P,%20Palma%20V%20(2021)%20Netrin-1%20in%20glioblastoma%20neovascularization:%20the%20new%20partner%20in%20crime?%20IJMS%2022:8248.%2010.3390/ijms22158248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Wang B, Chen S, Zhao J-Q, Xiang B-L, Gu X, Zou F, Zhang Z-H (2019) ADAMTS-1 inhibits angiogenesis via the PI3K/Akt-eNOS-VEGF pathway in lung cancer cells. Transl Cancer Res 8:2725–2735. 10.21037/tcr.2019.10.34
</cite> [<a href="https://doi.org/10.21037/tcr.2019.10.34" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8798392/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35117030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20B,%20Chen%20S,%20Zhao%20J-Q,%20Xiang%20B-L,%20Gu%20X,%20Zou%20F,%20Zhang%20Z-H%20(2019)%20ADAMTS-1%20inhibits%20angiogenesis%20via%20the%20PI3K/Akt-eNOS-VEGF%20pathway%20in%20lung%20cancer%20cells.%20Transl%20Cancer%20Res%208:2725%E2%80%932735.%2010.21037/tcr.2019.10.34" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Wang F, Ding P, Liang X, Ding X, Brandt CB, Sjöstedt E, Zhu J, Bolund S, Zhang L, de Rooij LPMH, Luo L, Wei Y, Zhao W, Lv Z, Haskó J, Li R, Qin Q, Jia Y, Wu W, Yuan Y, Pu M, Wang H, Wu A, Xie L, Liu P, Chen F, Herold J, Kalucka J, Karlsson M, Zhang X, Helmig RB, Fagerberg L, Lindskog C, Pontén F, Uhlen M, Bolund L, Jessen N, Jiang H, Xu X, Yang H, Carmeliet P, Mulder J, Chen D, Lin L, Luo Y (2022) Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level. Nat Commun 13:3620. 10.1038/s41467-022-31388-z
</cite> [<a href="https://doi.org/10.1038/s41467-022-31388-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9232580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35750885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20F,%20Ding%20P,%20Liang%20X,%20Ding%20X,%20Brandt%20CB,%20Sj%C3%B6stedt%20E,%20Zhu%20J,%20Bolund%20S,%20Zhang%20L,%20de%20Rooij%20LPMH,%20Luo%20L,%20Wei%20Y,%20Zhao%20W,%20Lv%20Z,%20Hask%C3%B3%20J,%20Li%20R,%20Qin%20Q,%20Jia%20Y,%20Wu%20W,%20Yuan%20Y,%20Pu%20M,%20Wang%20H,%20Wu%20A,%20Xie%20L,%20Liu%20P,%20Chen%20F,%20Herold%20J,%20Kalucka%20J,%20Karlsson%20M,%20Zhang%20X,%20Helmig%20RB,%20Fagerberg%20L,%20Lindskog%20C,%20Pont%C3%A9n%20F,%20Uhlen%20M,%20Bolund%20L,%20Jessen%20N,%20Jiang%20H,%20Xu%20X,%20Yang%20H,%20Carmeliet%20P,%20Mulder%20J,%20Chen%20D,%20Lin%20L,%20Luo%20Y%20(2022)%20Endothelial%20cell%20heterogeneity%20and%20microglia%20regulons%20revealed%20by%20a%20pig%20cell%20landscape%20at%20single-cell%20level.%20Nat%20Commun%2013:3620.%2010.1038/s41467-022-31388-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Wang P, Wan W, Xiong S-L, Feng H, Wu N (2017) Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer. Cell Death Discov 3:1–10. 10.1038/cddiscovery.2016.105</cite> [<a href="https://doi.org/10.1038/cddiscovery.2016.105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5253691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28179999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20P,%20Wan%20W,%20Xiong%20S-L,%20Feng%20H,%20Wu%20N%20(2017)%20Cancer%20stem-like%20cells%20can%20be%20induced%20through%20dedifferentiation%20under%20hypoxic%20conditions%20in%20glioma,%20hepatoma%20and%20lung%20cancer.%20Cell%20Death%20Discov%203:1%E2%80%9310.%2010.1038/cddiscovery.2016.105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Wang Q, Wu H, Hu J, Fu H, Qu Y, Yang Y, Cai Q, Efimov A, Wu M, Yen T, Wang Y, Yang Z (2021) Nestin is required for spindle assembly and cell cycle progression in glioblastoma cells. Mol Cancer Res 19:1651–1665. 10.1158/1541-7786.MCR-20-0994
</cite> [<a href="https://doi.org/10.1158/1541-7786.MCR-20-0994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8492506/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34158391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Q,%20Wu%20H,%20Hu%20J,%20Fu%20H,%20Qu%20Y,%20Yang%20Y,%20Cai%20Q,%20Efimov%20A,%20Wu%20M,%20Yen%20T,%20Wang%20Y,%20Yang%20Z%20(2021)%20Nestin%20is%20required%20for%20spindle%20assembly%20and%20cell%20cycle%20progression%20in%20glioblastoma%20cells.%20Mol%20Cancer%20Res%2019:1651%E2%80%931665.%2010.1158/1541-7786.MCR-20-0994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468:829–833. 10.1038/nature09624
</cite> [<a href="https://doi.org/10.1038/nature09624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21102433/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20R,%20Chadalavada%20K,%20Wilshire%20J,%20Kowalik%20U,%20Hovinga%20KE,%20Geber%20A,%20Fligelman%20B,%20Leversha%20M,%20Brennan%20C,%20Tabar%20V%20(2010)%20Glioblastoma%20stem-like%20cells%20give%20rise%20to%20tumour%20endothelium.%20Nature%20468:829%E2%80%93833.%2010.1038/nature09624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Wang X, Bove AM, Simone G, Ma B (2020) Molecular bases of VEGFR-2-mediated physiological function and pathological role. Front Cell Dev Biol 8:599281. 10.3389/fcell.2020.599281
</cite> [<a href="https://doi.org/10.3389/fcell.2020.599281" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7701214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33304904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Bove%20AM,%20Simone%20G,%20Ma%20B%20(2020)%20Molecular%20bases%20of%20VEGFR-2-mediated%20physiological%20function%20and%20pathological%20role.%20Front%20Cell%20Dev%20Biol%208:599281.%2010.3389/fcell.2020.599281" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Wee B, Pietras A, Ozawa T, Bazzoli E, Podlaha O, Antczak C, Westermark B, Nelander S, Uhrbom L, Forsberg-Nilsson K, Djaballah H, Michor F, Holland EC (2016) ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells. Sci Rep 6:25956. 10.1038/srep25956
</cite> [<a href="https://doi.org/10.1038/srep25956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4960591/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27456282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wee%20B,%20Pietras%20A,%20Ozawa%20T,%20Bazzoli%20E,%20Podlaha%20O,%20Antczak%20C,%20Westermark%20B,%20Nelander%20S,%20Uhrbom%20L,%20Forsberg-Nilsson%20K,%20Djaballah%20H,%20Michor%20F,%20Holland%20EC%20(2016)%20ABCG2%20regulates%20self-renewal%20and%20stem%20cell%20marker%20expression%20but%20not%20tumorigenicity%20or%20radiation%20resistance%20of%20glioma%20cells.%20Sci%20Rep%206:25956.%2010.1038/srep25956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR142">
<span class="label">142.</span><cite>Wu H-B, Yang S, Weng H-Y, Chen Q, Zhao X-L, Fu W-J, Niu Q, Ping Y-F, Wang JM, Zhang X, Yao X-H, Bian X-W (2017) Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells. Autophagy 13:1528. 10.1080/15548627.2017.1336277
</cite> [<a href="https://doi.org/10.1080/15548627.2017.1336277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5612353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28812437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20H-B,%20Yang%20S,%20Weng%20H-Y,%20Chen%20Q,%20Zhao%20X-L,%20Fu%20W-J,%20Niu%20Q,%20Ping%20Y-F,%20Wang%20JM,%20Zhang%20X,%20Yao%20X-H,%20Bian%20X-W%20(2017)%20Autophagy-induced%20KDR/VEGFR-2%20activation%20promotes%20the%20formation%20of%20vasculogenic%20mimicry%20by%20glioma%20stem%20cells.%20Autophagy%2013:1528.%2010.1080/15548627.2017.1336277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR143">
<span class="label">143.</span><cite>Wu L, Katsube T, Li X, Wang B, Xie Y (2025) Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells. Front Public Health. 10.3389/fpubh.2025.1509675
</cite> [<a href="https://doi.org/10.3389/fpubh.2025.1509675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11839412/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39980929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20L,%20Katsube%20T,%20Li%20X,%20Wang%20B,%20Xie%20Y%20(2025)%20Unveiling%20the%20impact%20of%20CD133%20on%20cell%20cycle%20regulation%20in%20radio-%20and%20chemo-resistance%20of%20cancer%20stem%20cells.%20Front%20Public%20Health.%2010.3389/fpubh.2025.1509675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR144">
<span class="label">144.</span><cite>Wurmser AE, Nakashima K, Summers RG, Toni N, D’Amour KA, Lie DC, Gage FH (2004) Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 430:350–356. 10.1038/nature02604
</cite> [<a href="https://doi.org/10.1038/nature02604" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15254537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wurmser%20AE,%20Nakashima%20K,%20Summers%20RG,%20Toni%20N,%20D%E2%80%99Amour%20KA,%20Lie%20DC,%20Gage%20FH%20(2004)%20Cell%20fusion-independent%20differentiation%20of%20neural%20stem%20cells%20to%20the%20endothelial%20lineage.%20Nature%20430:350%E2%80%93356.%2010.1038/nature02604" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR145">
<span class="label">145.</span><cite>Xie Y, He L, Lugano R, Zhang Y, Cao H, He Q, Chao M, Liu B, Cao Q, Wang J, Jiao Y, Hu Y, Han L, Zhang Y, Huang H, Uhrbom L, Betsholtz C, Wang L, Dimberg A, Zhang L (2021) Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing. JCI Insight 6:e150861. 10.1172/jci.insight.150861
</cite> [<a href="https://doi.org/10.1172/jci.insight.150861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8410070/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34228647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xie%20Y,%20He%20L,%20Lugano%20R,%20Zhang%20Y,%20Cao%20H,%20He%20Q,%20Chao%20M,%20Liu%20B,%20Cao%20Q,%20Wang%20J,%20Jiao%20Y,%20Hu%20Y,%20Han%20L,%20Zhang%20Y,%20Huang%20H,%20Uhrbom%20L,%20Betsholtz%20C,%20Wang%20L,%20Dimberg%20A,%20Zhang%20L%20(2021)%20Key%20molecular%20alterations%20in%20endothelial%20cells%20in%20human%20glioblastoma%20uncovered%20through%20single-cell%20RNA%20sequencing.%20JCI%20Insight%206:e150861.%2010.1172/jci.insight.150861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR146">
<span class="label">146.</span><cite>Xie Y, Yang F, He L, Huang H, Chao M, Cao H, Hu Y, Fan Z, Zhai Y, Zhao W, Liu X, Zhao R, Xiao B, Shi X, Luo Y, Yin J, Feng D, Hugnot J-P, Muhl L, Dimberg A, Betsholtz C, Zhang Y, Wang L, Zhang L (2024) Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier. Neuron 112:3089-3105.e7. 10.1016/j.neuron.2024.07.026
</cite> [<a href="https://doi.org/10.1016/j.neuron.2024.07.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39191260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xie%20Y,%20Yang%20F,%20He%20L,%20Huang%20H,%20Chao%20M,%20Cao%20H,%20Hu%20Y,%20Fan%20Z,%20Zhai%20Y,%20Zhao%20W,%20Liu%20X,%20Zhao%20R,%20Xiao%20B,%20Shi%20X,%20Luo%20Y,%20Yin%20J,%20Feng%20D,%20Hugnot%20J-P,%20Muhl%20L,%20Dimberg%20A,%20Betsholtz%20C,%20Zhang%20Y,%20Wang%20L,%20Zhang%20L%20(2024)%20Single-cell%20dissection%20of%20the%20human%20blood-brain%20barrier%20and%20glioma%20blood-tumor%20barrier.%20Neuron%20112:3089-3105.e7.%2010.1016/j.neuron.2024.07.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR147">
<span class="label">147.</span><cite>Xu X, Li L, Luo L, Shu L, Si X, Chen Z, Xia W, Huang J, Liu Y, Shao A, Ke Y (2021) Opportunities and challenges of glioma organoids. Cell Commun Signal 19:102. 10.1186/s12964-021-00777-0
</cite> [<a href="https://doi.org/10.1186/s12964-021-00777-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8504127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34635112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20X,%20Li%20L,%20Luo%20L,%20Shu%20L,%20Si%20X,%20Chen%20Z,%20Xia%20W,%20Huang%20J,%20Liu%20Y,%20Shao%20A,%20Ke%20Y%20(2021)%20Opportunities%20and%20challenges%20of%20glioma%20organoids.%20Cell%20Commun%20Signal%2019:102.%2010.1186/s12964-021-00777-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR148">
<span class="label">148.</span><cite>Xu Y, Sun P, Wang J-Y, Li Z-Z, Gao R-L, Wang X-Z, Phillips WD, Liang SX (2019) Differentiation of CD45-/CD31+ lung side population cells into endothelial and smooth muscle cells in vitro. Int J Mol Med 43:1128–1138. 10.3892/ijmm.2019.4053
</cite> [<a href="https://doi.org/10.3892/ijmm.2019.4053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6365051/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30628669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20Y,%20Sun%20P,%20Wang%20J-Y,%20Li%20Z-Z,%20Gao%20R-L,%20Wang%20X-Z,%20Phillips%20WD,%20Liang%20SX%20(2019)%20Differentiation%20of%20CD45-/CD31+%20lung%20side%20population%20cells%20into%20endothelial%20and%20smooth%20muscle%20cells%20in%20vitro.%20Int%20J%20Mol%20Med%2043:1128%E2%80%931138.%2010.3892/ijmm.2019.4053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR149">
<span class="label">149.</span><cite>Xu Z, Yu Y, Duh EJ (2006) Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling. Invest Ophthalmol Vis Sci 47:4059–4066. 10.1167/iovs.05-1528
</cite> [<a href="https://doi.org/10.1167/iovs.05-1528" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16936124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20Z,%20Yu%20Y,%20Duh%20EJ%20(2006)%20Vascular%20endothelial%20growth%20factor%20upregulates%20expression%20of%20ADAMTS1%20in%20endothelial%20cells%20through%20protein%20kinase%20C%20signaling.%20Invest%20Ophthalmol%20Vis%20Sci%2047:4059%E2%80%934066.%2010.1167/iovs.05-1528" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR150">
<span class="label">150.</span><cite>Yan H, Romero-López M, Benitez LI, Di K, Frieboes HB, Hughes CCW, Bota DA, Lowengrub JS (2017) 3D mathematical modeling of glioblastoma suggests that transdifferentiated vascular endothelial cells mediate resistance to current standard-of-care therapy. Cancer Res 77:4171–4184. 10.1158/0008-5472.CAN-16-3094
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-16-3094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5540807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28536277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yan%20H,%20Romero-L%C3%B3pez%20M,%20Benitez%20LI,%20Di%20K,%20Frieboes%20HB,%20Hughes%20CCW,%20Bota%20DA,%20Lowengrub%20JS%20(2017)%203D%20mathematical%20modeling%20of%20glioblastoma%20suggests%20that%20transdifferentiated%20vascular%20endothelial%20cells%20mediate%20resistance%20to%20current%20standard-of-care%20therapy.%20Cancer%20Res%2077:4171%E2%80%934184.%2010.1158/0008-5472.CAN-16-3094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR151">
<span class="label">151.</span><cite>Yao K, Yang M, Shu M, Wang T, Gao D, Zhou L, Wang G, Zhang Z, Tang J (2024) SOX4 promotes vascular abnormality in glioblastoma and is a novel target to improve drug delivery. Transl Oncol 50:102120. 10.1016/j.tranon.2024.102120
</cite> [<a href="https://doi.org/10.1016/j.tranon.2024.102120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11421337/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39288695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yao%20K,%20Yang%20M,%20Shu%20M,%20Wang%20T,%20Gao%20D,%20Zhou%20L,%20Wang%20G,%20Zhang%20Z,%20Tang%20J%20(2024)%20SOX4%20promotes%20vascular%20abnormality%20in%20glioblastoma%20and%20is%20a%20novel%20target%20to%20improve%20drug%20delivery.%20Transl%20Oncol%2050:102120.%2010.1016/j.tranon.2024.102120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR152">
<span class="label">152.</span><cite>Yao X, Ping Y, Liu Y, Chen K, Yoshimura T, Liu M, Gong W, Chen C, Niu Q, Guo D, Zhang X, Wang JM, Bian X (2013) Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by glioma stem-like cells. PLoS ONE 8:e57188. 10.1371/journal.pone.0057188
</cite> [<a href="https://doi.org/10.1371/journal.pone.0057188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3594239/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23536763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yao%20X,%20Ping%20Y,%20Liu%20Y,%20Chen%20K,%20Yoshimura%20T,%20Liu%20M,%20Gong%20W,%20Chen%20C,%20Niu%20Q,%20Guo%20D,%20Zhang%20X,%20Wang%20JM,%20Bian%20X%20(2013)%20Vascular%20endothelial%20growth%20factor%20receptor%202%20(VEGFR-2)%20plays%20a%20key%20role%20in%20vasculogenic%20mimicry%20formation,%20neovascularization%20and%20tumor%20initiation%20by%20glioma%20stem-like%20cells.%20PLoS%20ONE%208:e57188.%2010.1371/journal.pone.0057188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR153">
<span class="label">153.</span><cite>Yin Z, Wang L (2023) Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy. Ann Med 55:1058–1069. 10.1080/07853890.2023.2180155
</cite> [<a href="https://doi.org/10.1080/07853890.2023.2180155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10795639/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36908260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20Z,%20Wang%20L%20(2023)%20Endothelial-to-mesenchymal%20transition%20in%20tumour%20progression%20and%20its%20potential%20roles%20in%20tumour%20therapy.%20Ann%20Med%2055:1058%E2%80%931069.%2010.1080/07853890.2023.2180155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR154">
<span class="label">154.</span><cite>Zhao C, Gomez GA, Zhao Y, Yang Y, Cao D, Lu J, Yang H, Lin S (2018) ETV2 mediates endothelial transdifferentiation of glioblastoma. Signal Transduct Target Ther 3:4. 10.1038/s41392-018-0007-8
</cite> [<a href="https://doi.org/10.1038/s41392-018-0007-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5837107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29527330/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20C,%20Gomez%20GA,%20Zhao%20Y,%20Yang%20Y,%20Cao%20D,%20Lu%20J,%20Yang%20H,%20Lin%20S%20(2018)%20ETV2%20mediates%20endothelial%20transdifferentiation%20of%20glioblastoma.%20Signal%20Transduct%20Target%20Ther%203:4.%2010.1038/s41392-018-0007-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR155">
<span class="label">155.</span><cite>Zhao H, Yu H, Wang Y, Liu Y (2008) Human glioma cancer stem cells promote tumor invasion through gelatinases- MMP-2 and MMP-9. Can Res 68:1143</cite> [<a href="https://scholar.google.com/scholar_lookup?Zhao%20H,%20Yu%20H,%20Wang%20Y,%20Liu%20Y%20(2008)%20Human%20glioma%20cancer%20stem%20cells%20promote%20tumor%20invasion%20through%20gelatinases-%20MMP-2%20and%20MMP-9.%20Can%20Res%2068:1143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR156">
<span class="label">156.</span><cite>Zhao Y, Dong J, Huang Q, Lou M, Wang A, Lan Q (2010) Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro. Brain Res Bull 82:308–312. 10.1016/j.brainresbull.2010.06.006
</cite> [<a href="https://doi.org/10.1016/j.brainresbull.2010.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20599593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20Y,%20Dong%20J,%20Huang%20Q,%20Lou%20M,%20Wang%20A,%20Lan%20Q%20(2010)%20Endothelial%20cell%20transdifferentiation%20of%20human%20glioma%20stem%20progenitor%20cells%20in%20vitro.%20Brain%20Res%20Bull%2082:308%E2%80%93312.%2010.1016/j.brainresbull.2010.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR157">
<span class="label">157.</span><cite>Zheng P-P, van der Weiden M, van der Spek PJ, Vincent AJPE, Kros JM (2013) Intratumoral, not circulating, endothelial progenitor cells share genetic aberrations with glial tumor cells. J Cell Physiol 228:1383–1390. 10.1002/jcp.24309
</cite> [<a href="https://doi.org/10.1002/jcp.24309" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23254765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20P-P,%20van%20der%20Weiden%20M,%20van%20der%20Spek%20PJ,%20Vincent%20AJPE,%20Kros%20JM%20(2013)%20Intratumoral,%20not%20circulating,%20endothelial%20progenitor%20cells%20share%20genetic%20aberrations%20with%20glial%20tumor%20cells.%20J%20Cell%20Physiol%20228:1383%E2%80%931390.%2010.1002/jcp.24309" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR158">
<span class="label">158.</span><cite>Zheng Z-Q, Chen J-T, Zheng M-C, Yang L-J, Wang J-M, Liu Q-L, Chen L-F, Ye Z-C, Lin J-M, Lin Z-X (2021) Nestin+/CD31+ cells in the hypoxic perivascular niche regulate glioblastoma chemoresistance by upregulating JAG1 and DLL4. Neuro Oncol 23:905–919. 10.1093/neuonc/noaa265
</cite> [<a href="https://doi.org/10.1093/neuonc/noaa265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8168822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33249476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20Z-Q,%20Chen%20J-T,%20Zheng%20M-C,%20Yang%20L-J,%20Wang%20J-M,%20Liu%20Q-L,%20Chen%20L-F,%20Ye%20Z-C,%20Lin%20J-M,%20Lin%20Z-X%20(2021)%20Nestin+/CD31+%20cells%20in%20the%20hypoxic%20perivascular%20niche%20regulate%20glioblastoma%20chemoresistance%20by%20upregulating%20JAG1%20and%20DLL4.%20Neuro%20Oncol%2023:905%E2%80%93919.%2010.1093/neuonc/noaa265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR159">
<span class="label">159.</span><cite>Zhou Y, Jin G, Mi R, Zhang J, Zhang J, Xu H, Cheng S, Zhang Y, Song W, Liu F (2017) Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane. Oncotarget 8:35877–35889. 10.18632/oncotarget.16270
</cite> [<a href="https://doi.org/10.18632/oncotarget.16270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5482624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28415787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20Y,%20Jin%20G,%20Mi%20R,%20Zhang%20J,%20Zhang%20J,%20Xu%20H,%20Cheng%20S,%20Zhang%20Y,%20Song%20W,%20Liu%20F%20(2017)%20Knockdown%20of%20P4HA1%20inhibits%20neovascularization%20via%20targeting%20glioma%20stem%20cell-endothelial%20cell%20transdifferentiation%20and%20disrupting%20vascular%20basement%20membrane.%20Oncotarget%208:35877%E2%80%9335889.%2010.18632/oncotarget.16270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR160">
<span class="label">160.</span><cite>Zhu J-X, Cao G, Williams JT, DeLisser HM (2010) SHP-2 phosphatase activity is required for PECAM-1-dependent cell motility. Am J Physiol Cell Physiol 299:C854–C865. 10.1152/ajpcell.00436.2009
</cite> [<a href="https://doi.org/10.1152/ajpcell.00436.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2957272/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20631249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20J-X,%20Cao%20G,%20Williams%20JT,%20DeLisser%20HM%20(2010)%20SHP-2%20phosphatase%20activity%20is%20required%20for%20PECAM-1-dependent%20cell%20motility.%20Am%20J%20Physiol%20Cell%20Physiol%20299:C854%E2%80%93C865.%2010.1152/ajpcell.00436.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR161">
<span class="label">161.</span><cite>Zhu X, Liu S, Yang X, Wang W, Shao W, Ji T (2021) P4HA1 as an unfavorable prognostic marker promotes cell migration and invasion of glioblastoma via inducing EMT process under hypoxia microenvironment. Am J Cancer Res 11:590–617
</cite> [<a href="/articles/PMC7868758/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33575089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20X,%20Liu%20S,%20Yang%20X,%20Wang%20W,%20Shao%20W,%20Ji%20T%20(2021)%20P4HA1%20as%20an%20unfavorable%20prognostic%20marker%20promotes%20cell%20migration%20and%20invasion%20of%20glioblastoma%20via%20inducing%20EMT%20process%20under%20hypoxia%20microenvironment.%20Am%20J%20Cancer%20Res%2011:590%E2%80%93617" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Not applicable.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Acta Neuropathologica Communications are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s40478-025-02031-x"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/40478_2025_Article_2031.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372203/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372203/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372203%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372203/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372203/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372203/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841988/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372203/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841988/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372203/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372203/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="hzcy50vTGq7nSoldYQSY3Z9CLd0qehYOLapMxJQHi5OMyUuAUwdZlUDfsouEEuJA">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
